"ConceptCode","Target_IDX","PreferredName","AnnotationDate","ActiveConcept_Flag","Skip_Flag","Bypass_Flag","LAM_Flag","HGNC_Symbol","GeneVariant"
"C100089",1,"Interferon Gamma-1b",3/7/2019 0:00:00,-1,0,0,0,,
"C1001",1,"Rintatolimod",11/28/2018 0:00:00,-1,0,0,0,,
"C1005",1,"Arsenic Trioxide",11/2/2018 0:00:00,-1,0,0,0,"PML","wildtype"
"C1005",2,"Arsenic Trioxide",11/2/2018 0:00:00,-1,0,0,0,"RARa","wildtype"
"C1006",1,"Ossirene",10/11/2018 0:00:00,-1,0,0,0,,
"C101132",1,"ME-344",10/11/2018 0:00:00,-1,0,0,0,"MTOR","wildtype"
"C101227",1,"PU-H71",12/18/2018 0:00:00,-1,0,0,0,"HSP90",
"C101258",1,"CD19CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocyte Cells",10/31/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C101366",1,"Chi Lob 7/4",10/30/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C101368",1,"AZD9150",11/8/2018 0:00:00,0,0,0,0,"STAT3","wildtype"
"C101368",2,"Danvatirsen",4/10/2018 0:00:00,-1,0,0,0,"STAT3",
"C1014",1,"Verteporfin",9/26/2018 0:00:00,-1,0,0,0,,
"C101513",1,"Transarterial Chemoembolization",4/11/2019 0:00:00,-1,0,0,0,,
"C101519",1,"JNJ-40346527",11/8/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C101520",1,"AKN-028",10/11/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C101520",2,"AKN-028",10/11/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C101523",1,"TH-4000",9/26/2018 0:00:00,-1,0,0,0,"EGFR",
"C101523",2,"TH-4000",9/26/2018 0:00:00,-1,0,0,0,"ERBB2",
"C101523",3,"TH-4000",9/26/2018 0:00:00,-1,0,0,0,"ERBB3",
"C101523",4,"TH-4000",9/26/2018 0:00:00,-1,0,0,0,"ERBB4",
"C101532",1,"WX-554",10/11/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C101532",2,"WX-554",10/11/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C101538",1,"Molibresib",12/18/2018 0:00:00,-1,0,0,0,"BET",
"C101786",1,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"AKT1",
"C101786",2,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"AKT2",
"C101786",3,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"AKT3",
"C101786",4,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"RPS6KB1",
"C101786",5,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"PKA",
"C101786",6,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"ROCK1",
"C101786",7,"AT13148",9/26/2018 0:00:00,-1,0,0,0,"ROCK2",
"C101787",1,"TIL 1383I T Cell Receptor-Transduced Autologous T Cells",11/2/2018 0:00:00,-1,0,0,0,,
"C101790",1,"Alectinib",11/8/2018 0:00:00,-1,0,0,0,"ALK","ALK, ALK F1174L, ALK R1275Q, ALK L1196M"
"C101790",2,"Alectinib",11/8/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C101791",1,"Olmutinib",9/26/2018 0:00:00,-1,0,0,0,"EGFR",
"C101890",1,"Epidermal Growth Factor Ointment",10/11/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C101895",1,"Elgemtumab",9/26/2018 0:00:00,-1,0,0,0,"ERBB3",
"C102535",1,"AV-203",10/11/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C102535",2,"AV-203",10/11/2018 0:00:00,-1,0,0,0,"NRG1","wildtype"
"C102546",1,"Selinexor",11/8/2018 0:00:00,-1,0,0,0,"XPO1","wildtype"
"C102554",1,"TAS-102",11/8/2018 0:00:00,-1,0,0,0,,
"C102564",1,"AZD5363",11/8/2018 0:00:00,-1,0,-1,0,"AKT","wildtype"
"C102564",2,"Capivasertib",11/8/2018 0:00:00,-1,0,0,0,"AKT","wildtype"
"C102566",1,"Mirvetuximab Soravtansine",11/8/2018 0:00:00,-1,0,0,0,"FOLR1","wildtype"
"C102569",1,"sEphB4-HSA",11/8/2018 0:00:00,-1,0,0,0,"EFNB2","wildtype"
"C102571",1,"Epoetin Zeta",9/27/2018 0:00:00,-1,-1,0,0,"EPO",
"C1027",1,"Budesonide",11/8/2018 0:00:00,-1,0,0,0,,
"C102746",1,"E7449",9/27/2018 0:00:00,-1,0,0,0,"PARP1",
"C102746",2,"E7449",9/27/2018 0:00:00,-1,0,0,0,"PARP2",
"C102751",1,"WT2725",10/11/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C102754",1,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C102754",2,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C102754",3,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C102754",4,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"AXL","wildtype"
"C102754",5,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"EPHA2","wildtype"
"C102754",6,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"LTK","wildtype"
"C102754",7,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"ROS1","wildtype"
"C102754",8,"Ensartinib",11/8/2018 0:00:00,-1,0,0,0,"SLK","wildtype"
"C102758",1,"CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes",11/2/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C102783",1,"Sacituzumab Govitecan",2/28/2019 0:00:00,-1,0,0,0,"TROP2",
"C102789",1,"Inducible CD4+CD25+ Regulatory T Cells",10/15/2018 0:00:00,-1,0,0,0,,
"C102849",1,"CIGB-300",10/15/2018 0:00:00,-1,0,0,0,"CSNK2A1","wildtype"
"C102849",2,"CIGB-300",10/15/2018 0:00:00,-1,0,0,0,"CSNK2A2","wildtype"
"C102849",3,"CIGB-300",10/15/2018 0:00:00,-1,0,0,0,"CSNK2B","wildtype"
"C102852",1,"Fruquintinib",3/5/2019 0:00:00,-1,0,0,0,"EGFR",
"C102853",1,"IMC-TR1",9/12/2017 0:00:00,-1,0,0,0,"TGFB2",
"C102876",1,"Tirabrutinib",10/15/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C102877",1,"Tanibirumab",9/27/2018 0:00:00,-1,0,0,0,"KDR",
"C102881",1,"Thioureidobutyronitrile",9/27/2018 0:00:00,-1,0,0,0,"TP53",
"C102910",1,"RP1",2/15/2019 0:00:00,-1,0,0,0,,
"C102978",1,"Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells",11/2/2018 0:00:00,-1,0,0,0,,
"C103147",1,"Venetoclax",11/8/2018 0:00:00,-1,0,0,0,"BCL2","wildtype"
"C103192",1,"Plasmacytoid Dendritic Cell Vaccine",11/2/2018 0:00:00,-1,0,0,0,,
"C103194",1,"Durvalumab",11/8/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C103273",1,"Erdafitinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C103273",2,"Erdafitinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR2","wildtype"
"C103273",3,"Erdafitinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C103273",4,"Erdafitinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype"
"C103274",1,"Brontictuzumab",9/27/2018 0:00:00,-1,0,0,0,"NOTCH1",
"C103277",1,"Acalisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C103820",1,"Lirilumab",11/8/2018 0:00:00,-1,0,0,0,"KIR","wildtype"
"C103823",1,"PVX-410",11/8/2018 0:00:00,-1,0,0,0,"SDC1","wildtype"
"C103823",2,"PVX-410",11/8/2018 0:00:00,-1,0,0,0,"XBP1","wildtype"
"C103823",3,"PVX-410",11/8/2018 0:00:00,-1,0,0,0,"SLAMF7","wildtype"
"C103826",1,"Taladegib",9/27/2018 0:00:00,-1,0,0,0,"SMO",
"C103827",1,"MT112",10/15/2018 0:00:00,-1,0,0,0,"CD3E",
"C103857",1,"PAT-SM6",10/16/2018 0:00:00,-1,0,0,0,"HSPA5","wildtype"
"C103859",1,"Vofatamab",2/8/2019 0:00:00,-1,0,0,0,"FGFR3",
"C103861",1,"BAY1082439",9/27/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C103861",2,"BAY1082439",9/27/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C103863",1,"Istiratumab",10/16/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C103863",2,"Istiratumab",10/16/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C104006",1,"Anti-CD20-CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocyte Cells",10/31/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C104008",1,"Fimepinostat",11/8/2018 0:00:00,-1,0,0,0,"PIK3CA","wildtype"
"C104008",2,"Fimepinostat",11/8/2018 0:00:00,-1,0,0,0,"PIK3CB","wildtype"
"C104008",3,"Fimepinostat",11/8/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C104008",4,"Fimepinostat",11/8/2018 0:00:00,-1,0,0,0,"PIK3CG","wildtype"
"C104008",6,"Fimepinostat",11/8/2018 0:00:00,-1,0,0,0,"HDAC","wildtype"
"C104009",1,"MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells",11/8/2018 0:00:00,-1,0,0,0,,
"C104012",1,"Luspatercept",9/12/2017 0:00:00,-1,0,0,0,"TGFB1",
"C104012",2,"Luspatercept",9/12/2017 0:00:00,-1,0,0,0,"TGFB2",
"C104045",1,"MK-8353",11/8/2018 0:00:00,-1,0,0,0,"MAPK1","wildtype"
"C104045",2,"MK-8353",11/8/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C104055",1,"Telapristone Acetate",10/16/2018 0:00:00,-1,0,0,0,"PR","wildtype"
"C104057",1,"Telapristone",10/16/2018 0:00:00,-1,0,0,0,"PR","wildtype"
"C104058",1,"RO5479599",10/16/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C104260",1,"Imalumab",9/12/2017 0:00:00,-1,0,0,0,"MIF",
"C104267",1,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype, FGFR Fusions"
"C104267",2,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR2","wildtype, FGFR Fusions"
"C104267",3,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype, FGFR Fusions"
"C104267",4,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype, FGFR Fusions"
"C104267",5,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C104267",6,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C104267",7,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"ABL2","wildtype"
"C104267",8,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"LCK","wildtype"
"C104267",9,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C104267",10,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"DDR2","wildtype"
"C104267",11,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C104267",12,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C104267",13,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C104267",14,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C104267",15,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C104267",16,"Derazantinib",11/8/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C104280",1,"CGM097",9/27/2018 0:00:00,-1,0,0,0,"MDM2",
"C104413",1,"Umbralisib",10/16/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C104732",1,"Volitinib",11/8/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C104734",1,"WT1 235-243 Peptide Vaccine",10/16/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C104737",1,"WT1 247-261 Peptide Vaccine",10/16/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C104738",1,"WT1 124-138 Peptide Vaccine",10/16/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C104744",1,"Ulixertinib",11/8/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C104744",2,"Ulixertinib",11/8/2018 0:00:00,-1,0,0,0,"MAPK1","wildtype"
"C104745",1,"BBI503",11/8/2018 0:00:00,-1,0,0,0,"NANOG","wildtype"
"C104748",1,"Darolutamide",10/16/2018 0:00:00,-1,-1,0,0,"AR","wildtype"
"C105612",1,"Depatuxizumab",11/8/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C105614",1,"Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T Cells",11/2/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C105615",1,"Alectinib",10/16/2018 0:00:00,-1,0,0,0,"ALK","wildtype, ALK fusions, and ALK L1196M"
"C105615",2,"Alectinib",10/16/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C105802",1,"MRX34",10/16/2018 0:00:00,-1,0,0,0,"MYC","wildtype"
"C105802",2,"MRX34",10/16/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C105802",3,"MRX34",10/16/2018 0:00:00,-1,0,0,0,"BCL2","wildtype"
"C105802",4,"MRX34",10/16/2018 0:00:00,-1,0,0,0,"CCND1","wildtype"
"C105802",5,"MRX34",10/16/2018 0:00:00,-1,0,0,0,"CTNNB1","wildtype"
"C105803",1,"Andecaliximab",8/3/2017 0:00:00,-1,0,0,0,"MMP9",
"C105804",1,"PLX7486 Tosylate",10/30/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C105804",2,"PLX7486 Tosylate",10/30/2018 0:00:00,-1,-1,0,0,"NTRK1","wildtype"
"C105804",3,"PLX7486 Tosylate",10/30/2018 0:00:00,-1,0,0,0,"NTRK2","wildtype"
"C105804",4,"PLX7486 Tosylate",10/30/2018 0:00:00,-1,0,0,0,"NTRK3","wildtype"
"C105851",1,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"CDK1",
"C105851",2,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"CDK2",
"C105851",3,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"CDK7",
"C105851",4,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"CDK9",
"C105851",5,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"JAK2",
"C105851",6,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"FLT3",
"C105851",7,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"FLK2",
"C105851",8,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"STK1",
"C105851",9,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"TYK2",
"C105851",10,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"TYRO3",
"C105851",11,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"STAT5",
"C105851",12,"TG02 Citrate",9/27/2018 0:00:00,-1,0,0,0,"MAPK13",
"C105853",1,"Ralimetinib Mesylate",5/19/2017 0:00:00,-1,-1,0,0,"MAPK1",
"C105853",2,"Ralimetinib Mesylate",5/19/2017 0:00:00,-1,-1,0,0,"MAPK14",
"C1059",1,"Cyproterone Acetate",10/16/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C106116",1,"ARGX-110",10/30/2018 0:00:00,-1,0,0,0,"CD70","wildtype"
"C106117",1,"T1E28z CAR-expressing Autologous CD4-positive T Lymphocytes",11/2/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C106118",1,"Xentuzumab",2/21/2019 0:00:00,-1,0,0,0,"IGF1R",
"C106120",1,"MI-773",9/27/2018 0:00:00,-1,0,0,0,"MDM2",
"C106123",1,"iC9-GD2-CD28-OX40-expressing T Lymphocytes",11/2/2018 0:00:00,-1,0,0,0,,
"C106126",1,"BI-847325",10/16/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C106126",2,"BI-847325",10/16/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C106126",3,"BI-847325",10/16/2018 0:00:00,-1,0,0,0,"AURKA","wildtype"
"C106126",4,"BI-847325",10/16/2018 0:00:00,-1,0,0,0,"AURKB","wildtype"
"C106126",5,"BI-847325",10/16/2018 0:00:00,-1,0,0,0,"AURKC","wildtype"
"C106230",1,"cMet CAR-mRNA Electroporated Autologous T Lymphocytes",11/2/2018 0:00:00,-1,0,0,0,,
"C106242",1,"Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201",,-1,0,0,0,,
"C106250",1,"Atezolizumab",11/8/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C106253",1,"LY2510924",6/20/2017 0:00:00,-1,0,0,0,"CXCR4",
"C106254",1,"TAK-580",11/8/2018 0:00:00,-1,0,0,0,"ARAF","wildtype"
"C106254",2,"TAK-580",11/8/2018 0:00:00,-1,0,0,0,"BRAF","wildtype"
"C106254",3,"TAK-580",11/8/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C106257",1,"OCV-501",10/16/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C106261",1,"GSK2636771",11/8/2018 0:00:00,-1,0,0,0,"PIK3CB","wildtype"
"C106262",1,"ABT-700",9/27/2018 0:00:00,-1,0,0,0,"MET",
"C106266",1,"AMG 172",10/30/2018 0:00:00,-1,0,0,0,"CD70","wildtype"
"C106267",1,"Brachyury-expressing Yeast Vaccine GI-6301",,-1,0,0,0,,
"C106368",1,"S1P Receptor Agonist KRP203",,-1,0,0,0,,
"C106429",1,"PBTL CD19CAR-28/CD137/zeta",,-1,0,0,0,,
"C106430",1,"LB-100",9/27/2018 0:00:00,-1,0,0,0,"PTPA",
"C106432",1,"Pembrolizumab",11/8/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C107169",1,"Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine",,-1,0,0,0,,
"C107190",1,"CD33CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes",,-1,0,0,0,,
"C107191",1,"EGFR CAR-CD3zeta-4-1BB-expressing Autologous T-Lymphocytes",,-1,0,0,0,,
"C107238",1,"VS-4718",10/16/2018 0:00:00,-1,0,0,0,"PTK2","wildtype"
"C107241",1,"GDC-0994",10/16/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C107241",2,"GDC-0994",10/16/2018 0:00:00,-1,0,-1,0,"MAPK1","wildtype"
"C107242",1,"CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes",,-1,0,0,0,,
"C107245",1,"Agerafenib",9/28/2018 0:00:00,-1,0,0,0,"BRAF",
"C107384",1,"Milademetan Tosylate",10/16/2018 0:00:00,-1,0,0,0,"MDM2","wildtype"
"C107503",1,"ALT-803",6/20/2017 0:00:00,-1,0,0,0,"NK cells",
"C107503",2,"ALT-803",6/20/2017 0:00:00,-1,0,0,0,"IL15",
"C107503",3,"ALT-803",4/20/2018 0:00:00,-1,0,0,0,"CD8",
"C107505",1,"CD138CAR-CD137/TCRzeta-expressing T Lymphocytes",,-1,0,0,0,,
"C107506",1,"Tazemetostat",11/20/2017 0:00:00,-1,0,0,0,"EZH2",
"C107678",1,"Rovalpituzumab Tesirine",9/14/2017 0:00:00,-1,0,0,0,"DLL3",
"C107683",1,"BAY1179470",10/16/2018 0:00:00,-1,0,0,0,"FGFR2","wildtype"
"C107684",1,"AZD8186",5/8/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C107686",1,"Dezapelisib",10/16/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C108174",1,"Imgatuzumab",9/28/2018 0:00:00,-1,0,0,0,"EGFR",
"C1083",1,"Staphylococcal Enterotoxin A",,-1,0,0,0,,
"C1084",1,"Staphylococcal Enterotoxin B",,-1,0,0,0,,
"C1093",1,"Etoposide Phosphate",2/21/2019 0:00:00,-1,0,0,0,,
"C1094",1,"Fludarabine",3/1/2018 0:00:00,-1,0,0,0,,
"C109599",1,"NC043",9/28/2018 0:00:00,-1,0,0,0,"CARF",
"C1097",1,"Exemestane",3/1/2018 0:00:00,-1,0,0,0,"aromatase",
"C1098",1,"Fenretinide",9/28/2018 0:00:00,-1,0,0,0,"RARA",
"C1102",1,"Fludarabine Phosphate",3/1/2018 0:00:00,-1,0,0,0,,
"C111037",1,"ISA101",6/20/2017 0:00:00,-1,0,0,0,"N/A",
"C111038",1,"Anti-VEGFR2-CAR Retroviral Vector-transduced Autologous T-lymphocytes",,-1,0,0,0,,
"C111041",1,"Anti-CD19-CAR FMC63-28Z Retroviral Vector-transduced Allogeneic T-lymphocytes",,-1,0,0,0,,
"C111042",1,"WP1066",10/16/2018 0:00:00,-1,0,0,0,"JAK2","wildtype, JAK V617F"
"C111042",2,"WP1066",10/16/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C111565",1,"Anti-EGFRvIII CAR-transduced Allogeneic T-lymphocytes",,-1,0,0,0,,
"C111573",1,"Enasidenib",10/16/2018 0:00:00,-1,0,0,0,"IDH2","DH2 R140Q, R172S, and R172K"
"C111574",1,"CV9202",3/1/2018 0:00:00,-1,0,0,0,,
"C111575",1,"BAY1125976",9/28/2018 0:00:00,-1,0,0,0,"AKT1",
"C111575",2,"BAY1125976",9/28/2018 0:00:00,-1,0,0,0,"AKT2",
"C111684",1,"Imisopasem Manganese",3/4/2019 0:00:00,-1,0,0,0,,
"C111685",1,"CEP-37440",10/16/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C111685",2,"CEP-37440",10/16/2018 0:00:00,-1,0,0,0,"PTK2","wildtype"
"C111689",1,"HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001",10/16/2018 0:00:00,-1,0,0,0,"TERT","TERT 572Y (YLFFYRKSV; TYR-Vx001) and TERT 572 (RLFFYRKSV; ARG-Vx001)"
"C111759",1,"Activated Marrow Infiltrating Lymphocytes",,-1,0,0,0,,
"C111764",1,"Selatinib Ditosilate",10/16/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C111764",2,"Selatinib Ditosilate",10/16/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C111894",1,"Donor Regulatory T-lymphocytes",,-1,0,0,0,,
"C111895",1,"Pyrotinib",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C111895",2,"Pyrotinib",9/14/2018 0:00:00,-1,0,0,0,"ERBB2",
"C111898",1,"Bimiralisib",3/4/2019 0:00:00,-1,0,0,0,"PIK3CA",
"C111898",2,"Bimiralisib",3/4/2019 0:00:00,-1,0,0,0,"mTOR",
"C1119",1,"Ondansetron",3/6/2019 0:00:00,-1,0,0,0,,
"C111906",1,"IMGN289",10/16/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C11197",1,"FOLFOX",10/1/2018 0:00:00,-1,0,0,0,,
"C111988",1,"Debio 1347",9/11/2018 0:00:00,-1,0,0,0,"FGFR1",
"C111988",2,"Debio 1347",9/11/2018 0:00:00,-1,0,0,0,"FGFR2",
"C111988",3,"Debio 1347",9/11/2018 0:00:00,-1,0,0,0,"FGFR3",
"C111990",1,"CFI-400945",9/28/2018 0:00:00,-1,0,0,0,"PLK4",
"C111993",1,"AZD6738",9/28/2018 0:00:00,-1,0,0,0,"ATR",
"C111997",1,"GSK2849330",10/16/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C111999",1,"Relatlimab",10/25/2017 0:00:00,-1,0,0,0,"LAG3",
"C112000",1,"Oraxol",2/11/2019 0:00:00,-1,0,0,0,,
"C112001",1,"SGN-LIV1A",3/12/2018 0:00:00,-1,0,0,0,"SLC39A6",
"C112004",1,"MSC2363318A",9/28/2018 0:00:00,-1,0,0,0,"RPS6KB1",
"C112004",2,"MSC2363318A",9/28/2018 0:00:00,-1,0,0,0,"AKT1",
"C112179",1,"Anti-CD19-CAR-CD3zeta-4-1BB-Expressing Allogenic Natural Killer Cells",,-1,0,0,0,,
"C112205",1,"Rogaratinib",7/16/2018 0:00:00,-1,0,0,0,"FGFR1",
"C112205",2,"Rogaratinib",7/16/2018 0:00:00,-1,0,0,0,"FGFR2",
"C112205",3,"Rogaratinib",7/16/2018 0:00:00,-1,0,0,0,"FGFR3",
"C112205",4,"Rogaratinib",7/16/2018 0:00:00,-1,0,0,0,"FGFR4",
"C112207",1,"Bivalent HPV16/18 Therapeutic Cervical Cancer Vaccine",,-1,0,0,0,,
"C112497",1,"VS-5584",9/28/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C112497",2,"VS-5584",9/28/2018 0:00:00,-1,0,-1,0,"PIK3CB",
"C112497",3,"VS-5584",9/28/2018 0:00:00,-1,0,0,0,"MTOR",
"C112497",4,"VS-5584",9/28/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C112497",5,"VS-5584",9/28/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C112498",1,"Extended Release Flucytosine",10/16/2018 0:00:00,-1,0,0,0,,
"C112500",1,"RO6870810",11/21/2017 0:00:00,-1,0,0,0,"BET",
"C1128",1,"Leflunomide",4/24/2019 0:00:00,-1,0,0,0,,
"C112882",1,"Anti-CD2 Monoclonal Antibody",,-1,0,0,0,,
"C112884",1,"Anti-CD4 Monoclonal Antibody",,-1,0,0,0,,
"C112888",1,"Anti-CD8 Monoclonal Antibody",,-1,0,0,0,,
"C113162",1,"TAK-659",6/22/2017 0:00:00,-1,0,0,0,"SYK",
"C113164",1,"Tisotumab Vedotin",1/22/2019 0:00:00,-1,0,0,0,,
"C113173",1,"Cerdulatinib",10/16/2018 0:00:00,-1,0,0,0,"SYK","wildtype"
"C113173",2,"Cerdulatinib",10/16/2018 0:00:00,-1,0,0,0,"JAK1","wildtype"
"C113173",3,"Cerdulatinib",10/16/2018 0:00:00,-1,0,0,0,"JAK3","wildtype"
"C1132",1,"IMREG-1",,-1,0,0,0,,
"C113295",1,"AM0010",3/13/2018 0:00:00,-1,0,0,0,"IL2",
"C113295",2,"AM0010",3/13/2018 0:00:00,-1,0,0,0,"IL3",
"C113295",3,"AM0010",3/13/2018 0:00:00,-1,0,0,0,"TNF",
"C113295",4,"AM0010",3/13/2018 0:00:00,-1,0,0,0,"GM-CSF",
"C113295",5,"AM0010",4/20/2018 0:00:00,-1,0,0,0,"CD8",
"C113330",1,"PLX8394",9/14/2018 0:00:00,-1,0,0,0,"BRAF",
"C113331",1,"DKN-01",12/12/2017 0:00:00,-1,0,0,0,"DKK1",
"C113332",1,"MEDI0680",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C113333",1,"CDX-3379",8/21/2018 0:00:00,-1,0,0,0,"ERBB3",
"C113334",1,"GSK2816126",10/16/2018 0:00:00,-1,0,0,0,"EZH2","wildtype"
"C113432",1,"NY-ESO-1/GLA-SE Vaccine ID-G305",,-1,0,0,0,,
"C113433",1,"RP6530",9/28/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C113433",2,"RP6530",9/28/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C113434",1,"INCB050465",3/1/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C113437",1,"SGX942",3/5/2019 0:00:00,-1,0,0,0,,
"C113442",1,"Acalabrutinib",10/16/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C113649",1,"TLR4 Agonist GLA-SE",,-1,0,0,0,,
"C113653",1,"HS-410",10/16/2018 0:00:00,-1,0,0,0,,
"C113655",1,"Lorlatinib",6/20/2017 0:00:00,-1,0,0,0,"ALK",
"C113655",2,"Lorlatinib",6/20/2017 0:00:00,-1,0,0,0,"ROS1",
"C113786",1,"Enadenotucirev",3/1/2018 0:00:00,-1,0,0,0,,
"C113788",2,"TAK-243",10/16/2018 0:00:00,-1,0,0,0,"UBA1","wildtype"
"C113790",1,"VCN-01",10/1/2018 0:00:00,-1,0,0,0,,
"C113792",1,"ONC201",1/29/2018 0:00:00,-1,0,0,0,"Akt",
"C113792",2,"ONC201",1/29/2018 0:00:00,-1,0,0,0,"ERK",
"C113793",1,"GDC-0919",10/30/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C113794",1,"CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine",,-1,0,0,0,,
"C113797",1,"Extended-release Onapristone",10/16/2018 0:00:00,-1,0,0,0,"PR","wildtype"
"C1138",1,"Itraconazole",9/11/2018 0:00:00,-1,0,0,0,"P450 enzymes",
"C113802",1,"ARGX-111",9/28/2018 0:00:00,-1,0,0,0,"MET",
"C113804",1,"SFX-01",10/16/2018 0:00:00,-1,0,0,0,"NFE2L2","wildtype"
"C113807",1,"DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C114103",1,"Transdermal 4-OHT",10/16/2018 0:00:00,-1,0,0,0,"CYP19A1","wildtype"
"C114103",2,"Transdermal 4-OHT",10/16/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C114277",1,"Anatabine",10/16/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C114283",1,"TAS-120",9/28/2018 0:00:00,-1,0,0,0,"FGFR1",
"C114285",1,"Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine",10/16/2018 0:00:00,-1,0,0,0,"BIRC5","wildtype"
"C114285",2,"Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine",10/16/2018 0:00:00,-1,0,0,0,"TP53","wildtype"
"C114285",3,"Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine",10/16/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C114287",1,"TSR-011",10/16/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C114287",2,"TSR-011",10/16/2018 0:00:00,-1,0,0,0,"NTRK1","wildtype"
"C114287",3,"TSR-011",10/16/2018 0:00:00,-1,0,0,0,"NTRK2","wildtype"
"C114287",4,"TSR-011",10/16/2018 0:00:00,-1,0,0,0,"NTRK3","wildtype"
"C114299",1,"GSK2857916",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C114380",1,"NY-ESO-1",3/1/2018 0:00:00,-1,0,0,0,"NY-ESO-1",
"C114381",1,"CB-839",3/1/2018 0:00:00,-1,0,0,0,"glutaminase",
"C114383",1,"Ivosidenib",7/17/2018 0:00:00,-1,0,0,0,"IDH1",
"C114384",1,"ABT-737",9/28/2018 0:00:00,-1,0,0,0,"BCL2",
"C114384",2,"ABT-737",9/28/2018 0:00:00,-1,0,0,0,"BCL2L1",
"C114384",3,"ABT-737",9/28/2018 0:00:00,-1,0,0,0,"BCL2L2",
"C114500",1,"Enfortumab Vedotin",11/6/2017 0:00:00,-1,0,0,0,"nectin-4",
"C114500",2,"Enfortumab Vedotin",11/6/2017 0:00:00,-1,0,0,0,"tubulin",
"C114975",1,"IMO-8400",9/28/2018 0:00:00,-1,0,0,0,"MYD88",
"C114980",1,"RO6839921",9/28/2018 0:00:00,-1,0,0,0,"MDM2",
"C114984",1,"Entrectinib",7/17/2018 0:00:00,-1,0,0,0,"NTRK1",
"C114984",2,"Entrectinib",7/17/2018 0:00:00,-1,0,0,0,"NTRK2",
"C114984",3,"Entrectinib",7/17/2018 0:00:00,-1,0,0,0,"NTRK3",
"C114984",4,"Entrectinib",7/17/2018 0:00:00,-1,0,0,0,"ROS1",
"C114984",5,"Entrectinib",7/17/2018 0:00:00,-1,0,0,0,"ALK",
"C114990",1,"Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C115101",1,"AFM11",10/16/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C115101",2,"AFM11",10/16/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C115101",3,"AFM11",10/16/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C115101",4,"AFM11",10/16/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C115102",1,"ASTX727",8/12/2019 0:00:00,-1,0,0,0,"DNMT",
"C115109",1,"Nazartinib",9/28/2018 0:00:00,-1,0,0,0,"EGFR",
"C115110",1,"Naquotinib",10/16/2018 0:00:00,-1,0,0,0,"EGFR","EGFR Mutant, EGFR T790M"
"C115111",1,"GR-MD-02",6/20/2017 0:00:00,-1,0,0,0,"galectin",
"C115112",1,"Ceritinib",12/20/2017 0:00:00,-1,0,0,0,"ALK",
"C115977",1,"Larotrectinib",7/18/2017 0:00:00,-1,0,0,0,"NTRK1","fusion"
"C115977",2,"Larotrectinib",7/18/2017 0:00:00,-1,0,0,0,"NTRK2","fusion"
"C115977",3,"Larotrectinib",7/18/2017 0:00:00,-1,0,0,0,"NTRK3","fusion"
"C116065",1,"MK-4166",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C116066",1,"Sulfatinib",10/16/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C116066",2,"Sulfatinib",10/16/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C116066",3,"Sulfatinib",10/16/2018 0:00:00,-1,0,0,0,"FLT4","wildtype"
"C116066",4,"Sulfatinib",10/16/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C116067",1,"LPV7",3/1/2018 0:00:00,-1,0,0,0,,
"C116069",1,"CD19CAR-CD3zeta-4-1BB-CD28-expressing Autologous T-Lymphocytes",,-1,0,0,0,,
"C116074",1,"Empesertib",9/28/2018 0:00:00,-1,0,0,0,"TTK",
"C116321",1,"CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine",10/16/2018 0:00:00,-1,0,0,0,"ENG","wildtype"
"C116321",2,"CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine",10/16/2018 0:00:00,-1,0,0,0,"YBX1","wildtype"
"C116321",3,"CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine",10/16/2018 0:00:00,-1,0,0,0,"SOX2","wildtype"
"C116321",4,"CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine",10/16/2018 0:00:00,-1,0,0,0,"CDH3","wildtype"
"C116321",5,"CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine",10/16/2018 0:00:00,-1,0,0,0,"MDM2","wildtype"
"C116322",1,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"PTGS2","wildtype"
"C116322",2,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"NFKB1","wildtype"
"C116322",3,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C116322",4,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"ANXA2","wildtype"
"C116322",5,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"MMP9","wildtype"
"C116322",6,"Liposomal Curcumin",10/16/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C116325",1,"HDM201",9/28/2018 0:00:00,-1,0,0,0,"MDM2",
"C116326",1,"AZD5312",10/16/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C116355",1,"M6620",1/23/2019 0:00:00,-1,0,0,0,"ATR",
"C116357",1,"TEW-7197",9/12/2017 0:00:00,-1,0,0,0,"TGFB1",
"C116377",1,"Osimertinib",6/20/2017 0:00:00,-1,0,0,0,"EGFR",
"C116619",1,"Utomilumab",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF9","wildtype"
"C116624",1,"AMG 232",9/28/2018 0:00:00,-1,0,0,0,"MDM2",
"C116628",1,"Duligotuzumab",9/28/2018 0:00:00,-1,0,0,0,"ERBB3",
"C116628",2,"Duligotuzumab",9/28/2018 0:00:00,-1,0,0,0,"EGFR",
"C116709",1,"INO-9012",10/23/2018 0:00:00,-1,0,0,0,,
"C116722",1,"Gilteritinib",9/28/2018 0:00:00,-1,0,0,0,"FLT3",
"C116722",2,"Gilteritinib",9/28/2018 0:00:00,-1,0,0,0,"ALK",
"C116722",3,"Gilteritinib",9/28/2018 0:00:00,-1,0,0,0,"AXL",
"C116726",1,"AZD3514",10/16/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C116727",1,"ASP3026",10/16/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C116729",1,"Ilorasertib",3/4/2019 0:00:00,-1,0,0,0,"AURKA",
"C116729",2,"Ilorasertib",3/4/2019 0:00:00,-1,0,0,0,"AURKB",
"C116729",3,"Ilorasertib",3/4/2019 0:00:00,-1,0,0,0,"AURKC",
"C116729",4,"Ilorasertib",3/4/2019 0:00:00,-1,0,0,0,"EGFR",
"C116729",5,"Ilorasertib",3/4/2019 0:00:00,-1,0,0,0,"PDGFR",
"C116738",1,"CD30 CAR-expressing Autologous T Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF8","wildtype"
"C116740",1,"pp65 DC vaccine",3/1/2018 0:00:00,-1,0,0,0,"CMV pp65",
"C116750",1,"ABT-165",2/11/2019 0:00:00,-1,0,0,0,,
"C116756",1,"GDC-0425",10/1/2018 0:00:00,-1,0,0,0,"CHEK1",
"C116777",1,"Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine",,-1,0,0,0,,
"C116788",1,"Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736",,-1,0,0,0,,
"C116844",1,"Fenebrutinib",10/16/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C116845",1,"GDC-0575",10/1/2018 0:00:00,-1,0,0,0,"CHEK1",
"C116850",1,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC1",
"C116850",2,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC2",
"C116850",3,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC3",
"C116850",4,"AR-42",10/1/2018 0:00:00,-1,0,-1,0,"HDAC4",
"C116850",5,"AR-42",10/1/2018 0:00:00,-1,0,-1,0,"HDAC5",
"C116850",6,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC6",
"C116850",7,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC7",
"C116850",8,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC8",
"C116850",9,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC9",
"C116850",10,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC10",
"C116850",11,"AR-42",10/1/2018 0:00:00,-1,0,0,0,"HDAC11",
"C116853",1,"Hyperpolarized Carbon C 13 Pyruvate",3/6/2019 0:00:00,-1,0,0,0,,
"C116855",1,"Itacitinib",3/13/2018 0:00:00,-1,0,0,0,"JAK1",
"C116857",1,"Gandotinib",10/1/2018 0:00:00,-1,0,0,0,"JAK2",
"C116858",1,"KW-2449",10/16/2018 0:00:00,-1,0,0,0,"FLT3","wildtype and FLT3 D385Y"
"C116858",2,"KW-2449",10/16/2018 0:00:00,-1,0,0,0,"ABL1","wildtype and ABL1 T315I"
"C116858",3,"KW-2449",10/16/2018 0:00:00,-1,0,0,0,"AURKA","wildtype"
"C116858",4,"KW-2449",10/16/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C116860",1,"LGK974",3/1/2018 0:00:00,-1,0,0,0,"PORCN",
"C116861",1,"LY3009120",10/1/2018 0:00:00,-1,0,0,0,"BRAF",
"C116861",2,"LY3009120",10/1/2018 0:00:00,-1,0,0,0,"RAF1",
"C116861",3,"LY3009120",10/1/2018 0:00:00,-1,0,0,0,"ARAF",
"C116863",1,"MFGR1877S",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C116866",1,"MK8033",10/17/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C116866",2,"MK8033",10/17/2018 0:00:00,-1,0,0,0,"MST1R","wildtype"
"C116867",1,"MK-8242",10/1/2018 0:00:00,-1,0,0,0,"MDM2",
"C116868",1,"P53MVA",10/1/2018 0:00:00,-1,0,0,0,"TP53",
"C116870",1,"Avelumab",10/30/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C116873",1,"OPB-111077",10/1/2018 0:00:00,-1,0,0,0,"STAT1",
"C116873",2,"OPB-111077",10/1/2018 0:00:00,-1,0,0,0,"STAT2",
"C116873",3,"OPB-111077",10/1/2018 0:00:00,-1,0,0,0,"STAT3",
"C116874",1,"TAK-441",10/1/2018 0:00:00,-1,0,0,0,"SMO",
"C116875",1,"LGD-4665",10/16/2018 0:00:00,-1,0,0,0,"MPL","wildtype"
"C116876",1,"Taselisib",7/18/2017 0:00:00,-1,0,0,0,"PIK3CA",
"C116877",1,"GDC-0084",9/24/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C116877",2,"GDC-0084",9/24/2018 0:00:00,-1,0,0,0,"MTOR",
"C116880",1,"GSK2302024A",10/16/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C116881",1,"RO5429083",10/16/2018 0:00:00,-1,0,0,0,"CD44","wildtype"
"C116882",1,"SAR260301",10/16/2018 0:00:00,-1,0,0,0,"PIK3CB","wildtype"
"C116886",1,"DR5-targeting Tetrameric Nanobody Agonist TAS266",,-1,0,0,0,,
"C116891",1,"Galunisertib",7/18/2017 0:00:00,-1,0,0,0,"TGFB1",
"C116893",1,"VB-111",4/1/2019 0:00:00,-1,0,0,0,,
"C116894",1,"XL999",10/16/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C116894",2,"XL999",10/16/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C116894",3,"XL999",10/16/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C116894",4,"XL999",10/16/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C116894",5,"XL999",10/16/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C116894",6,"XL999",10/16/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C116894",7,"XL999",10/16/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C116894",8,"XL999",10/16/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C116914",1,"Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C1170",1,"Miltefosine",,-1,0,0,0,,
"C117232",1,"CD28CAR/CD137CAR-expressing T-Lymphocytes",,-1,0,0,0,,
"C117233",1,"IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,,
"C117235",1,"PEPIDH1M",9/14/2018 0:00:00,-1,0,0,0,,
"C117237",1,"ROR1 CAR-specific Autologous T-Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"ROR1","wildtype"
"C117238",1,"MGD006",10/16/2018 0:00:00,-1,0,0,0,"CD123","wildtype"
"C117238",2,"MGD006",10/16/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C117238",3,"MGD006",10/16/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C117238",4,"MGD006",10/16/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C117293",1,"MEDI6469",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C1173",1,"Nilutamide",3/6/2019 0:00:00,-1,0,0,0,"AR",
"C117724",1,"NY-ESO-1-specific CD4-positive T Lymphocytes",,-1,0,0,0,,
"C117726",1,"SCT200",10/16/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C117727",1,"EGFRvIII-specific CAR-transduced Autologous T Lymphocytes",10/16/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C117729",1,"BCMA-specific CAR-expressing T Lymphocytes",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C117730",1,"Hu5F9-G4",7/12/2018 0:00:00,-1,0,0,0,"CD47",
"C117732",1,"Anti-CD70 Antibody-drug Conjugate SGN-CD70A",,-1,0,0,0,,
"C117734",1,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"MET",
"C117734",2,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"AXL",
"C117734",3,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"KIT",
"C117734",4,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"MER",
"C117734",5,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"DDR2",
"C117734",6,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C117734",7,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C117734",8,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C117734",9,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C117734",10,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C117734",11,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"RET",
"C117734",12,"Sitravatinib",11/5/2018 0:00:00,-1,0,0,0,"NTRK1","wildtype"
"C117734",13,"Sitravatinib",3/1/2018 0:00:00,-1,0,0,0,"Eph",
"C117734",14,"Sitravatinib",11/5/2018 0:00:00,-1,0,0,0,"NTRK2","wildtype"
"C117734",15,"Sitravatinib",11/5/2018 0:00:00,-1,0,0,0,"NTRK3","wildtype"
"C117734",16,"Sitravatinib",11/5/2018 0:00:00,-1,0,0,0,"CBL","wildtype"
"C1178",1,"Tilarginine",1/22/2018 0:00:00,-1,0,0,0,"nitric oxide synthase",
"C117985",1,"Nelipepimut-S",9/14/2018 0:00:00,-1,0,0,0,,
"C1181",1,"Oxaliplatin",3/1/2018 0:00:00,-1,0,0,0,,
"C118281",1,"LY3164530",10/16/2018 0:00:00,-1,0,0,0,"EGFR",
"C118281",2,"LY3164530",10/16/2018 0:00:00,-1,0,0,0,"MET",
"C118282",1,"MEDI6383",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C118284",1,"Cirmtuzumab",3/6/2019 0:00:00,-1,0,0,0,"NTRK1",
"C118285",1,"TVB-2640",9/16/2018 0:00:00,-1,0,0,0,"FASN",
"C118287",1,"CB-5083",10/16/2018 0:00:00,-1,0,0,0,"VCP","wildtype"
"C118288",1,"Oral Azacitidine",3/1/2018 0:00:00,-1,0,0,0,,
"C118289",1,"AZD3759",10/16/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C118290",1,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C118290",2,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"KDR",
"C118290",3,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"TEK",
"C118290",4,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"NTRK1",
"C118290",5,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"NTRK2",
"C118290",6,"Altiratinib",10/1/2018 0:00:00,-1,0,0,0,"NTRK3",
"C118294",1,"Donafenib",10/16/2018 0:00:00,-1,0,0,0,"RAF",
"C118442",1,"MGD007",7/12/2018 0:00:00,-1,0,0,0,"CD3",
"C118442",2,"MGD007",7/12/2018 0:00:00,-1,0,0,0,"GPA33",
"C118443",1,"BMS-986012",3/1/2018 0:00:00,-1,0,0,0,"Fucosyl-GM1",
"C118568",1,"ACP-319",10/17/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C118571",1,"ABBV-399",6/20/2017 0:00:00,-1,0,0,0,"MET",
"C118571",2,"ABBV-399",6/20/2017 0:00:00,-1,0,0,0,"c-Met",
"C118578",1,"Vanucizumab",6/20/2017 0:00:00,-1,0,0,0,"Ang2",
"C118578",2,"Vanucizumab",6/20/2017 0:00:00,-1,0,0,0,"VEGFA",
"C118624",1,"AZD8835",10/1/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C118626",1,"MOR209/ES414",10/17/2018 0:00:00,-1,0,0,0,"FOLH1","wildtype"
"C118626",2,"MOR209/ES414",10/17/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C118626",3,"MOR209/ES414",10/17/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C118626",4,"MOR209/ES414",10/17/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C118629",1,"INCB052793",3/13/2018 0:00:00,-1,0,0,0,"JAK1",
"C118669",1,"ALRN-6924",10/17/2018 0:00:00,-1,0,0,0,"MDM2","wildtype"
"C118669",2,"ALRN-6924",10/17/2018 0:00:00,-1,0,0,0,"MDM4","wildtype"
"C118671",1,"Avitinib maleate",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C118672",1,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGF1",
"C118672",2,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGF2",
"C118672",3,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C118672",4,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C118672",5,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C118672",6,"E7090",10/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C118674",1,"Trastuzumab Duocarmazine",9/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C118798",1,"Anti-CD20 Antibody",,-1,0,0,0,,
"C118947",1,"RNA Electroporated CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C118948",1,"DS-6051b",10/17/2018 0:00:00,-1,0,0,0,"ROS1","wildtype, overexpression"
"C118948",2,"DS-6051b",10/17/2018 0:00:00,-1,0,0,0,"NTRK1","wildtype, overexpression"
"C118948",3,"DS-6051b",10/17/2018 0:00:00,-1,0,0,0,"NTRK2","wildtype, overexpression"
"C118948",4,"DS-6051b",10/17/2018 0:00:00,-1,0,0,0,"NTRK3","wildtype, overexpression"
"C118953",1,"FS102",10/17/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C119615",1,"REGN1979",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C119615",2,"REGN1979",5/23/2017 0:00:00,-1,0,0,0,"CD3",
"C119617",1,"Telomelysin",4/24/2019 0:00:00,-1,0,0,0,,
"C119618",1,"PT2385",8/3/2017 0:00:00,-1,0,0,0,"EPAS1",
"C119624",1,"PF-06459988",10/17/2018 0:00:00,-1,0,0,0,"EGFR","EGFR T790M"
"C119665",1,"Gilteritinib fumarate",10/30/2018 0:00:00,-1,0,0,0,"FLT3","FLT3 internal tandem duplication (FLT3-ITD), FLT3 D835Y, FLT3 F691L, and FLT3 D835 Mutant"
"C119665",2,"Gilteritinib fumarate",10/30/2018 0:00:00,-1,0,0,0,"AXL","wildtype"
"C119665",3,"Gilteritinib fumarate",10/30/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C119665",4,"Gilteritinib fumarate",10/30/2018 0:00:00,-1,0,0,0,"LTK","wildtype"
"C119701",1,"Antroquinonol Capsule",3/7/2019 0:00:00,-1,0,0,0,,
"C119735",1,"C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs",,-1,0,0,0,,
"C119739",1,"D2C7-(scdsFv)-PE38KDEL",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype and EGFRvIII"
"C119740",1,"Selicrelumab",10/30/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C119746",1,"Autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"L1CAM","wildtype"
"C119747",1,"CC-90003",10/1/2018 0:00:00,-1,0,0,0,"MAPK1",
"C119747",2,"CC-90003",10/1/2018 0:00:00,-1,0,0,0,"MAPK3",
"C1198",1,"Poly ICLC",3/1/2018 0:00:00,-1,0,0,0,,
"C120035",1,"Anti-CD22-CAR m971-BBz Lentiviral Vector-transduced Autologous T Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"CD22","wildtype"
"C120036",1,"Nedisertib",12/18/2018 0:00:00,-1,0,0,0,"DNA-PK",
"C120037",1,"SRN-927",10/17/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C120037",2,"SRN-927",10/17/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C120040",1,"Bemarituzumab",10/17/2018 0:00:00,-1,0,0,0,"FGFR2","wildtype isoform b"
"C120041",1,"Tavolimab",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C120042",1,"Eicosapentaenoic Acid-enriched Nutritional Supplement",,-1,0,0,0,,
"C120068",1,"L-DOS47",3/7/2019 0:00:00,-1,0,0,0,,
"C120097",1,"RO6958688",7/20/2017 0:00:00,-1,0,0,0,"CEA",
"C120097",2,"RO6958688",7/20/2017 0:00:00,-1,0,0,0,"CD3",
"C120100",1,"Fluorine F 18 Ara-G",8/2/2019 0:00:00,-1,0,0,0,,
"C120102",1,"FGF401",3/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C120103",1,"ADXS31-142",3/1/2018 0:00:00,-1,0,0,0,,
"C120140",1,"BMS-986004",5/23/2017 0:00:00,-1,0,0,0,"CD40LG",
"C120208",1,"Monalizumab",11/8/2018 0:00:00,-1,0,0,0,"KLRC1","wildtype"
"C120209",1,"FLX925",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C120209",2,"FLX925",10/1/2018 0:00:00,-1,0,0,0,"CDK4",
"C120209",3,"FLX925",10/1/2018 0:00:00,-1,0,0,0,"CDK6",
"C120211",1,"Elacestrant",10/17/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C120211",2,"Elacestrant",10/17/2018 0:00:00,-1,-1,0,0,"ESR2","wildtype"
"C120259",1,"Palbociclib Isethionate",10/17/2018 0:00:00,-1,0,0,0,"CDK4","wildtype"
"C120259",2,"Palbociclib Isethionate",10/17/2018 0:00:00,-1,0,0,0,"CDK6","wildtype"
"C120302",1,"CCX872-B",10/30/2018 0:00:00,-1,0,0,0,"CCR2","wildtype"
"C120303",1,"BMS-986148",3/1/2018 0:00:00,-1,0,0,0,"mesothelin",
"C120304",1,"ODM 204",10/17/2018 0:00:00,-1,0,0,0,"CYP17A1","wildtype"
"C120304",2,"ODM 204",10/17/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C120307",1,"PF-06747775",11/21/2017 0:00:00,-1,0,0,0,"EGFR T790M",
"C120309",1,"Anti-CD19/CD28/CD3zeta CAR Gammaretroviral Vector-transduced Autologous T Lymphocytes KTE-C19",,-1,0,0,0,,
"C120313",1,"S-equol",10/17/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C120313",2,"S-equol",10/17/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C120316",1,"GC1118",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C120318",1,"VO-100",10/1/2018 0:00:00,-1,0,0,0,"CASP3",
"C120473",1,"4-Hydroxyestradiol",10/17/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C120473",2,"4-Hydroxyestradiol",10/17/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C120546",1,"MT-3724",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C120553",1,"BGB-290",5/14/2018 0:00:00,-1,0,0,0,"PARP",
"C120555",1,"MAG-Tn3/AS15 Vaccine",,-1,0,0,0,,
"C120556",1,"ABBV-221",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C121158",1,"DS-8273a",2/28/2018 0:00:00,-1,0,0,0,"DR5",
"C121167",1,"scFv B9E9-streptavidin Fusion Protein",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C1212",1,"Sirolimus",5/8/2018 0:00:00,-1,-1,0,0,"FKBP-12",
"C1212",2,"Sirolimus",5/8/2018 0:00:00,-1,0,0,0,"MTOR",
"C1212",3,"Sirolimus",5/8/2018 0:00:00,-1,0,0,0,"IL2",
"C1212",4,"Sirolimus",5/8/2018 0:00:00,-1,0,0,0,"IL4",
"C1212",5,"Sirolimus",5/8/2018 0:00:00,-1,0,0,0,"IL15",
"C121212",1,"BAY1187982",10/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C121214",1,"Nanocell-encapsulated miR-16-based microRNA Mimic",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C121217",1,"SEA-CD40",10/31/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C121375",1,"PT-112",3/1/2018 0:00:00,-1,0,0,0,,
"C121376",1,"MOXR0916",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C121457",1,"IDH305",10/1/2018 0:00:00,-1,0,0,0,"IDH1",
"C121501",1,"CTLA-4 Ligand",,-1,0,0,0,,
"C121535",1,"LY3039478",10/1/2018 0:00:00,-1,0,0,0,"PSENEN",
"C121535",2,"LY3039478",10/1/2018 0:00:00,-1,0,0,0,"APH1A",
"C121535",3,"LY3039478",10/1/2018 0:00:00,-1,0,0,0,"APH1B",
"C121537",1,"TGF-beta-resistant T Lymphocytes",7/26/2017 0:00:00,-1,0,0,0,"TGFB1",
"C121538",1,"ADC-1013",10/31/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C121540",1,"REGN2810",3/9/2017 0:00:00,-1,0,-1,0,"PDCD1",
"C121540",2,"Cemiplimab",4/10/2018 0:00:00,-1,0,0,0,"PDCD1",
"C121541",1,"ADXS31-164",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C121550",1,"SYN004",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C121553",1,"INCB054828",7/26/2017 0:00:00,-1,0,-1,0,"FGFR1",
"C121553",2,"INCB054828",7/26/2017 0:00:00,-1,0,-1,0,"FGFR2",
"C121553",3,"INCB054828",7/26/2017 0:00:00,-1,0,-1,0,"FGFR3",
"C121553",4,"Pemigatinib",7/26/2017 0:00:00,-1,0,0,0,"FGFR1",
"C121553",5,"Pemigatinib",7/26/2017 0:00:00,-1,0,0,0,"FGFR2",
"C121553",6,"Pemigatinib",7/26/2017 0:00:00,-1,0,0,0,"FGFR3",
"C121625",1,"PDR001",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C121639",1,"CPI-1205",7/12/2018 0:00:00,-1,0,0,0,"EZH2",
"C121641",1,"ACY-241",7/20/2017 0:00:00,-1,0,0,0,"HDAC",
"C121645",1,"PTC596",3/5/2019 0:00:00,-1,0,0,0,"BMI1",
"C121646",1,"HM95573",10/1/2018 0:00:00,-1,0,0,0,"CRAF",
"C121646",2,"HM95573",10/1/2018 0:00:00,-1,0,0,0,"BRAF",
"C121646",3,"HM95573",10/1/2018 0:00:00,-1,0,0,0,"NRAS",
"C121646",4,"HM95573",10/1/2018 0:00:00,-1,0,-1,0,"KRAS",
"C121646",5,"HM95573",10/1/2018 0:00:00,-1,0,0,0,"HRAS",
"C121647",1,"PLX9486",7/17/2018 0:00:00,-1,0,0,0,"KIT",
"C121648",1,"HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN",10/31/2018 0:00:00,-1,0,0,0,,
"C121649",1,"B-701",3/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C121653",1,"LMB-100",8/27/2019 0:00:00,-1,0,0,0,"MSLN",
"C121664",1,"taminadenant",10/31/2018 0:00:00,-1,0,0,0,"ADORA2A","wildtype"
"C121775",1,"Tislelizumab",12/17/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C121777",1,"MVI-118",10/17/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C121782",1,"Anti-mesothelin iCasp9M28z CAR-transduced Autologous T Lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"MSLN","wildtype"
"C121817",1,"LY3023414",11/21/2017 0:00:00,-1,0,0,0,"PIK3CA",
"C121817",2,"LY3023414",11/21/2017 0:00:00,-1,0,0,0,"MTOR",
"C121849",1,"BMS-986158",2/27/2018 0:00:00,-1,0,0,0,"BET",
"C121850",1,"RM-1929",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C121854",1,"BGB324",7/13/2017 0:00:00,-1,0,-1,0,"AXL",
"C121854",2,"Bemcentinib",7/19/2018 0:00:00,-1,0,0,0,"AXL",
"C121927",1,"PF-04518600",11/8/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C121943",1,"Selonsertib",10/17/2018 0:00:00,-1,0,0,0,"MAP3K5","wildtype"
"C121949",1,"ADCT-301",2/21/2019 0:00:00,-1,0,0,0,"CD25",
"C121951",1,"COTI-2",9/14/2018 0:00:00,-1,0,0,0,"TP53",
"C121952",1,"CCT3833",10/17/2018 0:00:00,-1,0,0,0,"ARAF","wildtype"
"C121952",2,"CCT3833",10/17/2018 0:00:00,-1,0,0,0,"BRAF","wildtype"
"C121952",3,"CCT3833",10/17/2018 0:00:00,-1,-1,0,0,"RAF1","wildtype"
"C121957",1,"DSP-7888",3/1/2018 0:00:00,-1,0,0,0,"WT1",
"C121960",1,"Pirotinib",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C121960",2,"Pirotinib",10/17/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C121960",3,"Pirotinib",10/17/2018 0:00:00,-1,0,0,0,"ERBB4","wildtype"
"C122392",1,"AC0010MA",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C122396",1,"Tetravalent RNA-lipoplex Cancer Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C122406",1,"JNJ-64052781",10/17/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C122406",2,"JNJ-64052781",10/17/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C122406",3,"JNJ-64052781",10/17/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C122406",4,"JNJ-64052781",10/17/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C122406",5,"JNJ-64052781",10/17/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C122678",1,"IDH1R132H Mutation-targeting IDH1 Peptide Vaccine",10/17/2018 0:00:00,-1,0,0,0,"IDH1","IDH1 R132H"
"C122680",1,"SCT400",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C122683",1,"LAG525",10/30/2018 0:00:00,-1,0,0,0,"LAG3","wildtype"
"C122719",1,"ASP5878",10/1/2018 0:00:00,-1,0,0,0,"FGFR",
"C122719",2,"ASP5878",10/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C122719",3,"ASP5878",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C122719",4,"ASP5878",10/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C122777",1,"EGFR Antibody",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C122834",1,"AZD9496",10/17/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C122834",2,"AZD9496",10/17/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C122874",1,"AG-881",7/17/2018 0:00:00,-1,0,0,0,"IDH1",
"C122874",2,"AG-881",7/17/2018 0:00:00,-1,0,0,0,"IDH2",
"C122922",1,"CMB305",6/20/2017 0:00:00,-1,0,0,0,"NY-ESO-1",
"C123267",1,"MEDI-570",5/23/2017 0:00:00,-1,0,0,0,"ICOS",
"C123281",1,"Trilaciclib",3/1/2018 0:00:00,-1,0,0,0,"CDK4",
"C123281",2,"Trilaciclib",3/1/2018 0:00:00,-1,0,0,0,"CDK6",
"C123332",1,"AMG 330",10/17/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C123332",2,"AMG 330",10/17/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C123332",3,"AMG 330",10/17/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C123332",4,"AMG 330",10/17/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C123332",5,"AMG 330",10/17/2018 0:00:00,-1,0,0,0,"CD33","wildtype"
"C123362",1,"TTT-3002",10/17/2018 0:00:00,-1,0,0,0,"FLT3","FLT3 internal tandem duplication (FLT3-ITD), FLT3 D835Y"
"C123382",1,"MVX-ONCO-1",10/17/2018 0:00:00,-1,0,0,0,,
"C123383",1,"AZD5069",11/8/2018 0:00:00,-1,0,0,0,"CXCR2","wildtype"
"C123428",1,"Naxitamab",3/4/2019 0:00:00,-1,0,0,0,,
"C123649",1,"GSK 2132231A",10/17/2018 0:00:00,-1,0,0,0,"MAGEA3","wildtype"
"C123722",1,"Hemay022",10/17/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C123734",1,"APX005M",10/30/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C123792",1,"LY2452473",10/17/2018 0:00:00,-1,0,0,0,"AR",
"C123816",1,"SHR-1210",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C123817",1,"Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes",10/17/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C123817",2,"Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes",10/17/2018 0:00:00,-1,0,0,0,"CTAG1B","wildtype"
"C123817",3,"Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes",10/17/2018 0:00:00,-1,0,0,0,"PRAME","wildtype"
"C123817",4,"Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes",10/17/2018 0:00:00,-1,0,0,0,"BIRC5","wildtype"
"C123819",1,"Therapeutic Dendritic Cells/Cytokine-induced Killer Cells",,-1,0,0,0,,
"C123826",1,"BLU-554",10/18/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype"
"C123827",1,"BLU-285",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C123827",3,"BLU-285",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C123828",1,"PF-06647020",1/21/2020 0:00:00,-1,0,0,0,"PTK7",
"C123829",1,"LY3076226",10/18/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C123830",1,"ETC-1922159",10/18/2018 0:00:00,-1,0,0,0,"PORCN","wildtype"
"C123831",1,"Cabiralizumab",10/30/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C123882",1,"Trodusquemine",10/1/2018 0:00:00,-1,0,0,0,"PTPN1",
"C123913",1,"ASTX660",9/14/2018 0:00:00,-1,0,0,0,"XIAP",
"C123913",2,"ASTX660",9/14/2018 0:00:00,-1,0,0,0,"cIAP1",
"C123914",1,"MEDI9447",11/8/2018 0:00:00,-1,0,-1,0,"CD73","wildtype"
"C123914",2,"Oleclumab",8/13/2018 0:00:00,-1,0,0,0,"CD73",
"C123915",1,"IGN002",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C123917",1,"ARX788",7/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C123921",1,"MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C123925",1,"PWT143",10/18/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C123930",1,"Ad5-yCD/mutTKSR39rep-Hil12",10/18/2018 0:00:00,-1,0,0,0,"IL12A","wildtype"
"C124058",1,"PF-06801591",10/31/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C124067",1,"DCC-2618",2/28/2018 0:00:00,-1,0,0,0,"KIT",
"C124067",2,"DCC-2618",2/28/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C124131",1,"Grapiprant",10/23/2018 0:00:00,-1,0,0,0,"EP4",
"C124133",1,"SC-003",5/8/2018 0:00:00,-1,0,0,0,,
"C124134",1,"ABBV-085",3/1/2018 0:00:00,-1,0,0,0,,
"C124226",1,"INCB053914",2/22/2019 0:00:00,-1,0,0,0,"PIM1",
"C124226",2,"INCB053914",2/22/2019 0:00:00,-1,0,0,0,"PIM2",
"C124226",3,"INCB053914",2/22/2019 0:00:00,-1,0,0,0,"PIM3",
"C124227",1,"BMS-986253",2/5/2018 0:00:00,-1,0,0,0,,
"C124229",1,"M7824",2/12/2018 0:00:00,-1,0,0,0,"CD274",
"C124229",2,"M7824",2/12/2018 0:00:00,-1,0,0,0,"TGFB1",
"C1244",1,"Temozolomide",3/1/2018 0:00:00,-1,0,0,0,,
"C1246",1,"Testosterone cypionate",1/15/2019 0:00:00,-1,0,0,0,"AR",
"C124648",1,"AZD0156",10/1/2018 0:00:00,-1,0,0,0,"ATM",
"C124650",1,"Anti-mesothelin CAR Vector-transduced Autologous T-lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"MSLN","wildtype"
"C124651",1,"MEDI1873",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C124653",1,"MEDI9197",7/21/2017 0:00:00,-1,0,0,0,"TLR7",
"C124653",2,"MEDI9197",7/21/2017 0:00:00,-1,0,0,0,"TLR8",
"C124654",1,"Ralaniten Acetate",10/18/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C124656",1,"Anti-CD22 scFv TCRz:41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"CD22","wildtype"
"C124783",1,"GSK3174998",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C124796",1,"IDE196",7/1/2019 0:00:00,-1,0,0,0,"GNAQ",
"C124796",2,"IDE196",7/1/2019 0:00:00,-1,0,0,0,"GNA11",
"C124800",1,"FLT3 Inhibitor",10/18/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C124801",1,"BTK Inhibitor",10/18/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C124843",1,"JNJ-64041757",3/1/2018 0:00:00,-1,0,0,0,,
"C124850",1,"MBG453",10/30/2018 0:00:00,-1,0,0,0,"HAVCR2","wildtype"
"C124931",1,"PRN1371",10/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C124931",2,"PRN1371",10/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C124931",3,"PRN1371",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C124931",4,"PRN1371",10/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C124946",1,"PD1 Inhibitor",,-1,0,0,0,,
"C124993",1,"JNJ-61186372",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C124993",2,"JNJ-61186372",9/14/2018 0:00:00,-1,0,0,0,"MET",
"C124995",1,"Lifirafenib",10/1/2018 0:00:00,-1,0,0,0,"BRAF",
"C124995",2,"Lifirafenib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C125003",1,"LXH254",6/20/2017 0:00:00,-1,0,0,0,"Raf family",
"C125062",1,"eFT508",10/17/2017 0:00:00,-1,0,0,0,"MNK1",
"C125062",2,"eFT508",10/17/2017 0:00:00,-1,0,0,0,"MNK2",
"C125080",1,"IMO-2125",11/21/2017 0:00:00,-1,0,0,0,"TLR9",
"C125103",1,"TTFields",3/13/2018 0:00:00,-1,0,0,0,,
"C125143",1,"Pegzilarginase",1/29/2018 0:00:00,-1,0,0,0,"arginase",
"C125193",1,"Eltanexor",10/18/2018 0:00:00,-1,0,0,0,"XPO1","wildtype"
"C125392",1,"Crofelemer",9/14/2018 0:00:00,-1,0,0,0,"CTFR",
"C125392",2,"Crofelemer",9/14/2018 0:00:00,-1,0,0,0,"CaCC",
"C12542",1,"CD8-Positive T-Lymphocyte",3/1/2018 0:00:00,-1,0,0,0,,
"C125420",1,"Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes",,-1,0,0,0,,
"C125450",1,"JAK2 Inhibitor",10/18/2018 0:00:00,-1,0,0,0,"JAK2","wildtype"
"C12546",1,"TILs",3/1/2018 0:00:00,-1,0,0,0,,
"C125471",1,"IPI-549",6/20/2017 0:00:00,-1,0,0,0,"PIK3CG",
"C125548",1,"Emactuzumab",10/30/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C125620",1,"KTN0158",10/18/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C125633",1,"Anti-Epidermal Growth Factor Receptor 2 Antibody Expressing Pluripotent Killer T-Lymphocytes",10/18/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C125654",1,"Anti-Programmed Cell Death Protein 1 Antibody Expressing Pluripotent Killer T-Lymphocytes",,-1,0,0,0,,
"C125659",1,"CPI-444",10/30/2018 0:00:00,-1,0,0,0,"ADORA2A","wildtype"
"C125899",1,"SHR6390",10/18/2018 0:00:00,-1,0,0,0,"CDK4","wildtype"
"C125899",2,"SHR6390",10/18/2018 0:00:00,-1,0,0,0,"CDK6","wildtype"
"C125902",1,"MIW815",10/17/2017 0:00:00,-1,0,0,0,"STING",
"C1261",1,"Trichostatin A",10/1/2018 0:00:00,-1,0,0,0,"HDAC1",
"C1261",2,"Trichostatin A",10/1/2018 0:00:00,-1,0,0,0,"HDAC3",
"C1261",3,"Trichostatin A",10/1/2018 0:00:00,-1,0,0,0,"HDAC4",
"C1261",4,"Trichostatin A",10/1/2018 0:00:00,-1,0,0,0,"HDAC6",
"C1261",5,"Trichostatin A",10/1/2018 0:00:00,-1,0,0,0,"HDAC10",
"C126105",1,"EDO-S101",2/12/2019 0:00:00,-1,0,0,0,"HDACi",
"C126113",1,"zalifrelimab",10/30/2018 0:00:00,-1,0,0,0,"CTLA4","wildtype"
"C126276",1,"PE/HPV16 E7/KDEL Fusion Protein TVGV-1",10/18/2018 0:00:00,-1,0,0,0,"LRP1","wildtype"
"C126334",1,"U3-1784",10/18/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype"
"C126335",1,"SHR3680",10/18/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C126355",1,"MEDI4276",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C126421",1,"INCB059872",3/6/2019 0:00:00,-1,0,0,0,"LSD1",
"C126422",1,"CMP-001",7/18/2017 0:00:00,-1,0,0,0,"TLR9",
"C1266",1,"Trioxifene",10/18/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C126643",1,"INCAGN01876",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C126646",1,"KPT-9274",3/6/2019 0:00:00,-1,0,0,0,"PAK4",
"C126646",2,"KPT-9274",3/6/2019 0:00:00,-1,0,0,0,"NAMPT",
"C126648",1,"CT-707",10/18/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C126648",2,"CT-707",10/18/2018 0:00:00,-1,0,0,0,"PTK2","wildtype"
"C126648",3,"CT-707",10/18/2018 0:00:00,-1,0,0,0,"PYK2","wildtype"
"C126660",1,"X4P-001",6/20/2017 0:00:00,-1,0,0,0,"CXCR4",
"C126687",1,"LTT462",9/14/2018 0:00:00,-1,0,0,0,"MAPK1",
"C126687",2,"LTT462",9/14/2018 0:00:00,-1,0,0,0,"MAPK3",
"C126752",1,"AP32788",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C126752",2,"AP32788",9/14/2018 0:00:00,-1,0,0,0,"ERBB2",
"C126798",1,"CX5461",10/1/2018 0:00:00,-1,0,0,0,"POLR1A",
"C126799",1,"TSR-042",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C126804",1,"GSK3359609",10/30/2018 0:00:00,-1,0,0,0,"ICOS","wildtype"
"C126805",1,"ZEN-3694",5/3/2019 0:00:00,-1,0,0,0,"BET",
"C126840",1,"MK-1966",10/30/2018 0:00:00,-1,0,0,0,"IL10","wildtype"
"C127012",1,"Baricitinib",10/18/2018 0:00:00,-1,0,0,0,"JAK1","wildtype"
"C127012",2,"Baricitinib",10/18/2018 0:00:00,-1,0,0,0,"JAK2","wildtype"
"C127012",3,"Baricitinib",10/18/2018 0:00:00,-1,0,0,0,"JAK3","wildtype"
"C127012",4,"Baricitinib",10/18/2018 0:00:00,-1,0,0,0,"TYK2","wildtype"
"C1271",1,"UCN-01",10/18/2018 0:00:00,-1,0,0,0,"AKT","wildtype"
"C1271",2,"UCN-01",10/18/2018 0:00:00,-1,0,0,0,"PRKCA","wildtype"
"C1271",3,"UCN-01",10/18/2018 0:00:00,-1,0,0,0,"CHEK1","wildtype"
"C1271",4,"UCN-01",10/18/2018 0:00:00,-1,0,0,0,"PRKCG","wildtype"
"C1271",5,"UCN-01",10/18/2018 0:00:00,-1,0,0,0,"PRKCB","wildtype"
"C127114",1,"DS-3201",10/15/2018 0:00:00,-1,0,0,0,"EZH1","wildtype"
"C127114",2,"DS-3201",10/15/2018 0:00:00,-1,0,0,0,"EZH2","wildtype"
"C127116",1,"TP-0903",7/17/2018 0:00:00,-1,0,0,0,"AXL",
"C127120",1,"XmAb1404",10/15/2018 0:00:00,-1,0,0,0,"IL3RA","wildtype"
"C127120",2,"XmAb1404",10/15/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C127120",3,"XmAb1404",10/15/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C127120",4,"XmAb1404",10/15/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C127123",1,"NI-0501",9/13/2017 0:00:00,-1,0,0,0,"IFNG",
"C127124",1,"JNJ-61610588",10/30/2018 0:00:00,-1,0,0,0,"VSIR","wildtype"
"C127154",1,"Ad-ISF35",,-1,0,0,0,,
"C12741",1,"NK Cells",9/14/2018 0:00:00,-1,0,0,0,,
"C1275",1,"Vinorelbine",6/20/2017 0:00:00,-1,0,0,0,"tubulin",
"C127900",1,"LMP744",7/1/2019 0:00:00,-1,0,0,0,"TOP1",
"C127906",1,"Sym015",9/14/2018 0:00:00,-1,0,0,0,"MET",
"C127910",1,"pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine",10/15/2018 0:00:00,0,0,0,0,"IGFBP2","wildtype"
"C127910",2,"pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine",10/15/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C127910",3,"pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine",10/15/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C128026",1,"BMS 986178",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C128028",1,"GWN 323",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C128036",1,"Anti-CTLA4 Monoclonal Antibody",1/9/2018 0:00:00,-1,0,-1,0,"CTLA4",
"C128037",1,"Anti-PD-1 Monoclonal Antibody",1/9/2018 0:00:00,-1,0,-1,0,"PDCD1",
"C128039",1,"Defactinib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"FAK",
"C128057",1,"Anti-PD-L1 Monoclonal Antibody",1/9/2018 0:00:00,-1,0,-1,0,"CD274",
"C128059",1,"Dabrafenib Mesylate",10/18/2018 0:00:00,-1,0,0,0,"BRAF","wildtype and BRAF V600E"
"C128059",2,"Dabrafenib Mesylate",10/18/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C128107",1,"ALKS 4230",2/28/2018 0:00:00,-1,0,-1,0,"IL2",
"C128107",2,"ALKS 4230",4/20/2018 0:00:00,-1,0,0,0,"CD8",
"C128138",1,"LY3300054",10/30/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C1282",1,"Carboplatin",3/1/2018 0:00:00,-1,0,0,0,,
"C128246",1,"SL-801",10/18/2018 0:00:00,-1,0,0,0,"XPO1","wildtype"
"C128250",1,"ARQ 751",9/14/2018 0:00:00,-1,0,0,0,"AKT1",
"C128250",2,"ARQ 751",9/14/2018 0:00:00,-1,0,0,0,"AKT2",
"C128250",3,"ARQ 751",9/14/2018 0:00:00,-1,0,0,0,"AKT3",
"C128280",1,"LSZ102",9/24/2018 0:00:00,-1,0,0,0,"ER",
"C1284",1,"Dextran Sulfate Sodium",,-1,0,0,0,,
"C128486",1,"JNJ-63709178",10/15/2018 0:00:00,-1,0,0,0,"IL3RA","wildtype"
"C128486",2,"JNJ-63709178",10/15/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C128486",3,"JNJ-63709178",10/15/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C128486",4,"JNJ-63709178",10/15/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C128489",1,"GRN-1201",3/1/2019 0:00:00,-1,0,0,0,,
"C128558",1,"GSK1795091",4/10/2018 0:00:00,-1,0,0,0,"TLR4",
"C128627",1,"TSR-022",3/8/2017 0:00:00,-1,0,0,0,"HAVCR2",
"C1287",1,"G-CSF",9/11/2018 0:00:00,-1,0,0,0,,
"C128799",1,"DS-8201a",7/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C1288",1,"GM-CSF",3/1/2018 0:00:00,-1,0,0,0,,
"C128862",1,"H3B-6527",10/15/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype"
"C128892",1,"Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes",10/15/2018 0:00:00,-1,0,0,0,"MAGEA3","wildtype"
"C128892",2,"Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes",10/15/2018 0:00:00,-1,0,0,0,"MAGEA4","wildtype"
"C128892",3,"Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes",10/15/2018 0:00:00,-1,0,0,0,"BIRC5","wildtype"
"C128892",4,"Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes",10/15/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C128892",5,"Type-1 Polarized Dendritic Cell-induced Antigen-specific Autologous Cytotoxic T Lymphocytes",10/15/2018 0:00:00,-1,0,0,0,"PTGS2","wildtype"
"C128894",1,"Thrombomodulin Alfa",10/15/2018 0:00:00,-1,0,0,0,"F2","wildtype"
"C128897",1,"Doxorubicin-loaded EGFR-targeting Nanocells",10/15/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C128898",1,"TPIV-200",3/1/2018 0:00:00,-1,0,0,0,"FOLR1",
"C12920",1,"EBV-specific Cytotoxic T-lymphocyte",7/19/2018 0:00:00,-1,0,0,0,,
"C129316",1,"Metformide Hydrochloride",8/2/2019 0:00:00,-1,0,0,0,,
"C129375",1,"PF-06840003",10/30/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C129376",1,"4G8-SDIEM",10/15/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C129383",1,"RO6874281",7/18/2017 0:00:00,-1,0,0,0,"FAP",
"C129448",1,"cetrelimab",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C129546",1,"H3B-8800",10/1/2018 0:00:00,-1,0,0,0,"SF3B1",
"C129555",1,"Kynurenine",,-1,0,0,0,,
"C129593",1,"Anti-hCD70-CAR Retroviral Vector-transduced Autologous PBLs",,-1,0,0,0,,
"C129594",1,"CA-170",10/30/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C129594",2,"CA-170",10/30/2018 0:00:00,-1,0,-1,0,"PDCD1LG2","wildtype"
"C129594",3,"CA-170",10/30/2018 0:00:00,-1,0,0,0,"VSIR","wildtype"
"C129594",4,"CA-170",10/30/2018 0:00:00,-1,0,0,0,"C10orf54","wildtype"
"C129650",1,"JAK1 Inhibitor",10/15/2018 0:00:00,-1,0,0,0,"JAK1","wildtype"
"C129653",1,"BLZ945",10/31/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C129687",1,"FT-2102",10/15/2018 0:00:00,-1,0,0,0,"IDH1","IDH1 R132 Mutant"
"C129688",1,"PLX73086",10/31/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C129689",1,"E7046",3/1/2018 0:00:00,-1,0,0,0,"PGE2",
"C129689",2,"E7046",3/1/2018 0:00:00,-1,0,0,0,"EP4",
"C129691",1,"BTCT4465A",10/31/2018 0:00:00,-1,-1,0,0,"MS4A1","wildtype"
"C129691",2,"BTCT4465A",10/31/2018 0:00:00,-1,-1,0,0,"CD3","wildtype"
"C129691",3,"BTCT4465A",10/31/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C129691",4,"BTCT4465A",10/31/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C129691",5,"BTCT4465A",10/31/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C129693",1,"M4344",12/9/2019 0:00:00,-1,0,0,0,"ATR",
"C129693",2,"M4344",12/9/2019 0:00:00,-1,0,0,0,"CHK1",
"C129694",1,"AMG 228",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C129710",1,"M7583",10/15/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C129714",1,"KN035",10/30/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C129715",1,"Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087",,-1,0,0,0,,
"C129790",1,"KHK2455",10/30/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C129876",1,"Vopratelimab",10/30/2018 0:00:00,-1,0,0,0,"ICOS","wildtype"
"C129877",1,"Autologous Monocytes",3/7/2019 0:00:00,-1,0,0,0,,
"C129906",1,"Natural Killer T-Cell",7/18/2018 0:00:00,-1,0,0,0,,
"C129935",1,"NEO-PV-01",3/1/2018 0:00:00,-1,0,0,0,,
"C129936",1,"ERY974",10/15/2018 0:00:00,-1,0,0,0,"GPC3","wildtype"
"C129936",2,"ERY974",10/15/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C129936",3,"ERY974",10/15/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C129936",4,"ERY974",10/15/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C129937",1,"AGS62P1",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C129967",1,"INCAGN01949",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C129983",1,"ABY-029",9/14/2018 0:00:00,-1,0,0,0,"EGFR (imaging)",
"C130001",1,"DTRMWXHS-12",10/15/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C130010",1,"ZW25",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C130012",1,"IACS-010759",8/12/2019 0:00:00,-1,0,0,0,"NADH",
"C130036",1,"Proxalutamide",10/18/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C130050",1,"XmAb13676",10/31/2018 0:00:00,-1,-1,0,0,"MS4A1","wildtype"
"C130050",2,"XmAb13676",10/31/2018 0:00:00,-1,-1,0,0,"CD3","wildtype"
"C130050",3,"XmAb13676",10/31/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C130050",4,"XmAb13676",10/31/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C130050",5,"XmAb13676",10/31/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C131019",1,"Bempegaldesleukin",10/17/2017 0:00:00,-1,0,0,0,"IL2RB",
"C131019",2,"Bempegaldesleukin",4/20/2018 0:00:00,-1,0,0,0,"CD8",
"C131129",1,"CV301",2/28/2018 0:00:00,-1,0,0,0,,
"C131175",1,"Sym013",10/15/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C131175",2,"Sym013",10/15/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C131175",3,"Sym013",10/15/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C131178",1,"Rucaparib Camsylate",7/16/2018 0:00:00,-1,0,0,0,"PARP1",
"C131178",2,"Rucaparib Camsylate",7/16/2018 0:00:00,-1,0,0,0,"PARP2",
"C131178",3,"Rucaparib Camsylate",7/16/2018 0:00:00,-1,0,0,0,"PARP3",
"C131213",1,"AR160",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C131289",1,"SGN-2FF",4/10/2018 0:00:00,-1,0,0,0,"fucosylation",
"C131291",1,"MTIG7192A",6/20/2017 0:00:00,-1,0,0,0,"TIGIT",
"C131294",1,"LYC-55716",1/16/2018 0:00:00,-1,0,0,0,"RORg",
"C131301",1,"PD-0360324",10/31/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C131334",1,"JS001",10/31/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C131335",1,"LY3214996",9/14/2018 0:00:00,-1,0,0,0,"ERK1",
"C131335",2,"LY3214996",9/14/2018 0:00:00,-1,0,0,0,"ERK2",
"C131492",1,"SKLB1028",10/18/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C131492",2,"SKLB1028",10/18/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C131492",3,"SKLB1028",10/18/2018 0:00:00,-1,0,0,0,"ABL","wildtype"
"C131496",1,"SXL01",10/18/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C131537",1,"FAZ053",10/31/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C131562",1,"PEN-221",3/4/2019 0:00:00,-1,0,0,0,"SSTR2",
"C131607",1,"BTP-114",9/14/2018 0:00:00,-1,0,0,0,,
"C131690",1,"BAY1436032",10/15/2018 0:00:00,-1,0,0,0,"IDH1","IDH1 R132 Mutant"
"C131825",1,"Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3",,-1,0,0,0,,
"C131828",1,"Anti-CD133-PE38-KDEL Fusion Protein",10/15/2018 0:00:00,-1,0,0,0,"PROM1","wildtype"
"C131874",1,"TRC253",10/18/2018 0:00:00,-1,0,0,0,"AR","wildtype and certain AR mutant"
"C1319",1,"Leuprolide Acetate",8/14/2018 0:00:00,-1,0,0,0,"GnRH",
"C131907",1,"BMS-986207",6/22/2017 0:00:00,-1,0,0,0,"TIGIT",
"C131909",1,"BPI-15086",10/18/2018 0:00:00,-1,0,0,0,"EGFR","EGFR T790M"
"C131910",1,"RGX-104",3/13/2018 0:00:00,-1,0,0,0,"NR1H2",
"C132013",1,"LY3200882",9/26/2017 0:00:00,-1,0,0,0,"TGFB1",
"C132017",1,"Anti-AXL Monoclonal Antibody-MMAE Conjugate",10/18/2018 0:00:00,-1,0,0,0,"AXL","wildtype"
"C132023",1,"CK-101",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C132025",1,"BPI-9016M",10/18/2018 0:00:00,-1,0,0,0,"AXL","wildtype"
"C132025",2,"BPI-9016M",10/18/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C1321",1,"OKT3",10/15/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C1321",2,"OKT3",10/15/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C1321",3,"OKT3",10/15/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C132112",1,"XMT-1522",9/14/2018 0:00:00,-1,0,0,0,"ERBB2",
"C132166",1,"GDC-0077",9/14/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C132166",2,"GDC-0077",9/14/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C132166",3,"GDC-0077",9/14/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C132166",4,"GDC-0077",9/14/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C132173",1,"K0706",10/18/2018 0:00:00,-1,0,0,0,"ABL1","ABL1 T315I"
"C132192",1,"CX-072",7/21/2017 0:00:00,-1,0,0,0,"CD274",
"C132250",1,"NIS793",5/4/2017 0:00:00,-1,0,0,0,"TGFB1",
"C132252",1,"BI 754091",5/23/2017 0:00:00,-1,0,0,0,"PDCD1",
"C132258",1,"MK-1454",1/23/2018 0:00:00,-1,0,0,0,"STING",
"C132266",1,"BMS-986179",6/20/2017 0:00:00,-1,0,0,0,"CD73",
"C132267",1,"BMS-986156",5/4/2017 0:00:00,-1,0,0,0,"TNFRSF18",
"C132295",1,"BLU-667",9/14/2018 0:00:00,-1,0,0,0,"RET",
"C132339",1,"REGN3767",5/4/2017 0:00:00,-1,0,0,0,"LAG3",
"C1326",1,"Doxorubicin Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,,
"C132681",1,"ABBV-428",2/28/2018 0:00:00,-1,0,0,0,"CD40",
"C132681",2,"ABBV-428",2/28/2018 0:00:00,-1,0,0,0,"TAA",
"C132851",1,"ALX148",3/1/2018 0:00:00,-1,0,0,0,"CD47",
"C132990",1,"PROSTVAC",3/1/2018 0:00:00,-1,0,0,0,,
"C132991",1,"APG-115",10/1/2018 0:00:00,-1,0,0,0,"MDM2",
"C132992",1,"IBI308",3/8/2018 0:00:00,-1,0,0,0,"PDCD1",
"C1333",1,"Dexrazoxane",2/21/2019 0:00:00,-1,0,0,0,,
"C13336",1,"PA700 Regulatory Module",,-1,0,0,0,,
"C133540",1,"SEL24",10/15/2018 0:00:00,-1,0,0,0,"FLT3","FLT3 Mutant"
"C133540",2,"SEL24",10/15/2018 0:00:00,-1,0,-1,0,"PIM1","wildtype"
"C133540",3,"SEL24",10/15/2018 0:00:00,-1,0,0,0,"PIM2","wildtype"
"C133540",4,"SEL24",10/15/2018 0:00:00,-1,0,0,0,"PIM3","wildtype"
"C133691",1,"HS-10296",7/17/2018 0:00:00,-1,0,0,0,"EGFR T790M",
"C133719",1,"Alflutinib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C133819",1,"MAK683",10/18/2018 0:00:00,-1,0,0,0,"EED","wildtype"
"C133821",1,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"ALK",
"C133821",2,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"ROS1",
"C133821",3,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"NTRK1",
"C133821",4,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"NTRK2",
"C133821",5,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"NTRK3",
"C133821",6,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"SRC",
"C133821",7,"TPX-0005",9/16/2018 0:00:00,-1,0,0,0,"PTK2",
"C133877",1,"Anti-CD40 Monoclonal Antibody",10/18/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C133878",1,"Anti-EGFR Monoclonal Antibody",10/15/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C134305",1,"Anti-LAG-3 Monoclonal Antibody",10/15/2018 0:00:00,-1,0,0,0,"LAG3","wildtype"
"C134448",1,"TAS-116",9/14/2018 0:00:00,-1,0,0,0,"HSP90A",
"C134448",2,"TAS-116",9/14/2018 0:00:00,-1,0,0,0,"HSP90B",
"C134967",1,"ASN003",10/1/2018 0:00:00,-1,-1,-1,0,"BRAF",
"C134967",2,"ASN003",10/1/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C134967",3,"ASN003",10/1/2018 0:00:00,-1,0,0,0,"PTEN",
"C134987",1,"LOXO-292",9/16/2018 0:00:00,-1,0,0,0,"RET",
"C135627",1,"PT2977",3/6/2019 0:00:00,-1,0,0,0,"HIF-2a",
"C135632",1,"AMV564",10/15/2018 0:00:00,-1,0,0,0,"CD33","wildtype"
"C135632",2,"AMV564",10/15/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C135632",3,"AMV564",10/15/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C135632",4,"AMV564",10/15/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C135633",1,"BMS-986218",7/18/2017 0:00:00,-1,0,0,0,"CTLA4",
"C135634",1,"LN-145",3/12/2018 0:00:00,-1,0,0,0,,
"C136416",1,"Vecabrutinib",10/15/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C136424",1,"DCC-3014",2/28/2018 0:00:00,-1,0,0,0,"CSF1R",
"C136426",1,"PF-06688992",12/18/2018 0:00:00,-1,0,0,0,"CD3",
"C136465",1,"AGEN2034",11/2/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C136782",1,"CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR",10/15/2018 0:00:00,-1,0,0,0,,
"C136823",1,"JNJ-64007957",10/19/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C136823",2,"JNJ-64007957",10/19/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C136823",3,"JNJ-64007957",10/19/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C136823",4,"JNJ-64007957",10/19/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C136823",5,"JNJ-64007957",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C136891",1,"Neratinib Maleate",10/19/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C136891",2,"Neratinib Maleate",10/19/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C136891",3,"Neratinib Maleate",10/19/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C136891",4,"Neratinib Maleate",10/19/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C136981",1,"MM-310",3/6/2019 0:00:00,-1,0,0,0,"EPHA2",
"C136983",1,"MGD009",1/29/2018 0:00:00,-1,0,0,0,"CD276",
"C136983",2,"MGD009",1/29/2018 0:00:00,-1,0,0,0,"CD3",
"C136987",1,"U3-1402",10/19/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C1374",1,"Goserelin",9/11/2018 0:00:00,-1,0,0,0,"GnRH",
"C137682",1,"Budigalimab",9/13/2017 0:00:00,-1,0,0,0,"PDCD1",
"C137800",1,"Rucaparib",2/26/2018 0:00:00,-1,0,0,0,"PARP1",
"C137800",2,"Rucaparib",9/17/2018 0:00:00,-1,0,0,0,"PARP2",
"C137800",3,"Rucaparib",9/17/2018 0:00:00,-1,0,0,0,"PARP3",
"C137818",1,"TAS3681",10/19/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C137819",1,"Allogeneic CD19-specific Universal CAR19-expressing T-lymphocytes",10/19/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C137820",1,"LY3321367",4/16/2018 0:00:00,-1,0,0,0,"HAVCR2",
"C137821",1,"MEDI7247",2/15/2019 0:00:00,-1,0,0,0,"ASCT2",
"C137825",1,"Enasidenib Mesylate",10/19/2018 0:00:00,-1,0,0,0,"IDH2","IDH2  R140Q, R172S, and R172K"
"C137863",1,"FATE-NK100",9/17/2018 0:00:00,-1,0,0,0,"KLRC2",
"C137863",2,"FATE-NK100",9/17/2018 0:00:00,-1,0,0,0,"B3GAT1",
"C137866",1,"Autologous CD19 CAR+ EGFRt + CD4+ and CD8+ T Cells",10/19/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C1379",1,"Fulvestrant",3/1/2018 0:00:00,-1,0,0,0,,
"C137950",1,"RAD140",10/19/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C137988",1,"FF-10101 succinate",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C138066",1,"ARQ 531",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype and BTK C481S"
"C138076",1,"M 3541",10/19/2018 0:00:00,-1,0,0,0,"ATM","wildtype"
"C138160",1,"LOXO-195",7/17/2018 0:00:00,-1,0,0,0,"NTRK1",
"C138160",2,"LOXO-195",7/17/2018 0:00:00,-1,0,0,0,"NTRK2",
"C138160",3,"LOXO-195",7/17/2018 0:00:00,-1,0,0,0,"NTRK3",
"C138164",1,"CT-1530",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C138165",1,"G1T38",7/17/2018 0:00:00,-1,0,0,0,"CDK4",
"C138165",2,"G1T38",7/17/2018 0:00:00,-1,0,0,0,"CDK6",
"C1382",1,"K 252a",10/1/2018 0:00:00,-1,0,0,0,"PRKCA",
"C1382",2,"K 252a",10/1/2018 0:00:00,-1,0,0,0,"PRKCB",
"C1382",3,"K 252a",10/1/2018 0:00:00,-1,0,0,0,"PRKCG",
"C138991",1,"Flumatinib",10/1/2018 0:00:00,-1,0,0,0,"BCR",
"C138991",2,"Flumatinib",10/1/2018 0:00:00,-1,0,0,0,"ABL",
"C138991",3,"Flumatinib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C138991",4,"Flumatinib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C138991",5,"Flumatinib",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C138994",1,"Copanlisib Hydrochloride",11/18/2019 0:00:00,-1,0,0,0,"PI3K",
"C138996",1,"Icotinib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C138997",1,"Anlotinib",2/20/2019 0:00:00,-1,0,0,0,"EGFR",
"C139004",1,"LY2874455",10/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C139004",2,"LY2874455",10/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C139004",3,"LY2874455",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C139004",4,"LY2874455",10/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C139549",1,"BFCR4350A",10/19/2018 0:00:00,-1,0,0,0,"FCRL5","wildtype"
"C139549",2,"BFCR4350A",10/19/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C139549",3,"BFCR4350A",10/19/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C139549",4,"BFCR4350A",10/19/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C139549",5,"BFCR4350A",10/19/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C139550",1,"BMS-813160",4/16/2018 0:00:00,-1,0,0,0,"CCR2",
"C139550",2,"BMS-813160",4/16/2018 0:00:00,-1,0,0,0,"CCR5",
"C139552",1,"SY-1365",2/22/2019 0:00:00,-1,0,0,0,"CDK7",
"C139553",1,"ABBV-927",5/2/2018 0:00:00,-1,0,0,0,"CD40",
"C139559",1,"TNO155",9/16/2018 0:00:00,-1,0,0,0,"PTPN11",
"C139730",1,"ACTR707",10/19/2018 0:00:00,-1,0,0,0,"FCGR3A","wildtype"
"C139800",1,"ADCT-502",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C140041",1,"MK-7684",1/15/2018 0:00:00,-1,0,0,0,"TIGIT",
"C140162",1,"RO7198457",2/21/2019 0:00:00,-1,0,0,0,,
"C140310",1,"bb21217",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype and BTK Mutant"
"C140354",1,"SAR439859",10/19/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C140354",2,"SAR439859",10/19/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C140379",1,"ONO-7579",10/19/2018 0:00:00,-1,0,0,0,"NTRK1","wildtype"
"C140379",2,"ONO-7579",10/19/2018 0:00:00,-1,0,0,0,"NTRK2","wildtype"
"C140379",3,"ONO-7579",10/19/2018 0:00:00,-1,0,0,0,"NTRK3","wildtype"
"C140427",1,"TAK-573",10/19/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C140551",1,"IRX4204",10/2/2018 0:00:00,-1,0,0,0,"RXRA",
"C141074",1,"KO-947",9/14/2018 0:00:00,-1,0,0,0,"MAPK1",
"C141074",2,"KO-947",9/14/2018 0:00:00,-1,0,0,0,"MAPK3",
"C1411",1,"Paclitaxel",3/1/2018 0:00:00,-1,0,0,0,,
"C141135",1,"linrodostat",4/16/2018 0:00:00,-1,0,0,0,"IDO1",
"C141136",1,"ALK Inhibitor",10/19/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C141215",1,"Anti-CD20 Monoclonal Antibody",10/19/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C141273",1,"Poseltinib",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C141298",1,"CV301",10/19/2018 0:00:00,-1,0,0,0,,
"C1413",1,"Topotecan",3/1/2018 0:00:00,-1,0,0,0,,
"C1414",1,"Trioxifene Mesylate",10/19/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C141419",1,"Recombinant Human Interleukin-22 IgG2-Fc",10/19/2018 0:00:00,-1,0,0,0,"IL22RA1","wildtype"
"C141420",1,"PF-06804103",9/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C141421",1,"ASP8374",2/27/2019 0:00:00,-1,0,0,0,,
"C141425",1,"Spebrutinib Besylate",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C141426",1,"Tirabrutinib Hydrochloride",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C141427",1,"Evobrutinib",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C141428",1,"Zanubrutinib",10/19/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C141430",1,"Voruciclib",10/2/2018 0:00:00,-1,0,0,0,"CDK4",
"C141430",2,"Voruciclib",10/2/2018 0:00:00,-1,0,0,0,"CDK6",
"C141432",1,"Milademetan",10/19/2018 0:00:00,-1,0,0,0,"MDM2","wildtype"
"C141443",1,"PF-04217903 Monophosphate",10/19/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C141494",1,"HER2-Positive by Immunohistochemistry",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C1417",1,"Goserelin Acetate",3/6/2019 0:00:00,-1,0,0,0,,
"C142077",1,"MK-4280",4/16/2018 0:00:00,-1,0,0,0,"LAG3",
"C142137",1,"mRNA-2416",10/19/2018 0:00:00,-1,-1,0,0,"TNFRSF4","wildtype"
"C142139",1,"INO-140",10/12/2018 0:00:00,-1,0,0,0,,
"C142168",1,"MGA012",4/16/2018 0:00:00,-1,0,0,0,"PDCD1",
"C142177",1,"GSK3326595",2/15/2019 0:00:00,-1,0,0,0,"PRMT5",
"C142205",1,"Autologous CD4 and CD8 Positive Truncated CD19-expressing Antigen Presenting T-cells",10/12/2018 0:00:00,-1,0,0,0,,
"C142374",1,"NIR178",7/12/2018 0:00:00,-1,0,0,0,"ADORA2A",
"C142807",1,"FCARH143",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C142813",1,"SPL-108",10/12/2018 0:00:00,-1,0,0,0,"CD44","wildtype"
"C142821",1,"OMP-313M32",1/15/2018 0:00:00,-1,0,0,0,"TIGIT",
"C142822",1,"BION-1301",10/19/2018 0:00:00,-1,0,0,0,"TNFSF13","wildtype"
"C142826",1,"TRK-950",4/1/2019 0:00:00,-1,0,0,0,,
"C142864",1,"P-BCMA-101",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C142865",1,"Sym021",4/16/2018 0:00:00,-1,0,0,0,"PDCD1",
"C142866",1,"CB-1158",4/16/2018 0:00:00,-1,0,0,0,"arginase",
"C142889",1,"GBR 1302",10/12/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C142890",1,"PRS-343",4/16/2018 0:00:00,-1,0,0,0,"TNFRSF9",
"C142890",2,"PRS-343",4/16/2018 0:00:00,-1,0,0,0,"ERBB2",
"C142941",1,"Avatrombopag Maleate",10/12/2018 0:00:00,-1,0,-1,0,"MPL","wildtype"
"C142978",1,"TSR-033",4/16/2018 0:00:00,-1,0,0,0,"LAG3",
"C142980",1,"H3B-6545",10/12/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C142998",1,"Triciribine",10/1/2018 0:00:00,-1,0,0,0,"AKT",
"C143006",1,"DV281",4/16/2018 0:00:00,-1,0,0,0,"TLR9",
"C143046",1,"Ralimetinib",10/1/2018 0:00:00,-1,-1,-1,0,"MAPK14",
"C143059",1,"MVA-BN-CV301",10/12/2018 0:00:00,-1,0,0,0,,
"C143060",1,"Autologous Gamma-retroviral MSGV1 139 scFv EGFRvIII CAR Gene-modified T Cells",10/12/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C143067",1,"INCB062079",10/12/2018 0:00:00,-1,0,0,0,"FGFR4","wildtype"
"C143068",1,"LY3381916",4/16/2018 0:00:00,-1,0,0,0,"IDO1",
"C1431",1,"Imiquimod",3/1/2018 0:00:00,-1,0,0,0,,
"C143155",1,"OMP-336B11",4/16/2018 0:00:00,-1,0,0,0,"TNFRSF18",
"C143156",1,"Anti-CD19-CD20-CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes",10/12/2018 0:00:00,-1,0,0,0,,
"C143953",1,"Ad-RTS-hIL-12",10/12/2018 0:00:00,-1,0,0,0,,
"C143957",1,"MGD013",7/26/2017 0:00:00,-1,0,0,0,"PDCD1",
"C143957",2,"MGD013",7/26/2017 0:00:00,-1,0,0,0,"LAG3",
"C1452",1,"Enoxaparin",,-1,0,0,0,,
"C146667",1,"HTI-1066",2/12/2019 0:00:00,-1,0,0,0,"MET",
"C146762",1,"BMS-986226",11/7/2017 0:00:00,-1,0,0,0,"ICOS",
"C146765",1,"BMS-986249",12/18/2017 0:00:00,-1,0,0,0,"CTLA4",
"C1468",1,"Mycophenolate Mofetil",7/16/2019 0:00:00,-1,0,0,0,,
"C146807",1,"BAY1895344",12/18/2018 0:00:00,-1,0,0,0,"ATR",
"C146808",1,"CJM112",7/28/2017 0:00:00,-1,0,0,0,"IL17A",
"C146810",1,"TAS0728",7/23/2018 0:00:00,-1,0,0,0,"ERBB2",
"C146820",1,"XmAb18087",10/12/2018 0:00:00,-1,0,0,0,"SSTR2","wildtype"
"C146824",1,"AMG 596",10/19/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C146824",2,"AMG 596",10/19/2018 0:00:00,-1,-1,0,0,"CD3D","wildtype"
"C146824",3,"AMG 596",10/19/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C146824",4,"AMG 596",10/19/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C146824",5,"AMG 596",10/19/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C146853",1,"CGX1321",5/8/2018 0:00:00,-1,0,0,0,"PORCN",
"C146854",1,"ABBV-621",7/17/2018 0:00:00,-1,0,0,0,"TRAIL",
"C146860",1,"PF-06863135",10/19/2018 0:00:00,-1,0,-1,0,"CD3D","wildtype"
"C146860",2,"PF-06863135",10/19/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C146860",3,"PF-06863135",10/19/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C146860",4,"PF-06863135",10/19/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C146860",5,"PF-06863135",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C146862",1,"SAR-439459",9/19/2018 0:00:00,-1,0,0,0,"TGFB1",
"C146993",1,"Androgen Receptor Inhibitor",10/12/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C147026",1,"AMG 673",10/22/2018 0:00:00,-1,0,0,0,"CD33","wildtype"
"C147026",2,"AMG 673",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C147026",3,"AMG 673",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C147026",4,"AMG 673",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C147026",5,"AMG 673",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C147027",1,"AMG 757",10/22/2018 0:00:00,-1,0,0,0,"DLL3","wildtype"
"C147027",2,"AMG 757",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C147027",3,"AMG 757",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C147027",4,"AMG 757",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C147027",5,"AMG 757",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C147028",1,"AMG 701",10/19/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C147028",2,"AMG 701",10/19/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C147028",3,"AMG 701",10/19/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C147028",4,"AMG 701",10/19/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C147028",5,"AMG 701",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17)","wildtype"
"C147030",1,"GDC-9545",10/22/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C147030",2,"GDC-9545",10/22/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C1471",1,"Lamivudine",9/16/2018 0:00:00,-1,0,0,0,"HIV-1",
"C147125",1,"Avitinib",10/22/2018 0:00:00,-1,0,0,0,"EGFR","EGFR L858R/T790M double mutations"
"C147125",2,"Avitinib",10/22/2018 0:00:00,-1,0,0,0,"JAK3","wildtype"
"C147125",3,"Avitinib",10/22/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C147134",1,"Allogeneic Double Negative T Cells",10/22/2018 0:00:00,-1,0,0,0,,
"C1474",1,"Filgrastim",7/28/2017 0:00:00,-1,0,0,0,"G-CSF",
"C147521",1,"AZD4785",9/16/2018 0:00:00,-1,0,0,0,"KRAS",
"C147523",1,"JCARH125",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C147534",1,"JNJ-64407564",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C147534",2,"JNJ-64407564",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C147534",3,"JNJ-64407564",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C147534",4,"JNJ-64407564",10/22/2018 0:00:00,-1,0,-1,0,"CD3","wildtype"
"C147534",5,"JNJ-64407564",10/22/2018 0:00:00,-1,0,0,0,"GPRC5D","wildtype"
"C147563",1,"GBR 1342",10/22/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C147563",2,"GBR 1342",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C147563",3,"GBR 1342",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C147563",4,"GBR 1342",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C147563",5,"GBR 1342",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C147577",1,"XMT-1536",10/1/2018 0:00:00,-1,0,0,0,"SLC34A2",
"C148039",1,"AZD4635",7/24/2017 0:00:00,-1,0,0,0,"ADORA2A",
"C148042",1,"BMS-986258",4/10/2018 0:00:00,-1,0,0,0,"HAVCR2",
"C148078",1,"TAK-079",10/22/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C148133",1,"Autologous PD-1 Antibody-expressing Mesothelin-specific CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C148134",1,"DS-1001",10/22/2018 0:00:00,-1,0,0,0,"IDH1","IDH1 R132"
"C148135",1,"iC9-GD2-CAR-CD28-OX40-expressing Autologous NKT Cells",10/22/2018 0:00:00,-1,0,0,0,,
"C148141",1,"MCLA117",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C148141",2,"MCLA117",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C148141",3,"MCLA117",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C148141",4,"MCLA117",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C148141",5,"MCLA117",10/22/2018 0:00:00,-1,0,0,0,"CLEC12A","wildtype"
"C148145",2,"lutetium Lu 177-PSMA-617",8/27/2019 0:00:00,-1,0,0,0,"FOLH1",
"C148146",1,"PD-L1 Peptide Vaccine",10/22/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C148147",1,"Lazertinib",10/22/2018 0:00:00,-1,0,0,0,"EGFR","EGFR Del19/T790M, L858R/T790M, Del19, L858R and wildtype"
"C148154",1,"PD-L1/IDO Peptide Vaccine",10/22/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C148154",2,"PD-L1/IDO Peptide Vaccine",10/22/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C148154",3,"PD-L1/IDO Peptide Vaccine",10/22/2018 0:00:00,-1,0,0,0,"IDO2","wildtype"
"C148154",4,"PD-L1/IDO Peptide Vaccine",10/22/2018 0:00:00,-1,0,0,0,"IDO","wildtype"
"C148155",1,"BCD-100",10/22/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C148156",1,"Autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T-lymphocytes",10/22/2018 0:00:00,-1,0,0,0,,
"C148158",1,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"BRAF","wildtype and BRAF V600E"
"C148158",2,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C148158",3,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C148158",4,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C148158",5,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C148158",6,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C148158",7,"RXDX-105",10/22/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C148159",1,"Genolimzumab",10/22/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C148162",1,"CON-4619",10/22/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C148165",1,"BI-CON-02",10/22/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C148168",1,"Autologous EGFRt/BCMA-41BBz-targeted CAR T Cells",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C148176",1,"SEA-BCMA",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C148177",1,"Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes",10/22/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C148180",1,"PD-1 knockout EBV-specific Cytotoxic T Lymphocytes",10/22/2018 0:00:00,-1,0,0,0,,
"C148185",1,"CRISPR/Cas9-edited HPV16/18 E6/E7 Plasmid",10/22/2018 0:00:00,-1,0,0,0,,
"C148186",1,"TALEN-edited HPV16/18 E6/E7 Plasmid",10/22/2018 0:00:00,-1,0,0,0,,
"C148187",1,"RGT100",10/22/2018 0:00:00,-1,0,0,0,"DDX58","wildtype"
"C148213",1,"Donor-derived Cytokine-induced Memory-like Natural Killer Cells",10/22/2018 0:00:00,-1,0,0,0,,
"C148215",1,"Allogeneic iC9/CD19-CAR-CD28-zeta-2A-IL15-transduced Cord Blood-derived Natural Killer Cells",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C148216",1,"Autologous PD-L1/CD80/CD86-targeted CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C148216",2,"Autologous PD-L1/CD80/CD86-targeted CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD80","wildtype"
"C148216",3,"Autologous PD-L1/CD80/CD86-targeted CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD86","wildtype"
"C148229",1,"LY294002",10/1/2018 0:00:00,-1,0,0,0,"BRD2",
"C148229",2,"LY294002",10/1/2018 0:00:00,-1,0,0,0,"BRD3",
"C148229",3,"LY294002",10/1/2018 0:00:00,-1,0,0,0,"BRD4",
"C148229",4,"LY294002",10/1/2018 0:00:00,-1,0,0,0,"BRDT",
"C148229",5,"LY294002",10/1/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C148235",1,"MK-7162",12/18/2017 0:00:00,-1,0,0,0,"IDO1",
"C148241",1,"Autologous Dendritic Cells Transduced with Wild-type p53 Adenovirus Vaccine",10/22/2018 0:00:00,-1,0,0,0,"TP53","wildtype and TP53 Mutant"
"C148289",1,"NKTR-262",4/10/2018 0:00:00,-1,0,0,0,"TLR7",
"C148289",2,"NKTR-262",4/10/2018 0:00:00,-1,0,0,0,"TLR8",
"C148400",1,"MVA-BN-Brachyury-TRICOM Vaccine",10/22/2018 0:00:00,-1,0,0,0,,
"C148402",1,"FPV-Brachyury-TRICOM Vaccine",10/22/2018 0:00:00,-1,0,-1,0,,
"C148410",1,"Milciclib",10/1/2018 0:00:00,-1,0,0,0,"CDK2",
"C148410",2,"Milciclib",10/1/2018 0:00:00,-1,0,0,0,"NTRK1",
"C148410",3,"Milciclib",10/1/2018 0:00:00,-1,0,0,0,"CDK7",
"C148410",4,"Milciclib",10/1/2018 0:00:00,-1,0,0,0,"CDK4",
"C148410",5,"Milciclib",10/1/2018 0:00:00,-1,0,0,0,"CDK5",
"C148416",1,"MEDI5083",5/21/2018 0:00:00,-1,0,0,0,"CD40",
"C148435",1,"PBF-1129",3/5/2019 0:00:00,-1,0,0,0,"ADORA2B","wildtype"
"C148455",1,"CA-4948",10/22/2018 0:00:00,-1,0,0,0,"IRAK4","wildtype"
"C148462",1,"LOAd703",10/22/2018 0:00:00,-1,0,0,0,,
"C148485",1,"ONC1-0013B",10/22/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C148486",1,"RO7082859",10/22/2018 0:00:00,-1,0,0,0,"CD20","wildtype"
"C148486",2,"RO7082859",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C148486",3,"RO7082859",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C148486",4,"RO7082859",10/22/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C148486",5,"RO7082859",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C148490",1,"Autologous CD5-specific CAR-28 zeta CAR T-cells",10/22/2018 0:00:00,-1,0,0,0,"CD5","wildtype"
"C148496",1,"Autologous PSMA-specific TGFb-resistant CAR T Cells",10/15/2018 0:00:00,-1,0,0,0,,
"C148498",1,"LCAR-B38M",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C148499",1,"Allogeneic interleukin-17-producing CD8-positive T-cells",10/15/2018 0:00:00,-1,0,0,0,,
"C148501",1,"LY3295668 Erbumine",8/27/2019 0:00:00,-1,0,0,0,"AURKA",
"C148506",1,"Autologous BCMA-4-1BBz-targeted CAR T-cells",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C148507",1,"AVID100",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C148513",1,"TQ-B3139",10/15/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C148513",2,"TQ-B3139",10/15/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C148518",1,"EPS8 Peptide-specific Dendritic Cells",10/15/2018 0:00:00,-1,0,0,0,"EPS8","wildtype"
"C148520",1,"BAY 1161116",10/15/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C148522",1,"SNS-301",8/12/2019 0:00:00,-1,0,0,0,"ASPH",
"C148523",1,"Autologous CD38-4SCAR-expressing T-cells 4SCAR38",10/22/2018 0:00:00,-1,0,0,0,,
"C148524",1,"Autologous CD22-4SCAR-expressing T-cells 4SCAR22",10/22/2018 0:00:00,-1,0,0,0,,
"C148525",1,"Autologous CD20-4SCAR-expressing T-cells 4SCAR20",10/22/2018 0:00:00,-1,0,0,0,,
"C148526",1,"Autologous CD123-4SCAR-expressing T-cells 4SCAR123",10/22/2018 0:00:00,-1,0,0,0,,
"C148529",1,"Ningetinib",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C148529",2,"Ningetinib",10/1/2018 0:00:00,-1,0,0,0,"KDR",
"C148529",3,"Ningetinib",10/1/2018 0:00:00,-1,0,0,0,"AXL",
"C148529",4,"Ningetinib",10/1/2018 0:00:00,-1,0,0,0,"MERTK",
"C148529",5,"Ningetinib",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C148532",1,"HMPL 689",10/22/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C148533",1,"PLB 1003",10/22/2018 0:00:00,-1,0,0,0,"ALK","wildtype"
"C148535",1,"SHR-1316",10/15/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C148537",1,"OMO-1",10/22/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C148543",1,"Anti-CD3/MUC1 Antibody-armed PD-1 Inhibitor-induced Cytokine-induced Killer Cells",10/22/2018 0:00:00,-1,0,0,0,"MUC1","wildtype"
"C148543",2,"Anti-CD3/MUC1 Antibody-armed PD-1 Inhibitor-induced Cytokine-induced Killer Cells",10/22/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C148543",3,"Anti-CD3/MUC1 Antibody-armed PD-1 Inhibitor-induced Cytokine-induced Killer Cells",10/22/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C148543",4,"Anti-CD3/MUC1 Antibody-armed PD-1 Inhibitor-induced Cytokine-induced Killer Cells",10/22/2018 0:00:00,-1,-1,0,0,"CD3G","wildtype"
"C148543",5,"Anti-CD3/MUC1 Antibody-armed PD-1 Inhibitor-induced Cytokine-induced Killer Cells",10/22/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C1492",1,"Sargramostim",3/1/2018 0:00:00,-1,0,0,0,,
"C1498",1,"Aldesleukin",3/1/2018 0:00:00,-1,0,0,0,"IL2RB",
"C1498",2,"Aldesleukin",3/1/2018 0:00:00,-1,0,0,0,"IL2RG",
"C150127",1,"MEDI2228",10/19/2018 0:00:00,-1,0,0,0,"TNFRSF17","wildtype"
"C150167",1,"AZD1390",10/1/2018 0:00:00,-1,0,0,0,"ATM",
"C150216",1,"APX3330",10/22/2018 0:00:00,-1,0,0,0,"APEX1","wildtype"
"C150248",1,"ASN007",9/17/2018 0:00:00,-1,0,0,0,"MAPK1",
"C150248",2,"ASN007",9/17/2018 0:00:00,-1,0,0,0,"MAPK3",
"C150363",1,"TTC-352",10/15/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C150376",1,"BMS-986310",10/23/2018 0:00:00,-1,0,0,0,,
"C150378",1,"Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T Lymphocytes BinD19",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C150383",1,"HMPL-453",10/22/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C150383",2,"HMPL-453",10/22/2018 0:00:00,-1,0,0,0,"FGFR2","wildtype"
"C150383",3,"HMPL-453",10/22/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C150393",1,"NLG802",2/2/2018 0:00:00,-1,0,0,0,"IDO1",
"C150401",1,"CV8102",10/22/2018 0:00:00,-1,0,0,0,,
"C150403",1,"BI 754111",6/5/2017 0:00:00,-1,0,0,0,"LAG3",
"C150413",1,"CB-839 Hydrochloride",5/21/2019 0:00:00,-1,0,0,0,,
"C150463",1,"XmAb20717",7/16/2018 0:00:00,-1,0,0,0,"PDCD1",
"C150463",2,"XmAb20717",7/16/2018 0:00:00,-1,0,0,0,"CTLA4",
"C150507",1,"BI 891065",7/18/2018 0:00:00,-1,0,0,0,"IAPs",
"C150517",1,"ETBX-021",10/22/2018 0:00:00,-1,0,0,0,,
"C150518",3,"Autologous Anti-EGFRvIII 4SCAR-IgT Cells",10/22/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C150552",1,"G1T48",10/22/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C150558",1,"CDX-1140",1/8/2018 0:00:00,-1,0,0,0,"CD40",
"C150560",1,"Sym023",5/8/2018 0:00:00,-1,0,0,0,"HAVCR2",
"C150585",1,"RXDX-106",10/22/2018 0:00:00,-1,0,0,0,"AXL","wildtype"
"C150585",2,"RXDX-106",10/22/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C150585",3,"RXDX-106",10/22/2018 0:00:00,-1,0,0,0,"TYRO3","wildtype"
"C150585",4,"RXDX-106",10/22/2018 0:00:00,-1,0,0,0,"MERTK","wildtype"
"C150585",5,"RXDX-106",10/22/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C150590",1,"ABBV-321",9/17/2018 0:00:00,-1,0,0,0,"EGFR",
"C150671",1,"Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C150675",1,"CBT-101",9/16/2018 0:00:00,-1,0,0,0,"MET",
"C150679",1,"MK-1308",7/26/2017 0:00:00,-1,0,0,0,"CTLA4",
"C150680",1,"SHR 7390",10/22/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C150682",1,"Autologous Mesothelin-specific CAR-T-Cells Expressing Anti-PD-1/CTLA-4 Antibodies",10/22/2018 0:00:00,-1,0,0,0,,
"C150695",1,"Autologous EGFR-specific CAR-T-Cells Expressing Anti-PD-1/CTLA-4 Antibodies",10/22/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C150698",1,"Autologous FRa-4SCAR-expressing T-cells 4SCAR-Fra",10/22/2018 0:00:00,-1,0,0,0,,
"C150699",1,"Autologous PSMA-4SCAR-expressing T-cells 4SCAR-PSMA",10/22/2018 0:00:00,-1,0,0,0,,
"C150734",1,"FS118",5/8/2018 0:00:00,-1,0,0,0,"LAG3",
"C150734",2,"FS118",5/8/2018 0:00:00,-1,0,0,0,"CD274",
"C150807",1,"TAR-200",10/23/2018 0:00:00,-1,0,0,0,,
"C150906",1,"Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C151407",1,"MRX-2843",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C151407",2,"MRX-2843",10/1/2018 0:00:00,-1,0,0,0,"MERTK",
"C1518",1,"Raloxifene",10/22/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C1519",1,"Roquinimex",,-1,0,0,0,,
"C151927",1,"GX-I7",9/10/2019 0:00:00,-1,0,0,0,,
"C151932",1,"C188-9",10/22/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C151935",1,"Anti-CD19/CD20/CD22/CD30 CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C151935",2,"Anti-CD19/CD20/CD22/CD30 CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD20","wildtype"
"C151935",3,"Anti-CD19/CD20/CD22/CD30 CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD22","wildtype"
"C151935",4,"Anti-CD19/CD20/CD22/CD30 CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD30","wildtype"
"C151942",1,"IMA970A",10/22/2018 0:00:00,-1,0,0,0,,
"C151943",1,"AZD5153",10/1/2018 0:00:00,-1,0,0,0,"BRD4",
"C151944",1,"Autologous PD1-inhibiting Anti-CD19 4-1BB CAR T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C151945",1,"HTI-1090",10/22/2018 0:00:00,-1,0,0,0,"ID01","wildtype"
"C151947",1,"CK-301",10/22/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C151952",1,"CHO H01",10/22/2018 0:00:00,-1,0,0,0,"CD20","wildtype"
"C151953",1,"PEN-866",3/5/2019 0:00:00,-1,0,0,0,"HSP90",
"C151954",1,"Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"MUC1","wildtype"
"C151954",2,"Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD33","wildtype"
"C151954",3,"Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C151954",4,"Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD56","wildtype"
"C151954",5,"Autologous Anti-Muc1/CD33/CD38/CD56/CD123 Gene-engineered CAR-T Cells",10/22/2018 0:00:00,-1,0,0,0,"CD123","wildtype"
"C151958",1,"HPV16-E7-T512",10/22/2018 0:00:00,-1,0,0,0,,
"C151968",1,"MDR-101",10/22/2018 0:00:00,-1,0,0,0,,
"C151988",1,"PF-06873600",9/24/2018 0:00:00,-1,0,0,0,"CDK4",
"C151988",2,"PF-06873600",9/24/2018 0:00:00,-1,0,0,0,"CDK6",
"C151994",1,"DSP-0337",10/22/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C152075",1,"Modotuximab",9/24/2018 0:00:00,-1,0,0,0,"EGFR",
"C152162",1,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"ABL",
"C152162",2,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C152162",3,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"SRC",
"C152162",4,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"LYN",
"C152162",5,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"FGR",
"C152162",6,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"HCK",
"C152162",7,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"KDR",
"C152162",8,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"TEK",
"C152162",9,"Rebastinib",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C152216",1,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"PLK1","wildtype"
"C152216",2,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C152216",3,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C152216",4,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"BCR","wildtype"
"C152216",5,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C152216",6,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"BCR-ABL","wildtype"
"C152216",7,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C152216",8,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C152216",9,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"FYN","wildtype"
"C152216",10,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"CDK1","wildtype"
"C152216",11,"Rigosertib",11/2/2018 0:00:00,-1,0,0,0,"PLK2","wildtype"
"C152323",1,"Selicrelumab",7/18/2018 0:00:00,0,0,0,0,"CD40",
"C152494",1,"Talazoparib Tosylate",7/17/2018 0:00:00,-1,0,0,0,"PARP",
"C152514",1,"Tarloxotinib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C152547",1,"Telisotuzumab Vedotin",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C1526",1,"Docetaxel",3/1/2018 0:00:00,-1,0,0,0,,
"C15262",1,"Immunotherapy",9/17/2018 0:00:00,-1,0,0,0,"general",
"C152632",1,"Tilsotolimod",10/21/2019 0:00:00,-1,0,0,0,"TLR9",
"C15269",1,"Leukapheresis",8/14/2018 0:00:00,-1,0,0,0,"CD8",
"C1527",1,"Letrozole",3/1/2018 0:00:00,-1,0,0,0,,
"C152711",1,"Trametinib Dimethyl Sulfoxide",10/21/2019 0:00:00,-1,0,0,0,"MAP2K1",
"C152711",2,"Trametinib Dimethyl Sulfoxide",10/21/2019 0:00:00,-1,0,0,0,"MAP2K2",
"C152716",1,"Trastuzumab Deruxtecan",6/20/2017 0:00:00,-1,0,0,0,"ERBB2",
"C152795",1,"Umbralisib Tosylate",10/22/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C152971",1,"Futuximab",9/24/2018 0:00:00,-1,0,0,0,"EGFR",
"C152976",1,"DS-1205a",9/17/2018 0:00:00,-1,0,0,0,"AXL",
"C153083",1,"Autologous CD8+ SLC45A2-specific T Lymphocytes",10/22/2018 0:00:00,-1,0,0,0,"SLC45A2","wildtype"
"C153094",1,"TetMYB DNA Vaccine",10/1/2018 0:00:00,-1,0,0,0,"MYB",
"C153095",1,"Epitinib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C153097",1,"CD137L/Epstein-Barr Virus-Targeting Autologous Dendritic Cell Vaccine",10/22/2018 0:00:00,-1,0,0,0,,
"C153116",1,"VMD-928",7/16/2018 0:00:00,-1,0,0,0,"NTRK1",
"C153118",1,"PZ01",10/22/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C153122",1,"INCB081776",8/13/2018 0:00:00,-1,0,0,0,"AXL",
"C153122",2,"INCB081776",8/13/2018 0:00:00,-1,0,0,0,"MERTK",
"C153129",1,"REGN4018",7/12/2018 0:00:00,-1,0,0,0,"MUC16",
"C153129",2,"REGN4018",7/12/2018 0:00:00,-1,0,0,0,"CD3",
"C15313",1,"Radiation Therapy",3/1/2018 0:00:00,-1,0,0,0,,
"C153130",1,"Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso",10/22/2018 0:00:00,-1,0,0,0,"CTAG1B",
"C153130",2,"Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso",10/22/2018 0:00:00,-1,0,0,0,"CTAG2",
"C153147",1,"AMG 424",10/23/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C153147",2,"AMG 424",10/23/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C153147",3,"AMG 424",10/23/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C153147",4,"AMG 424",10/23/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C153147",5,"AMG 424",10/23/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C153149",1,"LZM009",9/25/2018 0:00:00,-1,-1,0,0,"PDCD1",
"C153173",1,"ZN-e4",7/17/2018 0:00:00,-1,0,0,0,"EGFR T790M et al",
"C153180",1,"AG-270",7/17/2018 0:00:00,-1,0,0,0,"MAT2A",
"C153205",1,"Chemokine Modulation Therapy",2/6/2019 0:00:00,-1,0,0,0,"CXCR",
"C153211",1,"MCLA-128",9/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C153211",2,"MCLA-128",9/17/2018 0:00:00,-1,0,0,0,"ERBB3",
"C153214",1,"Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA",10/23/2018 0:00:00,-1,0,0,0,,
"C153215",1,"Anti-CD19/CD3 BiTE Antibody AMG 562",10/23/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C153215",2,"Anti-CD19/CD3 BiTE Antibody AMG 562",10/23/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C153215",3,"Anti-CD19/CD3 BiTE Antibody AMG 562",10/23/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C153215",4,"Anti-CD19/CD3 BiTE Antibody AMG 562",10/23/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C153215",5,"Anti-CD19/CD3 BiTE Antibody AMG 562",10/23/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C153259",1,"GEN1029",10/23/2018 0:00:00,-1,0,0,0,"TNFRSF10B","wildtype"
"C1533",1,"Pemetrexed Disodium",3/1/2018 0:00:00,-1,0,0,0,,
"C153309",1,"CORT125281",2/12/2019 0:00:00,-1,0,0,0,"GR",
"C153312",1,"MDA-TIL",10/23/2018 0:00:00,-1,0,0,0,,
"C153314",1,"DSP-0509",10/8/2019 0:00:00,-1,0,0,0,"TLR7",
"C153353",1,"Pterostilbene",10/23/2018 0:00:00,-1,0,0,0,,
"C153354",1,"RGX-202",9/21/2018 0:00:00,-1,0,0,0,"SLC6A8",
"C153375",1,"Nidanilimab",10/23/2018 0:00:00,-1,0,0,0,"IL1RAP","wildtype"
"C153379",1,"AK104",10/23/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C153379",2,"AK104",10/23/2018 0:00:00,-1,0,0,0,"CTLA4","wildtype"
"C1540",1,"Tyrphostin A46",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C154287",1,"AMG 510",1/17/2019 0:00:00,-1,0,0,0,"KRAS","G12C"
"C154332",1,"HS-196",3/5/2019 0:00:00,-1,0,0,0,"HSP90",
"C1544",1,"Romidepsin",6/20/2017 0:00:00,-1,0,0,0,"HDAC",
"C15445",1,"Endocrine Therapy",2/1/2019 0:00:00,-1,0,0,0,,
"C1545",1,"IL15",2/28/2018 0:00:00,-1,0,0,0,"IL15",
"C154550",1,"CS1001",1/4/2019 0:00:00,-1,0,0,0,"CD274",
"C154553",1,"GNS561",3/5/2019 0:00:00,-1,0,0,0,"SLCT",
"C154627",1,"Daromun",3/4/2019 0:00:00,-1,0,0,0,,
"C154674",1,"CBM588",5/3/2019 0:00:00,-1,0,0,0,,
"C15481",1,"Antiandrogen Therapy",3/1/2019 0:00:00,-1,0,0,0,,
"C1555",1,"Pegylated Liposomal Doxorubicin Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,,
"C155746",1,"mFOLFOX6",11/27/2018 0:00:00,-1,0,0,0,,
"C155785",1,"ASTX029",7/16/2018 0:00:00,-1,0,0,0,"MAPK1",
"C155785",2,"ASTX029",7/16/2018 0:00:00,-1,0,0,0,"MAPK3",
"C155799",1,"Filgotinib",10/2/2018 0:00:00,-1,0,0,0,"JAK1",
"C155799",2,"Filgotinib",10/2/2018 0:00:00,-1,0,0,0,"JAK2",
"C155799",3,"Filgotinib",10/2/2018 0:00:00,-1,0,0,0,"JAK3",
"C155799",4,"Filgotinib",10/2/2018 0:00:00,-1,0,0,0,"TYK2",
"C155813",1,"SNDX-6352",9/26/2017 0:00:00,-1,0,0,0,"CSF1R",
"C155850",1,"RMC-4630",2/22/2019 0:00:00,-1,0,0,0,"PTPN11",
"C155907",1,"EDP1503",2/28/2019 0:00:00,-1,0,0,0,,
"C155931",1,"MSB2311",5/8/2018 0:00:00,-1,0,0,0,"CD274",
"C155940",1,"DHES0815A",11/9/2018 0:00:00,0,0,0,0,"ERBB2",
"C155945",1,"BMS-986299",4/10/2018 0:00:00,-1,0,0,0,,
"C155967",1,"FPA150",5/8/2018 0:00:00,-1,0,0,0,"VTCN1",
"C156017",1,"AVB-S6-500",2/11/2019 0:00:00,-1,0,0,0,"AXL",
"C156061",1,"CPI-006",4/10/2018 0:00:00,-1,0,0,0,"CD73",
"C156141",1,"BA3011",3/4/2019 0:00:00,-1,0,0,0,"AXL",
"C156177",1,"Sym022",5/8/2018 0:00:00,-1,0,0,0,"LAG3",
"C156395",1,"BDB001",4/10/2018 0:00:00,-1,0,0,0,"TLR7",
"C156395",2,"BDB001",4/10/2018 0:00:00,-1,0,0,0,"TLR9",
"C156415",1,"KRT-232",4/24/2019 0:00:00,-1,0,0,0,"MDM2",
"C156458",1,"BI-1206",2/27/2020 0:00:00,-1,0,0,0,"CD32B",
"C156480",1,"A166",9/21/2018 0:00:00,-1,0,0,0,"ERBB2",
"C156490",1,"BAY1905254",2/21/2019 0:00:00,-1,0,0,0,"ILDR2",
"C156700",1,"SCC244",10/5/2018 0:00:00,-1,0,0,0,"MET",
"C156705",1,"BTRC4017A",7/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C156709",1,"BI 907828",7/17/2018 0:00:00,-1,0,0,0,"MDM2",
"C156729",1,"TP-0184",3/4/2019 0:00:00,-1,0,0,0,"ALK",
"C156730",1,"Navarixin",11/2/2018 0:00:00,-1,0,0,0,"CXCR2","wildtype"
"C156730",2,"Navarixin",11/2/2018 0:00:00,-1,0,0,0,"CXCR1","wildtype"
"C156737",1,"GSK3145095",1/31/2019 0:00:00,-1,0,0,0,,
"C156743",1,"PF-06821497",3/5/2019 0:00:00,-1,0,0,0,"EZH2",
"C156759",1,"GSK3368715",1/11/2019 0:00:00,-1,0,0,0,"PRMT1",
"C156791",1,"COM701",2/1/2019 0:00:00,-1,0,0,0,,
"C156792",1,"9-ING-41",2/11/2019 0:00:00,-1,0,0,0,"GSK-3?",
"C15696",1,"Radiosurgery",3/1/2018 0:00:00,-1,0,0,0,,
"C1570",1,"Dinutuximab",2/21/2019 0:00:00,-1,0,0,0,"GD2",
"C157061",1,"NC318",11/18/2019 0:00:00,-1,0,0,0,"S15/SIGLEC15",
"C157079",1,"Arfolitixorin",1/23/2019 0:00:00,-1,0,0,0,,
"C157127",1,"INCAGN02385",9/19/2018 0:00:00,-1,0,0,0,"LAG3",
"C157231",1,"CA102N",7/1/2019 0:00:00,-1,0,0,0,"CD44",
"C157240",1,"FLX475",1/31/2019 0:00:00,-1,0,0,0,"CCR4",
"C157242",1,"BGB-A425",12/17/2018 0:00:00,-1,0,0,0,"HAVCR2",
"C157279",1,"ABBV-155",11/5/2019 0:00:00,-1,0,0,0,"TAA",
"C1573",1,"Incomplete Freund's Adjuvant",3/1/2018 0:00:00,-1,0,0,0,,
"C157345",1,"mFOLFIRINOX",11/18/2019 0:00:00,-1,0,0,0,,
"C157485",1,"JTX-4014",1/3/2019 0:00:00,-1,0,0,0,"PDCD1",
"C157493",1,"MRTX849",1/3/2019 0:00:00,-1,0,0,0,"KRAS","G12C"
"C1575",1,"Disaccharide Tripeptide Glycerol Dipalmitoyl",,-1,0,0,0,,
"C157578",1,"XmAb23104",5/21/2019 0:00:00,-1,0,0,0,"PDCD1",
"C157578",2,"XmAb23104",5/21/2019 0:00:00,-1,0,0,0,"ICOS",
"C157771",1,"AST-008",1/23/2019 0:00:00,-1,0,0,0,,
"C158078",1,"Nicotinamide Riboside",11/18/2019 0:00:00,-1,0,0,0,,
"C158085",1,"EMB-01",1/22/2019 0:00:00,-1,0,0,0,"EGFR",
"C158085",2,"EMB-01",1/22/2019 0:00:00,-1,0,0,0,"MET",
"C158091",1,"TRQ15-01",2/21/2019 0:00:00,-1,0,0,0,,
"C158100",1,"PF-06939999",4/11/2019 0:00:00,-1,0,0,0,"PRMT5",
"C158132",1,"NZV930",2/12/2019 0:00:00,-1,0,0,0,"CD73",
"C158438",1,"FT500",4/11/2019 0:00:00,-1,0,0,0,"NK cells",
"C158466",1,"ADXS-503",7/25/2019 0:00:00,-1,0,0,0,,
"C158505",1,"MGD019",1/23/2019 0:00:00,-1,0,0,0,"PDCD1",
"C158505",2,"MGD019",3/5/2019 0:00:00,-1,0,0,0,"CTLA4",
"C158513",2,"TR1801",8/27/2019 0:00:00,-1,0,0,0,"MET",
"C158532",1,"INCB086550",1/23/2019 0:00:00,-1,0,0,0,"CD274",
"C158532",2,"INCB086550",4/15/2019 0:00:00,-1,0,0,0,"CTLA4",
"C158557",1,"AGEN1181",4/11/2019 0:00:00,-1,0,0,0,"CTLA4",
"C158603",1,"MEN1611",10/4/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C158603",2,"MEN1611",10/4/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C158603",3,"MEN1611",10/4/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C158603",4,"MEN1611",10/4/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C159168",1,"TJ004309",4/24/2019 0:00:00,-1,0,0,0,"CD73",
"C1594",1,"Anthracycline",11/5/2019 0:00:00,-1,0,0,0,,
"C159411",1,"ASP1951",2/27/2020 0:00:00,-1,0,0,0,"TNFRSF18",
"C159495",1,"MGC018",2/21/2019 0:00:00,-1,0,0,0,"CD276",
"C159530",1,"XmAb22841",7/1/2019 0:00:00,-1,0,0,0,"CTLA4",
"C159530",2,"XmAb22841",7/1/2019 0:00:00,-1,0,0,0,"LAG3",
"C159549",1,"GLS-010",4/2/2019 0:00:00,-1,0,0,0,"PDCD1",
"C159564",1,"AB928",12/18/2018 0:00:00,-1,0,0,0,"ADORA2A",
"C159564",2,"AB928",3/5/2019 0:00:00,-1,0,0,0,"ADORA2B",
"C159600",1,"AO-176",2/21/2019 0:00:00,-1,0,0,0,"CD47",
"C159609",1,"BAY1834942",2/11/2019 0:00:00,-1,0,0,0,"CEACAM6",
"C159719",1,"Cantrixil",4/2/2019 0:00:00,-1,0,0,0,"CD44",
"C159764",1,"REGN4659",8/13/2018 0:00:00,-1,0,0,0,"CTLA4",
"C1598",1,"Gusperimus Trihydrochloride",,-1,0,0,0,,
"C1599",1,"Bicalutamide",10/29/2018 0:00:00,-1,0,0,0,,
"C16035",1,"Radiation Therapy",3/1/2018 0:00:00,-1,0,-1,0,,
"C16039",1,"Autologous Hematopoietic Stem Cell Transplantation",3/5/2019 0:00:00,-1,0,0,0,,
"C160605",1,"LY3434172",6/17/2019 0:00:00,-1,0,0,0,"PDCD1",
"C160605",2,"LY3434172",6/17/2019 0:00:00,-1,0,0,0,"CD274",
"C1607",1,"Anastrozole",3/1/2018 0:00:00,-1,0,0,0,,
"C160714",1,"RO7121661",7/29/2019 0:00:00,-1,0,0,0,"PDCD1",
"C160714",2,"RO7121661",7/29/2019 0:00:00,-1,0,0,0,"HAVCR2",
"C160716",1,"CX-188",2/27/2020 0:00:00,-1,0,0,0,"PDCD1",
"C160772",1,"MCLA-145",11/18/2019 0:00:00,-1,0,0,0,"CD137",
"C160772",2,"MCLA-145",11/18/2019 0:00:00,-1,0,0,0,"PDCD1",
"C160867",1,"MEDI1191",5/21/2019 0:00:00,-1,0,0,0,"IL12",
"C160890",1,"ADCT-601",2/21/2019 0:00:00,-1,0,0,0,"AXL",
"C161597",1,"AMG 404",4/11/2019 0:00:00,-1,0,0,0,"PDCD1",
"C161599",1,"SC-011",1/31/2019 0:00:00,-1,0,0,0,,
"C161803",1,"SL-279252",4/11/2019 0:00:00,-1,0,0,0,"PDCD1",
"C161803",2,"SL-279252",4/11/2019 0:00:00,-1,0,0,0,"TNFSF4",
"C161864",1,"ABBV-368",5/3/2018 0:00:00,-1,0,0,0,"TNFRSF4",
"C162039",1,"CTX-471",6/4/2019 0:00:00,-1,0,0,0,"CD137",
"C162115",1,"ZW49",2/21/2019 0:00:00,-1,0,0,0,"ERBB2",
"C1624",1,"Nelfinavir Mesylate",3/1/2018 0:00:00,-1,0,0,0,"HIV1",
"C1624",2,"Nelfinavir Mesylate",3/1/2018 0:00:00,-1,0,0,0,"HIV2",
"C162509",1,"ORIC-101",11/5/2019 0:00:00,-1,0,0,0,"GR",
"C162521",1,"KY1044",2/15/2019 0:00:00,-1,0,0,0,"ICOS",
"C162532",1,"TT-00420",10/29/2018 0:00:00,-1,0,0,0,"AURKA","wildtype"
"C162532",2,"TT-00420",10/29/2018 0:00:00,-1,0,0,0,"AURKB","wildtype"
"C162535",1,"APG-1387",4/2/2019 0:00:00,-1,0,0,0,,
"C162552",1,"Theliatinib",10/5/2018 0:00:00,-1,0,0,0,"EGFR",
"C162573",1,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"FLT3",
"C162573",2,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"BTK",
"C162573",3,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"AURKA",
"C162573",4,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"RET",
"C162573",5,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"MET",
"C162573",6,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"DDR2",
"C162573",7,"CG'806",10/4/2018 0:00:00,-1,0,0,0,"SRC",
"C162577",1,"KN026",7/1/2019 0:00:00,-1,0,0,0,"ERBB2",
"C162625",1,"INCAGN02390",9/19/2018 0:00:00,-1,0,0,0,"HAVCR2",
"C162649",1,"MT-5111",9/24/2019 0:00:00,-1,0,0,0,"ERBB2",
"C162676",1,"TPX-0022",8/12/2019 0:00:00,-1,0,0,0,"MET",
"C162676",2,"TPX-0022",8/12/2019 0:00:00,-1,0,0,0,"CSF1R",
"C162676",3,"TPX-0022",8/12/2019 0:00:00,-1,0,0,0,"SRC",
"C162693",1,"TTX-030",3/28/2019 0:00:00,-1,0,0,0,"CD39",
"C162749",1,"ASTX295",8/12/2019 0:00:00,-1,0,0,0,"MDM2",
"C162805",1,"GAd-209-FSP",11/18/2019 0:00:00,-1,0,0,0,"CTL",
"C162875",1,"AB154",4/24/2019 0:00:00,-1,0,0,0,"TIGIT",
"C162936",1,"REGN5678",7/29/2019 0:00:00,-1,0,0,0,"CD28",
"C163020",1,"IPH5401",2/21/2019 0:00:00,-1,0,0,0,"CD88",
"C1635",1,"Bexarotene",3/5/2019 0:00:00,-1,0,0,0,,
"C163977",1,"TJ011133",5/21/2019 0:00:00,-1,0,0,0,"CD47",
"C163977",2,"TJ011133",5/21/2019 0:00:00,-1,0,0,0,"SIRPa",
"C163978",1,"INO-5151",7/29/2019 0:00:00,-1,0,0,0,,
"C164217",1,"NGM120",11/18/2019 0:00:00,-1,0,0,0,"GDF15",
"C164217",2,"NGM120",11/18/2019 0:00:00,-1,0,0,0,"GFRAL",
"C164317",1,"BAY2416964",9/24/2019 0:00:00,-1,0,0,0,"AHR",
"C1647",1,"Trastuzumab",6/20/2017 0:00:00,-1,0,0,0,"ERBB2",
"C1650",1,"Peldesine",10/23/2018 0:00:00,-1,0,0,0,"PNP","wildtype"
"C165199",1,"FCN-437",8/27/2019 0:00:00,-1,0,0,0,"CDK4",
"C165199",2,"FCN-437",8/27/2019 0:00:00,-1,0,0,0,"CDK6",
"C1652",1,"Marimastat",,-1,0,0,0,,
"C165256",1,"SQZ-PBMC-HPV",11/18/2019 0:00:00,-1,0,0,0,"CD8",
"C165420",1,"ARV-471",9/10/2019 0:00:00,-1,0,0,0,"ER",
"C165479",1,"Pictilisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C165479",2,"Pictilisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C165479",3,"Pictilisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C165479",4,"Pictilisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C165479",5,"Pictilisib",10/2/2018 0:00:00,-1,0,0,0,"MTOR",
"C165519",1,"SER-401",2/21/2019 0:00:00,-1,0,0,0,,
"C165566",1,"SB 11285",10/21/2019 0:00:00,-1,0,0,0,"STING",
"C165567",1,"CLN-081",11/5/2019 0:00:00,-1,0,0,0,"EGFR",
"C165588",1,"AMG 199",1/21/2020 0:00:00,-1,0,0,0,"CD3",
"C165588",2,"AMG 199",1/21/2020 0:00:00,-1,0,0,0,"MUC17",
"C165598",1,"OBT076",8/27/2019 0:00:00,-1,0,0,0,"CD205",
"C165605",1,"GB1275",8/27/2019 0:00:00,-1,0,0,0,"ITGAM",
"C165612",1,"IPN60090",4/11/2019 0:00:00,-1,0,0,0,,
"C165621",1,"ATP128",8/12/2019 0:00:00,-1,0,0,0,,
"C165626",1,"LNS8801",10/21/2019 0:00:00,-1,0,0,0,"GPER",
"C165655",1,"IMSA101",10/8/2019 0:00:00,-1,0,0,0,"STING",
"C165684",1,"ABBV-151",4/2/2019 0:00:00,-1,0,0,0,,
"C165748",1,"GSK3745417",4/24/2019 0:00:00,-1,0,0,0,,
"C165778",1,"WSD0922-FU",1/21/2020 0:00:00,-1,0,0,0,"EGFR",
"C166138",1,"BI 1701963",12/23/2019 0:00:00,-1,0,0,0,"SOS1",
"C166138",2,"BI 1701963",12/23/2019 0:00:00,-1,0,0,0,"KRAS","G12"
"C166258",1,"PF-07062119",12/23/2019 0:00:00,-1,0,0,0,"CD3",
"C166258",2,"PF-07062119",12/23/2019 0:00:00,-1,0,0,0,"GUCY2C",
"C166362",1,"LHC165",11/2/2017 0:00:00,-1,0,0,0,"TLR7",
"C166375",1,"SAR441000",2/11/2020 0:00:00,-1,0,0,0,,
"C1664",1,"Recombinant Interferon-alpha Inducible Protein 10",10/23/2018 0:00:00,-1,0,0,0,,
"C166410",1,"LY3499446",12/9/2019 0:00:00,-1,0,0,0,"KRAS","G12C"
"C167064",1,"ZN-c3",12/10/2019 0:00:00,-1,0,0,0,,
"C167156",1,"AB680",12/9/2019 0:00:00,-1,0,0,0,"CD73",
"C167157",1,"JNJ-74699157",8/27/2019 0:00:00,-1,0,0,0,"KRAS","G12C"
"C167188",1,"REGN5093",12/9/2019 0:00:00,-1,0,0,0,"MET",
"C167210",1,"TPX-0046",12/9/2019 0:00:00,-1,0,0,0,"SRC",
"C167210",2,"TPX-0046",12/9/2019 0:00:00,-1,0,0,0,"RET",
"C167270",1,"SYNB1891",12/9/2019 0:00:00,-1,0,0,0,"STING",
"C167271",1,"GMI-1359",10/9/2018 0:00:00,-1,0,0,0,"SELE",
"C167271",2,"GMI-1359",10/9/2018 0:00:00,-1,0,0,0,"CXCR4",
"C167278",1,"NMS-03305293",12/9/2019 0:00:00,-1,0,0,0,"PARP1",
"C167278",2,"NMS-03305293",12/9/2019 0:00:00,-1,0,0,0,"PARP2",
"C167278",3,"NMS-03305293",12/9/2019 0:00:00,-1,0,0,0,"PARP3",
"C167278",4,"NMS-03305293",12/9/2019 0:00:00,-1,0,0,0,"PARP4",
"C167292",1,"BMS-986301",6/4/2019 0:00:00,-1,0,0,0,"STING",
"C167393",1,"VE800",1/21/2020 0:00:00,-1,0,0,0,"CD8",
"C168522",1,"AGEN2373",12/9/2019 0:00:00,-1,0,0,0,"CD137",
"C168580",1,"AMG 509",3/3/2020 0:00:00,-1,0,0,0,,
"C1687",1,"Imatinib Mesylate",3/1/2018 0:00:00,-1,0,0,0,,
"C1691",1,"Trabectedin",3/1/2018 0:00:00,-1,0,0,0,,
"C1702",1,"Rituximab",10/31/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C1703",1,"Tipifarnib",9/14/2018 0:00:00,-1,0,0,0,"farnesyltransferase",
"C1714",1,"Flt3L",1/29/2019 0:00:00,-1,0,0,0,,
"C1723",1,"Cetuximab",6/20/2017 0:00:00,-1,0,0,0,"EGFR",
"C1725",1,"SU5402",10/23/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C1725",2,"SU5402",10/23/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C1725",3,"SU5402",10/23/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C1727",1,"Perifosine",10/2/2018 0:00:00,-1,0,0,0,"AKT1",
"C1727",2,"Perifosine",10/2/2018 0:00:00,-1,0,0,0,"AKT2",
"C1727",3,"Perifosine",10/2/2018 0:00:00,-1,0,0,0,"AKT3",
"C1728",1,"Celecoxib",10/2/2018 0:00:00,-1,0,0,0,"MTCO2",
"C1739",1,"Vincristine Sulfate",7/16/2018 0:00:00,-1,0,0,0,,
"C1786",1,"Cyanovirin-N",,-1,0,0,0,,
"C1787",1,"AG 1517",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C1789",1,"Infliximab",5/23/2017 0:00:00,-1,0,0,0,"TNF",
"C1794",1,"Capecitabine",3/1/2018 0:00:00,-1,0,0,0,,
"C1796",1,"Vorinostat",6/20/2017 0:00:00,-1,0,0,0,"HDAC",
"C1820",1,"Mitomycin",2/6/2019 0:00:00,-1,0,0,0,,
"C1831",1,"Semaxanib",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C1833",1,"TS-1",11/2/2018 0:00:00,0,0,0,0,,
"C1840",1,"L-778123",10/23/2018 0:00:00,-1,0,0,0,,
"C1844",1,"Temsirolimus",3/1/2018 0:00:00,-1,0,0,0,"MTOR",
"C1845",1,"Peginterferon alfa-2b",3/1/2018 0:00:00,-1,0,0,0,,
"C1851",1,"Bortezomib",3/1/2018 0:00:00,-1,0,0,0,,
"C1854",1,"Pegfilgrastim",7/28/2017 0:00:00,-1,0,0,0,"G-CSF",
"C1855",1,"Gefitinib",3/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C1857",1,"Panitumumab",4/10/2018 0:00:00,-1,0,0,0,"EGFR",
"C1863",1,"Entinostat",7/18/2017 0:00:00,-1,0,0,0,"HDAC",
"C1871",1,"PKI166",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C1871",2,"PKI166",10/23/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C1872",1,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"PRKCA",
"C1872",2,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"KDR",
"C1872",3,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C1872",4,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C1872",5,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C1872",6,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C1872",7,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"PRKCG",
"C1872",8,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"PRKCB",
"C1872",9,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"SRC",
"C1872",10,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C1872",11,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C1872",12,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"SYK",
"C1872",13,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"FGR",
"C1872",14,"Midostaurin",10/1/2018 0:00:00,-1,0,0,0,"CDK1",
"C1874",1,"Pipendoxifene",10/23/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C1910",1,"GnRH agonist",3/1/2019 0:00:00,-1,0,0,0,"GNRH",
"C192",1,"Mesna",3/1/2018 0:00:00,-1,0,0,0,,
"C1920",1,"Attenuated Live Virus Vaccine",,-1,0,0,0,,
"C195",1,"Mercaptopurine",10/3/2018 0:00:00,-1,0,0,0,,
"C1953",1,"Interferon alfa-2b",3/1/2018 0:00:00,-1,0,0,0,,
"C1967",1,"Tyrosine Kinase Inhibitor",9/17/2018 0:00:00,-1,0,0,0,"general",
"C1978",1,"GVAX",3/1/2018 0:00:00,-1,0,0,0,,
"C198",1,"Acetaminophen",3/6/2019 0:00:00,-1,0,0,0,,
"C19817",1,"HSV-Tk",3/1/2019 0:00:00,-1,0,0,0,"TK",
"C1985",1,"Sipuleucel-T",3/1/2018 0:00:00,-1,0,0,0,,
"C2005",1,"SGN-14",5/23/2017 0:00:00,-1,0,0,0,"CD40",
"C2007",1,"Monoclonal Antibody SGN-30",,-1,0,0,0,,
"C2012",1,"Matuzumab",10/10/2018 0:00:00,-1,0,0,0,"EGFR",
"C2030",1,"Tyrphostin AG 1288",,-1,0,0,0,,
"C2037",1,"IMC-1C11",10/10/2018 0:00:00,-1,0,0,0,"KDR",
"C2039",1,"Bevacizumab",6/20/2017 0:00:00,-1,0,0,0,"VEGFA",
"C2041",1,"KF58333",10/23/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C2041",2,"KF58333",10/23/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C2041",3,"KF58333",10/23/2018 0:00:00,-1,0,0,0,"AKT1","wildtype"
"C20496",1,"Inerferon Gamma",9/16/2018 0:00:00,-1,0,0,0,,
"C20506",1,"Interleukin-1",,-1,0,0,0,,
"C20507",1,"Interleukin-2",3/1/2018 0:00:00,-1,0,0,0,,
"C2057",1,"Lapuleucel-T",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C2073",1,"Monoclonal Antibody B1",10/23/2018 0:00:00,-1,0,0,0,"CD20","wildtype"
"C2167",1,"Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor",10/10/2018 0:00:00,-1,0,0,0,"EGFR",
"C2192",1,"TRICOM",10/10/2018 0:00:00,-1,0,0,0,,
"C2194",1,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"BRAF",
"C2194",2,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"RAF1",
"C2194",3,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"FLT4",
"C2194",4,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"KDR",
"C2194",5,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C2194",6,"Sorafenib Tosylate",8/13/2018 0:00:00,-1,0,0,0,"Raf kinase",
"C2204",1,"Adenovirus B7-1",,-1,0,0,0,,
"C2207",1,"MDX447",10/23/2018 0:00:00,-1,0,0,0,"FCGR1A","wildtype"
"C2207",2,"MDX447",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2210",1,"CC-1088",,-1,0,0,0,,
"C2213",1,"Liposomal Daunorubicin Citrate",10/2/2018 0:00:00,-1,0,0,0,,
"C2222",1,"IL12",2/28/2018 0:00:00,-1,0,0,0,"IL12",
"C2229",1,"Visilizumab",10/23/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C2233",1,"Phenethyl Isothiocyanate",,-1,0,0,0,"MAPK1",
"C2233",2,"Phenethyl Isothiocyanate",10/23/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C2233",3,"Phenethyl Isothiocyanate",10/23/2018 0:00:00,-1,0,0,0,"MAPK8","wildtype"
"C2233",4,"Phenethyl Isothiocyanate",10/23/2018 0:00:00,-1,0,0,0,"MAPK9","wildtype"
"C2233",5,"Phenethyl Isothiocyanate",10/23/2018 0:00:00,-1,0,0,0,"MAPK10","wildtype"
"C2237",1,"Recombinant Vaccinia-B7.1 Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C2241",1,"MVA-MUC1-IL2 Vaccine",3/1/2018 0:00:00,-1,0,0,0,,
"C226",1,"Eflornithine",3/6/2019 0:00:00,-1,0,0,0,,
"C2305",1,"WT1-Ricin A Immunotoxin",10/23/2018 0:00:00,-1,0,0,0,"CD7","wildtype"
"C2370",1,"3F8",9/14/2018 0:00:00,-1,0,0,0,"GD2",
"C2374",1,"TP40 Immunotoxin",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2381",1,"Etanercept",,-1,0,0,0,,
"C2383",1,"DAB389EGF",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2385",1,"Theramide",,-1,0,0,0,,
"C2419",1,"HPV 16 E7:12-20 Peptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C2467",1,"Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C2471",1,"Ad5CMV-p53 Gene",10/2/2018 0:00:00,-1,0,0,0,"TP53",
"C2485",1,"ALVAC-hB7.1",,-1,0,0,0,,
"C2492",1,"Von Hippel-Lindau Peptide Vaccine",10/23/2018 0:00:00,-1,0,0,0,,
"C2493",1,"RAd-hCD40L",2/28/2018 0:00:00,-1,0,0,0,,
"C2509",1,"hu14.18-IL2",8/27/2019 0:00:00,-1,0,0,0,"GD2",
"C2521",1,"Fowlpox Virus Vaccine",,-1,0,0,0,,
"C2524",1,"Ocaratuzumab",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C2537",1,"HER-2/neu Peptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C2539",1,"BIBX 1382",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2543",1,"Tositumomab",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C2548",1,"Prostatic Acid Phosphatase-Sargramostim Fusion Protein",10/10/2018 0:00:00,-1,0,0,0,"ACPP",
"C2573",1,"Murine Monoclonal Antibody 2B8",,-1,0,0,0,,
"C2587",1,"Progenipoietin",10/10/2018 0:00:00,-1,0,0,0,"CSF3",
"C2587",2,"Progenipoietin",10/10/2018 0:00:00,-1,0,0,0,"FLT3",
"C2594",1,"Therapeutic Autologous Dendritic Cells",10/23/2018 0:00:00,-1,0,0,0,,
"C2617",1,"EGFR Antisense DNA",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2620",1,"Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C2635",1,"Pirfenidone",12/18/2018 0:00:00,-1,0,0,0,,
"C2644",1,"Doxorubicin-Magnetic Targeted Carrier Complex",10/23/2018 0:00:00,-1,0,0,0,,
"C26441",1,"Iratumumab",,-1,0,0,0,,
"C26444",1,"Golnerminogene Pradenovec",,-1,0,0,0,,
"C26447",1,"Galiximab",9/13/2017 0:00:00,-1,0,0,0,"CD28",
"C26447",2,"Galiximab",9/13/2017 0:00:00,-1,0,0,0,"CD80",
"C2654",1,"Ipilimumab",10/31/2018 0:00:00,-1,0,0,0,"CTLA4","wildtype"
"C2658",1,"Ertumaxomab",10/23/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C2658",2,"Ertumaxomab",10/23/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C2658",3,"Ertumaxomab",10/23/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C2658",4,"Ertumaxomab",10/23/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C2658",5,"Ertumaxomab",10/23/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C26640",1,"CMV N495 Peptide",,-1,0,0,0,,
"C26644",1,"Eribulin Mesylate",3/1/2018 0:00:00,-1,0,0,0,,
"C26648",1,"CP-724,714",10/23/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C26653",1,"Lapatinib",7/17/2018 0:00:00,-1,0,0,0,"EGFR",
"C26653",2,"Lapatinib",7/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C26653",3,"Lapatinib",7/17/2018 0:00:00,-1,0,0,0,"MAPK1",
"C26653",4,"Lapatinib",7/17/2018 0:00:00,-1,0,0,0,"MAPK3",
"C26655",1,"Forodesine Hydrochloride",10/23/2018 0:00:00,-1,0,0,0,"PNP","wildtype"
"C2666",1,"Recombinant Fowlpox-B7.1 Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C26661",1,"Modafinil",4/1/2019 0:00:00,-1,0,0,0,,
"C26673",1,"Sunitinib Malate",6/20/2017 0:00:00,-1,0,0,0,"KDR",
"C26673",2,"Sunitinib Malate",6/20/2017 0:00:00,-1,0,0,0,"PDGFR-beta",
"C26673",3,"Sunitinib Malate",6/20/2017 0:00:00,-1,0,0,0,"c-Kit",
"C26673",4,"Sunitinib Malate",6/20/2017 0:00:00,-1,0,0,0,"FLT3 phosphorylation",
"C2668",1,"Lenalidomide",1/22/2018 0:00:00,-1,0,0,0,"TNF",
"C2668",2,"Lenalidomide",1/22/2018 0:00:00,-1,0,0,0,"VEGFA",
"C2668",3,"Lenalidomide",1/22/2018 0:00:00,-1,0,0,0,"bFGF",
"C2670",1,"CI-1040",10/2/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C2670",2,"CI-1040",10/2/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C2678",1,"Beta-Glucan",3/4/2019 0:00:00,-1,0,0,0,,
"C2682",1,"Ziv-Aflibercept",3/4/2019 0:00:00,-1,0,0,0,,
"C2688",1,"Nab-Paclitaxel",11/8/2018 0:00:00,-1,0,0,0,,
"C2693",1,"Erlotinib",6/20/2017 0:00:00,-1,0,0,0,"EGFR",
"C2703",1,"Mistletoe Extract",3/6/2019 0:00:00,-1,0,0,0,,
"C2712",1,"E7.6.3",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2713",1,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2713",2,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C2713",3,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C2713",4,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C2713",5,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C2713",6,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"MAPK1","wildtype"
"C2713",7,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C2713",8,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"ARAF","wildtype"
"C2713",9,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"BRAF","wildtype"
"C2713",10,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C2713",11,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"RAF","wildtype"
"C2713",12,"Pelitinib",10/23/2018 0:00:00,-1,0,0,0,"ERBB4","wildtype"
"C2714",1,"EMD 55900",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2720",1,"ICR62",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype and EGFRvIII"
"C2727",1,"PD-168393",10/23/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C2733",1,"Nimotuzumab",7/18/2017 0:00:00,-1,0,0,0,"EGFR",
"C2737",1,"Vandetanib",9/24/2018 0:00:00,-1,0,0,0,"EGFR",
"C2737",2,"Vandetanib",9/24/2018 0:00:00,-1,0,0,0,"KDR",
"C2737",3,"Vandetanib",9/24/2018 0:00:00,-1,0,0,0,"RET",
"C2739",1,"Monoclonal Antibody 7C11",,-1,0,0,0,,
"C2740",1,"VHL16 Peptide",10/23/2018 0:00:00,-1,0,0,0,"VHL","VHL S111I"
"C2741",1,"VHL14 Peptide",10/23/2018 0:00:00,-1,0,0,0,"VHL","VHL 166"
"C2742",1,"ALVAC-B7-CEA",,-1,0,0,0,,
"C2745",1,"B7 Transfected Melanoma Cell Vaccine",,-1,0,0,0,,
"C2760",1,"gp100 and GM-CSF DNA/Gold Vaccine",10/23/2018 0:00:00,-1,0,0,0,,
"C2776",1,"MART-1 Fowlpox Vaccine",,-1,0,0,0,,
"C2777",1,"Monoclonal Antibody 95-5-49",10/24/2018 0:00:00,-1,0,0,0,"CD2","wildtype"
"C28235",1,"Valacyclovir",3/1/2018 0:00:00,-1,0,0,0,,
"C2824",1,"VHL2 (Y12M) Peptide",10/24/2018 0:00:00,-1,0,0,0,"VHL","VHL Y12M"
"C285",1,"Ascorbic Acid",3/1/2018 0:00:00,-1,0,0,0,,
"C286",1,"Asparaginase",10/3/2018 0:00:00,-1,0,0,0,,
"C28694",1,"Lapachone",10/24/2018 0:00:00,-1,0,0,0,"TOP1","wildtype"
"C28694",2,"Lapachone",10/24/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C287",1,"Aspirin",3/1/2018 0:00:00,-1,0,0,0,,
"C28776",1,"(H115D)VHL35 Peptide",10/24/2018 0:00:00,-1,0,0,0,"VHL","VHL Mutant"
"C288",1,"Azacitidine",6/20/2017 0:00:00,-1,0,0,0,"DNA methyltransferase",
"C28827",1,"Anthralin",10/24/2018 0:00:00,-1,0,0,0,,
"C28898",1,"Abatacept",,-1,0,0,0,,
"C28900",1,"Calcipotriene",2/28/2019 0:00:00,-1,0,0,0,,
"C28906",1,"Carvedilol",3/1/2019 0:00:00,-1,0,0,0,,
"C28974",1,"Delavirdine Mesylate",,-1,0,0,0,,
"C29040",1,"FGF-5:172-176 / 217-220 Peptide",,-1,0,0,0,,
"C29045",1,"Famotidine",3/1/2018 0:00:00,-1,0,0,0,"HRH2",
"C29045",2,"Famotidine",3/1/2018 0:00:00,-1,0,0,0,"propanimidamide",
"C29065",1,"FrSh61 (MEA) VHL33 Peptide",10/24/2018 0:00:00,-1,0,0,0,"VHL","VHLp18(MEA)"
"C29165",1,"Losartan Potassium",10/24/2018 0:00:00,-1,0,0,0,"AGTR1","wildtype"
"C29176",1,"Monoclonal Antibody hLEU 2A",10/24/2018 0:00:00,-1,0,0,0,"CD8","wildtype"
"C29176",2,"Monoclonal Antibody hLEU 2A",10/24/2018 0:00:00,-1,0,0,0,"CD8A","wildtype"
"C29176",3,"Monoclonal Antibody hLEU 2A",10/24/2018 0:00:00,-1,0,0,0,"CD8B","wildtype"
"C29198",1,"1F5",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C29201",1,"Monoclonal Antibody 528",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C29229",1,"RG 83852",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C29251",1,"Metformin Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,,
"C29277",1,"Nevirapine",,-1,0,0,0,,
"C29316",1,"Falimarev",,-1,0,0,0,,
"C29317",1,"Inalimarev",,-1,0,0,0,,
"C29382",1,"Propranolol Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,,
"C29474",1,"Transferrin Receptor-Targeted Liposomal p53 Cdna",10/24/2018 0:00:00,-1,0,0,0,,
"C29536",1,"Valproate",6/20/2017 0:00:00,-1,0,0,0,"HDAC",
"C29556",1,"gp100 Peptide-sensitized Autologous T-cells (CD4+ and CD8+)",,-1,0,0,0,,
"C29558",1,"rF-MUC1(DF3)/TRICOM Vaccine",,-1,0,0,0,,
"C29559",1,"rF-PSA/PSMA/TRICOM",,-1,0,0,0,,
"C29561",1,"rMVA-PSA/PSMA/TRICOM",,-1,0,0,0,,
"C298",1,"BCG Vaccine",3/1/2018 0:00:00,-1,0,0,0,,
"C29852",1,"Rebamipide",,-1,0,0,0,,
"C29981",1,"Ibritumomab Tiuxetan",10/25/2018 0:00:00,-1,0,0,0,"CD20","wildtype"
"C29982",1,"ALVAC-CEA (6D)-B7.1 Vaccine",,-1,0,0,0,,
"C313",1,"Bleomycin",1/22/2018 0:00:00,-1,0,0,0,,
"C321",1,"Busulfan",9/11/2018 0:00:00,-1,0,0,0,"DNA alkylation",
"C33987",1,"Peginterferon alfa-2a",3/1/2018 0:00:00,-1,0,0,0,,
"C362",1,"Chlorambucil",10/2/2018 0:00:00,-1,0,0,0,,
"C365",1,"Chlormadinone Acetate",10/25/2018 0:00:00,-1,0,0,0,"PGR","wildtype"
"C365",2,"Chlormadinone Acetate",10/25/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C37279",1,"Interferon Gamma Receptor Complex",,-1,0,0,0,,
"C37448",1,"AG-858",10/25/2018 0:00:00,-1,0,0,0,"HSPA1A","wildtype"
"C37448",2,"AG-858",10/25/2018 0:00:00,-1,0,0,0,"HSPA1B","wildtype"
"C37448",3,"AG-858",10/25/2018 0:00:00,-1,0,0,0,"HSPA1L","wildtype"
"C37451",1,"Tesetaxel",3/5/2019 0:00:00,-1,0,0,0,,
"C37452",1,"Ixabepilone",3/1/2018 0:00:00,-1,0,0,0,"tubulin",
"C376",1,"Cisplatin",3/1/2018 0:00:00,-1,0,0,0,,
"C37899",1,"Tanespimycin",10/2/2018 0:00:00,-1,0,0,0,"HSP90AA1",
"C38122",1,"VHL-42: 65-76(V74G) Peptide",10/24/2018 0:00:00,-1,0,0,0,"VHL","VHL V74G"
"C38123",1,"VHL-59: 116-128 Peptide",10/25/2018 0:00:00,-1,0,0,0,"VHL","VHL FrSh116-128"
"C38142",1,"Alvespimycin",10/2/2018 0:00:00,-1,0,0,0,"HSP90AA1",
"C38685",1,"Siplizumab",5/23/2017 0:00:00,-1,0,0,0,"CD2",
"C38692",1,"Pertuzumab",6/20/2017 0:00:00,-1,0,0,0,"ERBB2",
"C38693",1,"Paricalcitol",3/1/2018 0:00:00,-1,0,0,0,,
"C38713",1,"Dasatinib",7/18/2017 0:00:00,-1,0,0,0,"SRC-family kinases",
"C38717",1,"Anakinra",5/23/2017 0:00:00,-1,0,0,0,"IL1B",
"C38718",1,"Axitinib",6/20/2017 0:00:00,-1,0,0,0,"PDGF",
"C38718",2,"Axitinib",6/20/2017 0:00:00,-1,0,0,0,"VEGFA",
"C38897",1,"CD3 Complex",,-1,0,0,0,,
"C401",1,"Curcumin",2/27/2019 0:00:00,-1,0,0,0,,
"C405",1,"Cyclophosphamide",3/1/2018 0:00:00,-1,0,0,0,,
"C407",1,"Cyproterone",10/25/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C408",1,"Cytarabine",9/26/2018 0:00:00,-1,0,0,0,,
"C411",1,"Dacarbazine",3/1/2018 0:00:00,-1,0,0,0,,
"C422",1,"Dexamethsone",3/1/2018 0:00:00,-1,0,0,0,,
"C456",1,"Doxorubicin",3/1/2018 0:00:00,-1,0,0,0,,
"C457",1,"Doxycycline",3/1/2019 0:00:00,-1,0,0,0,,
"C4727060",1,"QBM076",2/5/2020 0:00:00,-1,0,0,0,"CXCR2",
"C47393",1,"Aminophylline",,-1,0,0,0,,
"C47395",1,"Amlexanox",10/2/2018 0:00:00,-1,0,0,0,"TBK1",
"C47395",2,"Amlexanox",10/2/2018 0:00:00,-1,0,0,0,"IKBKE",
"C47488",1,"Diflorasone Diacetate",,-1,0,0,0,,
"C47581",1,"Levetiracetam",9/11/2018 0:00:00,-1,0,0,0,,
"C47640",1,"Olmesartan Medoxomil",10/25/2018 0:00:00,-1,0,0,0,"AGTR1","wildtype"
"C47680",1,"Potassium Iodide",3/7/2019 0:00:00,-1,0,0,0,,
"C47705",1,"Rimexolone",,-1,0,0,0,,
"C48003",1,"Methylprednisolone Acetate",,-1,0,0,0,,
"C48004",1,"Methylprednisolone Sodium Succinate",,-1,0,0,0,,
"C48369",1,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"C48369",2,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C48369",3,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"ABL1",
"C48369",4,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"FLT1",
"C48369",5,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C48369",6,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"SRC",
"C48369",7,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C48369",8,"AEE788",10/2/2018 0:00:00,-1,0,0,0,"ERBB4",
"C48375",1,"Nilotinib",7/17/2018 0:00:00,-1,0,0,0,"ABL",
"C48378",1,"Saracatinib",9/28/2018 0:00:00,-1,0,0,0,"SRC",
"C48378",2,"Saracatinib",10/1/2018 0:00:00,-1,0,0,0,"ABL1",
"C48380",1,"AC480",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"C48380",2,"AC480",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C48380",3,"AC480",10/2/2018 0:00:00,-1,0,0,0,"ERBB4",
"C48382",1,"Bardoxolone",,-1,0,0,0,,
"C48383",1,"CNGRC Peptide-TNF Alpha Conjugate",,-1,0,0,0,,
"C48385",1,"Degarelix",2/21/2019 0:00:00,-1,0,0,0,,
"C48387",1,"Everolimus",3/1/2018 0:00:00,-1,0,0,0,"MTOR",
"C48390",1,"Fowlpox Virus Vaccine Vector",10/31/2018 0:00:00,-1,0,0,0,,
"C48391",1,"GM.CD40L",10/31/2018 0:00:00,-1,0,0,0,,
"C48402",1,"Lestaurtinib",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C48404",1,"Tandutinib",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C48404",2,"Tandutinib",10/2/2018 0:00:00,-1,0,0,0,"KIT",
"C48404",3,"Tandutinib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C48404",4,"Tandutinib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C48404",5,"Tandutinib",10/2/2018 0:00:00,-1,0,0,0,"CSF1R",
"C48405",1,"Lucatumumab",5/23/2017 0:00:00,-1,0,0,0,"CD40",
"C48406",1,"Veltuzumab",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C48418",1,"pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C48636",1,"Lenvatinib Mesylate",2/26/2018 0:00:00,-1,0,0,0,"KDR",
"C48638",1,"Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C48660",1,"Not Applicable",10/2/2018 0:00:00,-1,0,0,0,,
"C48812",1,"Belinostat",10/2/2018 0:00:00,-1,0,0,0,"HDAC1",
"C49061",1,"Ridaforolimus",10/1/2018 0:00:00,-1,0,0,0,"MTOR",
"C49085",1,"Tremelimumab",11/8/2018 0:00:00,-1,0,0,0,"CTLA4","wildtype"
"C49088",1,"Bavituximab",7/12/2018 0:00:00,-1,0,0,0,"anionic phospholipids",
"C49092",1,"Immunomodulator OHR/AVR118",,-1,0,0,0,,
"C49094",1,"Neratinib",3/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C491",1,"Etoposide",3/1/2018 0:00:00,-1,0,0,0,,
"C49176",1,"Palbociclib",6/20/2017 0:00:00,-1,0,0,0,"CDK4",
"C49176",2,"Palbociclib",6/20/2017 0:00:00,-1,0,0,0,"CDK6",
"C49177",1,"Recombinant dHER2 Vaccine",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C495",1,"Interferon Beta",3/1/2018 0:00:00,-1,0,0,0,,
"C49518",1,"PTPN11 wt Allele",10/2/2018 0:00:00,-1,0,0,0,"PTPN11",
"C505",1,"Fluorouracil",3/1/2018 0:00:00,-1,0,0,0,,
"C509",1,"Flutamide",3/6/2019 0:00:00,-1,0,0,0,"AR",
"C510",1,"Folic Acid",3/6/2019 0:00:00,-1,0,0,0,,
"C52100",1,"PSMD10 wt Allele",10/2/2018 0:00:00,-1,0,0,0,"PSMD10",
"C52184",1,"Atiprimod",10/25/2018 0:00:00,-1,0,0,0,"JAK2","wildtype"
"C52187",1,"Figitumumab",10/25/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C52195",1,"PD0325901",10/2/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C52195",2,"PD0325901",10/2/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C52196",1,"Carfilzomib",3/13/2018 0:00:00,-1,0,0,0,,
"C52200",1,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"MET",
"C52200",2,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"RET",
"C52200",3,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"FLT1",
"C52200",4,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"KDR",
"C52200",5,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"FLT4",
"C52200",6,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"KIT",
"C52200",7,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"FLT3",
"C52200",8,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"TEK",
"C52200",9,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"NTRK2",
"C52200",10,"Cabozantinib",8/3/2017 0:00:00,-1,0,0,0,"AXL",
"C52659",1,"Therapeutic Vasoactive Intestinal Peptide",10/25/2018 0:00:00,-1,0,0,0,,
"C53396",1,"IRX-2",,-1,0,0,0,,
"C53398",1,"Dacomitinib",9/11/2018 0:00:00,-1,0,0,0,"EGFR",
"C53398",2,"Dacomitinib",9/11/2018 0:00:00,-1,0,0,0,"ERBB2",
"C53398",3,"Dacomitinib",9/11/2018 0:00:00,-1,0,0,0,"ERBB4",
"C53412",1,"PV-10",3/1/2018 0:00:00,-1,0,0,0,,
"C53436",1,"Saponin-Cholesterol-Phospholipid Adjuvant",,-1,0,0,0,,
"C557",1,"Hydroxychloroquine",3/1/2018 0:00:00,-1,0,0,0,,
"C560",1,"Hydroxyurea",3/1/2018 0:00:00,-1,0,0,0,,
"C564",1,"Ifosfamide",1/22/2018 0:00:00,-1,0,0,0,,
"C572",1,"Immunoglobulin",,-1,0,0,0,,
"C586",1,"Therapeutic Interleukin-1",10/25/2018 0:00:00,-1,0,0,0,,
"C603",1,"Isotretinoin",9/11/2018 0:00:00,-1,0,0,0,"RARs",
"C605",1,"Ketoconazole",4/1/2019 0:00:00,-1,0,0,0,,
"C607",1,"Leucovorin Calcium",3/1/2018 0:00:00,-1,0,0,0,,
"C60768",1,"Veliparib",7/18/2017 0:00:00,-1,0,0,0,"PARP1",
"C60768",2,"Veliparib",7/18/2017 0:00:00,-1,0,0,0,"PARP2",
"C60770",1,"Obatoclax",10/2/2018 0:00:00,-1,0,0,0,"BCL2",
"C60774",1,"Reolysin",3/1/2018 0:00:00,-1,0,0,0,,
"C60779",1,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C60779",2,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C60779",3,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C60779",4,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"KIT",
"C60779",5,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C60779",6,"Pazopanib Hydrochloride",3/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C60809",1,"Bosutinib",3/1/2018 0:00:00,-1,0,0,0,"ABL",
"C60809",2,"Bosutinib",3/1/2018 0:00:00,-1,0,0,0,"SRC",
"C60882",1,"rM28",5/23/2017 0:00:00,-1,0,0,0,"CD28",
"C60882",2,"rM28",5/23/2017 0:00:00,-1,0,0,0,"MAPG",
"C61073",1,"Viagenpumatucel-L",3/1/2018 0:00:00,-1,0,0,0,,
"C61077",1,"Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine",10/31/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C61080",1,"ISS 1018 CpG Oligodeoxynucleotide",,-1,0,0,0,,
"C61084",1,"Siltuximab",3/3/2020 0:00:00,-1,0,0,0,"IL6",
"C61088",1,"MAGE-A3/HPV 16 Peptide Vaccine",10/25/2018 0:00:00,-1,0,0,0,,
"C61307",1,"Oportuzumab Monatox",11/2/2017 0:00:00,-1,0,0,0,"EpCAM",
"C61309",1,"Bcr-Abl (b2a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"BCR","BCR exon b2 to ABL exon a2 (B2A2) fusion"
"C61309",2,"Bcr-Abl (b2a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"ABL1","BCR exon b2 to ABL exon a2 (B2A2) fusion"
"C61309",3,"Bcr-Abl (b2a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"BCR-ABL","BCR exon b2 to ABL exon a2 (B2A2) fusion"
"C61310",1,"Bcr-Abl (b3a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"BCR","BCR exon b2 to ABL exon a2 (B2A2) fusion or BCR exon b3 to ABL exon a2 (B3A2)fusion"
"C61310",2,"Bcr-Abl (b3a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"ABL1","BCR exon b2 to ABL exon a2 (B2A2) fusion or BCR exon b3 to ABL exon a2 (B3A2)fusion"
"C61310",3,"Bcr-Abl (b3a2)-Derived Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"BCR-ABL","BCR exon b2 to ABL exon a2 (B2A2) fusion or BCR exon b3 to ABL exon a2 (B3A2)fusion"
"C61311",1,"RAF265",10/2/2018 0:00:00,-1,0,0,0,"RAF1",
"C61311",2,"RAF265",10/2/2018 0:00:00,-1,0,0,0,"BRAF",
"C61311",3,"RAF265",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C61313",1,"Denosumab",1/9/2018 0:00:00,-1,0,0,0,"RANKL",
"C61314",1,"Talimogene Laherparepvec",3/1/2018 0:00:00,-1,0,0,0,,
"C61442",1,"WT1 126-134 Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C61489",1,"GI-4000",10/2/2018 0:00:00,-1,0,0,0,,
"C61493",1,"CAVATAK",7/18/2017 0:00:00,-1,0,0,0,"ICAM1",
"C61493",2,"CAVATAK",7/18/2017 0:00:00,-1,0,0,0,"DAF",
"C61500",1,"Posaconazole",10/1/2018 0:00:00,-1,0,0,0,,
"C61502",1,"Mapatumumab",10/24/2018 0:00:00,-1,0,0,0,"TNFRSF10A","wildtype"
"C61504",1,"rHuPH20",7/18/2018 0:00:00,-1,0,0,0,,
"C61527",1,"Atorvastatin",9/24/2018 0:00:00,-1,0,0,0,"HMG-CoA",
"C61564",1,"Vinflunine",5/8/2018 0:00:00,-1,0,0,0,"tubulin",
"C61587",1,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"AURKA",
"C61587",2,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"ABL",
"C61587",3,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"RET",
"C61587",4,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"NTRK1",
"C61587",5,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C61587",6,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"AURKC",
"C61587",7,"Danusertib",10/1/2018 0:00:00,-1,0,0,0,"AURKB",
"C61590",1,"PR-104",10/2/2018 0:00:00,-1,0,0,0,,
"C61610",1,"Meclizine",3/5/2019 0:00:00,-1,0,0,0,"HRH1",
"C61612",1,"Metformin",3/1/2018 0:00:00,-1,0,0,0,,
"C61614",1,"Pemetrexed",3/1/2018 0:00:00,-1,0,0,0,,
"C61625",1,"Alendronic Acid",3/6/2019 0:00:00,-1,0,0,0,,
"C61635",1,"Amlodipine",3/6/2019 0:00:00,-1,0,0,0,,
"C61686",1,"Clopidogrel",3/1/2018 0:00:00,-1,0,0,0,,
"C617",1,"Lomustine",9/14/2018 0:00:00,-1,0,0,0,"DNA",
"C61722",1,"Diflorasone",,-1,0,0,0,,
"C61728",1,"Diphenhydramine",3/1/2018 0:00:00,-1,0,0,0,,
"C618",1,"Loperamide",9/14/2018 0:00:00,-1,0,0,0,,
"C61948",1,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"BRAF",
"C61948",2,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"RAF1",
"C61948",3,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"FLT4",
"C61948",4,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"KDR",
"C61948",5,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C61948",6,"Sorafenib",8/13/2018 0:00:00,-1,0,0,0,"Raf kinase",
"C62012",1,"Bupropion",4/1/2019 0:00:00,-1,0,0,0,,
"C62022",1,"Dextromethorphan",4/1/2019 0:00:00,-1,0,0,0,,
"C62028",1,"Epirubicin",3/1/2018 0:00:00,-1,0,0,0,"opoisomerase II",
"C62035",1,"Imatinib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C62035",2,"Imatinib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C62035",3,"Imatinib",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C62035",4,"Imatinib",10/1/2018 0:00:00,-1,0,0,0,"ABL1",
"C62040",1,"Irinotecan",3/1/2018 0:00:00,-1,0,0,0,"topoisomerase I",
"C62042",1,"Leuprolide",3/6/2019 0:00:00,-1,0,0,0,"GnRH",
"C62049",1,"Midazolam",9/11/2018 0:00:00,-1,0,0,0,"GABA",
"C62072",1,"Procarbazine",9/21/2018 0:00:00,-1,0,0,0,,
"C62078",1,"Tamoxifen",3/1/2018 0:00:00,-1,0,0,0,,
"C62091",1,"Daunorubicin",10/2/2018 0:00:00,-1,0,0,0,,
"C62179",1,"Dacetuzumab",5/23/2017 0:00:00,-1,0,0,0,"CD40",
"C62280",1,"CpG-28 Oligodeoxynucleotide",10/25/2018 0:00:00,-1,0,0,0,"TLR9","wildtype"
"C62435",1,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C62435",2,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C62435",3,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"FGFR1","wildtype"
"C62435",4,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"FLT4","wildtype"
"C62435",5,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C62435",6,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C62435",7,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C62435",8,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C62435",9,"Dovitinib Lactate",10/24/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C62445",1,"Catumaxomab",10/24/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C62445",2,"Catumaxomab",10/24/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C62445",3,"Catumaxomab",10/24/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C62445",4,"Catumaxomab",10/24/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C62445",5,"Catumaxomab",10/24/2018 0:00:00,-1,0,0,0,"EPCAM","wildtype"
"C62449",1,"Urelumab",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF9","wildtype"
"C62482",1,"Tigatuzumab",,-1,0,0,0,,
"C62492",1,"Denenicokin",9/14/2018 0:00:00,-1,0,0,0,"IL21",
"C62496",1,"Tesevatinib",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C62496",2,"Tesevatinib",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C62496",3,"Tesevatinib",10/24/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C62496",4,"Tesevatinib",10/24/2018 0:00:00,-1,0,0,0,"EPHB4","wildtype"
"C62496",5,"Tesevatinib",10/24/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C625",1,"Mannitol",2/1/2019 0:00:00,-1,0,0,0,,
"C62502",1,"Barasertib",2/20/2019 0:00:00,-1,0,0,0,"AURKB",
"C62508",1,"Diazepinomicin",10/24/2018 0:00:00,-1,0,0,0,"KRAS","wildtype"
"C62508",2,"Diazepinomicin",10/24/2018 0:00:00,-1,0,0,0,"HRAS","wildtype"
"C62508",3,"Diazepinomicin",10/24/2018 0:00:00,-1,0,0,0,"NRAS","wildtype"
"C62508",4,"Diazepinomicin",10/24/2018 0:00:00,-1,0,0,0,"RAS","wildtype"
"C62508",5,"Diazepinomicin",10/24/2018 0:00:00,-1,0,0,0,"TSPO","wildtype"
"C62509",1,"eftilagimod alpha",10/31/2018 0:00:00,-1,0,0,0,"LAG3","wildtype"
"C62510",1,"Mogamulizumab",10/31/2018 0:00:00,-1,0,0,0,"FOXP3","wildtype"
"C62510",2,"Mogamulizumab",10/31/2018 0:00:00,-1,0,0,0,"CCR4","wildtype"
"C62521",1,"Mocetinostat",6/20/2017 0:00:00,-1,0,0,0,"HDAC1",
"C62521",2,"Mocetinostat",6/20/2017 0:00:00,-1,0,0,0,"HDAC2",
"C62521",3,"Mocetinostat",6/20/2017 0:00:00,-1,0,0,0,"HDAC3",
"C62522",1,"BMS-641988",10/24/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C62526",1,"Iniparib",10/24/2018 0:00:00,-1,0,0,0,"PARP1","wildtype"
"C62527",1,"Adenovirus Encoding Rat HER-2/neu",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C62528",1,"Blinatumomab",10/24/2018 0:00:00,-1,0,0,0,"CD19","wildtype"
"C62528",2,"Blinatumomab",10/24/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C62528",3,"Blinatumomab",10/24/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C62528",4,"Blinatumomab",10/24/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C62528",5,"Blinatumomab",10/24/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C62530",1,"Varlitinib",10/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C62530",2,"Varlitinib",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C62535",1,"Radium-223",3/1/2018 0:00:00,-1,0,0,0,,
"C62537",1,"NOV-002",10/24/2018 0:00:00,-1,0,0,0,"GGT","wildtype"
"C62538",1,"Colloidal Gold-Bound Tumor Necrosis Factor",,-1,0,0,0,,
"C62541",1,"Fluoroestradiol F-18",3/6/2019 0:00:00,-1,0,0,0,,
"C62597",1,"CHP-HER-2 Peptide Vaccine",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C62600",1,"CRLX101",3/1/2019 0:00:00,-1,0,0,0,,
"C62720",1,"Enzyme Inhibitor Therapy",3/1/2018 0:00:00,-1,0,0,0,,
"C62762",1,"Clostridium Novyi-NT Spores",3/1/2019 0:00:00,-1,0,0,0,,
"C62765",1,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C62765",2,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C62765",3,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C62765",4,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C62765",5,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FGFR2",
"C62765",6,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"C62765",7,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FGFR4",
"C62765",8,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C62765",9,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C62765",10,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"SRC",
"C62765",11,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"LCK",
"C62765",12,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"LYN",
"C62765",13,"Nintedanib",3/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C62783",1,"Seliciclib",7/17/2018 0:00:00,-1,0,0,0,"CDK4",
"C62783",2,"Seliciclib",7/17/2018 0:00:00,-1,0,0,0,"CDK6",
"C633",1,"Melphalan",3/1/2018 0:00:00,-1,0,0,0,,
"C63546",1,"Fresolimumab",10/30/2018 0:00:00,-1,0,0,0,"TGFB1","wildtype"
"C63546",2,"Fresolimumab",10/30/2018 0:00:00,-1,0,0,0,"TGFB2","wildtype"
"C63546",3,"Fresolimumab",10/30/2018 0:00:00,-1,0,0,0,"TGFB3","wildtype"
"C63591",1,"FOLFOX-6",9/11/2018 0:00:00,-1,0,0,0,,
"C63593",1,"FOLFIRI",9/14/2018 0:00:00,-1,0,0,0,,
"C63597",1,"XELOX",10/26/2018 0:00:00,-1,0,0,0,,
"C63666",1,"Deguelin",10/2/2018 0:00:00,-1,0,0,0,"PI3KCA",
"C63666",2,"Deguelin",10/2/2018 0:00:00,-1,0,0,0,"AKT1",
"C63666",3,"Deguelin",10/2/2018 0:00:00,-1,0,0,0,"AKT2",
"C63666",4,"Deguelin",10/2/2018 0:00:00,-1,0,0,0,"AKT3",
"C63690",1,"Hydroxytyrosol",,-1,0,0,0,,
"C63958",1,"Resiquimod",3/1/2018 0:00:00,-1,0,0,0,"TLR7",
"C63958",2,"Resiquimod",3/1/2018 0:00:00,-1,0,0,0,"TLR8",
"C642",1,"Methotrexate",7/16/2018 0:00:00,-1,0,0,0,,
"C64541",1,"Sapacitabine",7/17/2018 0:00:00,-1,0,0,0,,
"C64544",1,"R547",10/2/2018 0:00:00,-1,0,0,0,"CDK4",
"C64544",2,"R547",10/2/2018 0:00:00,-1,0,0,0,"CCND1",
"C64544",3,"R547",10/2/2018 0:00:00,-1,0,0,0,"CDK1",
"C64544",4,"R547",10/2/2018 0:00:00,-1,0,0,0,"CCNB1",
"C64544",5,"R547",10/2/2018 0:00:00,-1,0,0,0,"CDK2",
"C64544",6,"R547",10/2/2018 0:00:00,-1,0,0,0,"CCNE1",
"C64620",1,"Zalutumumab",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C64621",1,"Lexatumumab",9/13/2017 0:00:00,-1,0,0,0,"TRAIL-R2",
"C64627",1,"AV-412",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"C64627",2,"AV-412",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C64639",1,"Crenolanib",9/14/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C64639",2,"Crenolanib",9/14/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C64639",3,"Crenolanib",9/14/2018 0:00:00,-1,0,0,0,"FLT3",
"C64761",1,"CDK Inhibitor AT7519",3/6/2019 0:00:00,-1,0,0,0,"CDK",
"C64765",1,"Mycobacterial Cell Wall-DNA Complex",,-1,0,0,0,,
"C64768",1,"Vemurafenib",6/20/2017 0:00:00,-1,0,0,0,"BRAF V600E kinase",
"C64776",1,"Navitoclax",3/1/2018 0:00:00,-1,0,0,0,"BCL2",
"C64776",2,"Navitoclax",9/27/2018 0:00:00,-1,0,0,0,"BCL2L1",
"C64776",3,"Navitoclax",9/27/2018 0:00:00,-1,0,0,0,"BCL2L2",
"C64846",1,"Alpha-type-1 Polarized Dendritic Cells",,-1,0,0,0,,
"C64982",1,"Surgery",3/1/2018 0:00:00,-1,0,0,0,,
"C65216",1,"Adalimumab",9/13/2017 0:00:00,-1,0,0,0,"TNF",
"C65220",1,"Alefacept",10/24/2018 0:00:00,-1,0,0,0,"CD2","wildtype"
"C65242",1,"Auranofin",10/24/2018 0:00:00,-1,0,0,0,"TRXR1","wildtype"
"C65242",2,"Auranofin",10/24/2018 0:00:00,-1,0,0,0,"TRXR2","wildtype"
"C65242",3,"Auranofin",10/24/2018 0:00:00,-1,0,0,0,"TRXR3","wildtype"
"C65242",4,"Auranofin",10/24/2018 0:00:00,-1,0,0,0,"TRXR","wildtype"
"C65320",1,"Chlorotrianisene",10/24/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C65320",2,"Chlorotrianisene",10/24/2018 0:00:00,-1,0,0,0,"ESR2","wildtype"
"C65366",1,"Delavirdine",,-1,0,0,0,,
"C655",1,"Mifepristone",7/26/2017 0:00:00,-1,0,0,0,"PGR",
"C65530",1,"Erlotinib",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype, EGFR exon 19 deletion and/or EGFR L858R"
"C65624",1,"Fasudil",10/2/2018 0:00:00,-1,0,0,0,"ROCK2",
"C65624",2,"Fasudil",10/2/2018 0:00:00,-1,0,0,0,"PRKACA",
"C65624",3,"Fasudil",10/2/2018 0:00:00,-1,0,0,0,"PRKG1",
"C65624",4,"Fasudil",10/2/2018 0:00:00,-1,0,0,0,"PRKCA",
"C65826",1,"Guanabenz Acetate",10/24/2018 0:00:00,-1,0,0,0,"ADRA2A","wildtype"
"C65826",2,"Guanabenz Acetate",10/24/2018 0:00:00,-1,0,0,0,"ADRA2B","wildtype"
"C65826",3,"Guanabenz Acetate",10/24/2018 0:00:00,-1,0,0,0,"ADRA2C","wildtype"
"C65978",1,"Isoflurane",,-1,0,0,0,,
"C66240",1,"Niclosamide",10/2/2018 0:00:00,-1,0,0,0,"STAT3",
"C66250",1,"Ocrelizumab",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C66253",1,"Olmesartan",10/24/2018 0:00:00,-1,0,0,0,"AGTR1","wildtype"
"C664",1,"Mitotane",9/24/2018 0:00:00,-1,0,0,0,,
"C66523",1,"Rosuvastatin",2/28/2019 0:00:00,-1,0,0,0,"HMGCR",
"C66869",1,"Losartan",10/24/2018 0:00:00,-1,0,0,0,"AGTR1","wildtype"
"C66876",1,"Gemcitabine",11/8/2018 0:00:00,-1,0,0,0,,
"C66878",1,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C66878",2,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C66878",3,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"ERBB4","wildtype"
"C66878",4,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"MAPK1","wildtype"
"C66878",5,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"MAPK3","wildtype"
"C66878",6,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"AKT","wildtype"
"C66878",7,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"AKT2","wildtype"
"C66878",8,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"AKT3","wildtype"
"C66878",9,"Lapatinib Ditosylate",10/24/2018 0:00:00,-1,0,0,0,"AKT1","wildtype"
"C66937",1,"Cabazitaxel",3/1/2018 0:00:00,-1,0,0,0,"tubulin",
"C66939",1,"Selumetinib",7/13/2017 0:00:00,-1,0,0,0,"MAPK1",
"C66939",2,"Selumetinib",7/13/2017 0:00:00,-1,0,0,0,"MAPK2",
"C66940",1,"Afatinib",7/18/2017 0:00:00,-1,0,0,0,"EGFR",
"C66940",2,"Afatinib",7/18/2017 0:00:00,-1,0,0,0,"ERBB2",
"C66940",3,"Afatinib",7/18/2017 0:00:00,-1,0,0,0,"ERBB4",
"C66942",1,"MV-NIS",3/1/2018 0:00:00,-1,0,0,0,,
"C66944",1,"Brentuximab Vedotin",1/22/2018 0:00:00,-1,0,0,0,"TNFRSF8",
"C66945",1,"Dexrazoxane Hydrochloride",3/5/2019 0:00:00,-1,0,0,0,,
"C66948",1,"Panobinostat",3/1/2018 0:00:00,-1,0,0,0,,
"C66952",1,"Ofatumumab",5/23/2017 0:00:00,-1,0,0,0,"MS4A1",
"C66961",1,"AZD7762",10/2/2018 0:00:00,-1,0,0,0,"CHEK1",
"C66961",2,"AZD7762",10/2/2018 0:00:00,-1,0,0,0,"CHEK2",
"C66982",1,"Elotuzumab",,-1,0,0,0,,
"C66985",1,"Tergenpumatucel-L",3/1/2018 0:00:00,-1,0,0,0,,
"C67040",1,"Brivanib",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C67040",2,"Brivanib",10/2/2018 0:00:00,-1,0,0,0,"FLK1",
"C67040",3,"Brivanib",10/2/2018 0:00:00,-1,0,0,0,"FGFR1",
"C67040",4,"Brivanib",10/2/2018 0:00:00,-1,0,0,0,"FLT1",
"C67041",1,"Fas Receptor Agonist APO010",,-1,0,0,0,,
"C67079",1,"Rilotumumab",3/1/2018 0:00:00,-1,0,0,0,"HGF",
"C67082",1,"Remestemcel-L",,-1,0,0,0,,
"C67088",1,"Brivudine",10/24/2018 0:00:00,-1,0,0,0,,
"C68814",1,"Nivolumab",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C68820",1,"PF-477736",10/3/2018 0:00:00,-1,0,0,0,"CHEK1",
"C68820",2,"PF-477736",10/3/2018 0:00:00,-1,0,0,0,"CHEK2",
"C68820",3,"PF-477736",10/3/2018 0:00:00,-1,0,0,0,"KDR",
"C68820",4,"PF-477736",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C68820",5,"PF-477736",10/3/2018 0:00:00,-1,0,0,0,"YES1",
"C68832",1,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"C68832",2,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"ERBB2",
"C68832",3,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"ERBB4",
"C68832",4,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"FLT1",
"C68832",5,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C68832",6,"BMS-690514",10/2/2018 0:00:00,-1,0,0,0,"FLT4",
"C68845",1,"Abiraterone acetate",3/1/2018 0:00:00,-1,0,0,0,,
"C689",1,"Niacin",3/6/2019 0:00:00,-1,0,0,0,,
"C68920",1,"Abexinostat",9/24/2018 0:00:00,-1,0,0,0,"HDAC",
"C68920",2,"Abexinostat",9/24/2018 0:00:00,-1,0,0,0,"RAD51",
"C68923",1,"Cobimetinib",6/20/2017 0:00:00,-1,0,0,0,"MAP2K1",
"C68923",2,"Cobimetinib",2/20/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C68929",1,"XL228",10/24/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C68929",2,"XL228",10/24/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C68929",3,"XL228",10/24/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C68929",4,"XL228",10/24/2018 0:00:00,-1,0,0,0,"BCR","wildtype"
"C68929",5,"XL228",10/24/2018 0:00:00,-1,0,0,0,"BCR-ABL","wildtype"
"C68936",1,"Quizartinib",9/28/2018 0:00:00,-1,0,0,0,"FLT3",
"C68936",2,"Quizartinib",9/28/2018 0:00:00,-1,0,0,0,"CSF1R",
"C68936",5,"Quizartinib",9/28/2018 0:00:00,-1,0,0,0,"KIT",
"C68936",6,"Quizartinib",9/28/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C68936",7,"Quizartinib",9/28/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C68963",1,"XL418",10/24/2018 0:00:00,-1,0,0,0,"AKT1","wildtype"
"C68963",2,"XL418",10/24/2018 0:00:00,-1,0,0,0,"RPS6KB1","wildtype"
"C69005",1,"E7107",10/2/2018 0:00:00,-1,0,0,0,"SAP130",
"C69076",1,"Rindopepimut",10/24/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C69135",1,"XL281",10/24/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C69135",2,"XL281",10/24/2018 0:00:00,-1,0,0,0,"BRAF","wildtype"
"C69135",3,"XL281",10/24/2018 0:00:00,-1,0,0,0,"ARAF","wildtype"
"C69139",1,"KW-2478",10/24/2018 0:00:00,-1,0,0,0,"HSP90","wildtype"
"C69139",2,"KW-2478",10/24/2018 0:00:00,-1,0,0,0,"HSP90AA1","wildtype"
"C69139",3,"KW-2478",10/24/2018 0:00:00,-1,0,0,0,"HSP90AB1","wildtype"
"C69143",1,"AZD8330",10/2/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C69143",2,"AZD8330",10/2/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C69161",1,"Enobosarm",3/1/2018 0:00:00,-1,0,0,0,,
"C70625",1,"PRLX 93936",10/24/2018 0:00:00,-1,0,0,0,"VDAC2","wildtype"
"C70625",2,"PRLX 93936",10/24/2018 0:00:00,-1,0,0,0,"VDAC3","wildtype"
"C70674",1,"CIMAvax",3/1/2018 0:00:00,-1,0,0,0,,
"C70677",1,"Micronutrient-Fortified Probiotic Yogurt",,-1,0,0,0,,
"C70741",1,"Obinutuzumab",10/30/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C70792",1,"Ramucirumab",6/20/2017 0:00:00,-1,0,0,0,"KDR",
"C70797",1,"CD20-targeted Polypeptide TRU-015",,-1,0,0,0,,
"C70948",1,"GSK461364",10/2/2018 0:00:00,-1,0,0,0,"PLK1",
"C70953",1,"PX-478",10/24/2018 0:00:00,-1,0,0,0,"HIF1A","wildtype"
"C70982",1,"Linsitinib",10/1/2018 0:00:00,-1,0,0,0,"IGF1R",
"C70982",2,"Linsitinib",10/1/2018 0:00:00,-1,0,0,0,"INSR",
"C70985",1,"Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine",,-1,0,0,0,,
"C71010",1,"Carlumab",10/30/2018 0:00:00,-1,0,-1,0,"CCL2","wildtype"
"C71014",1,"Pidilizumab",10/31/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C71015",1,"Conatumumab",10/24/2018 0:00:00,-1,0,0,0,"TNFRSF10B","wildtype"
"C71146",1,"Salirasib",10/2/2018 0:00:00,-1,0,0,0,"KRAS",
"C71146",2,"Salirasib",10/2/2018 0:00:00,-1,0,0,0,"NRAS",
"C71146",3,"Salirasib",10/2/2018 0:00:00,-1,0,0,0,"HRAS",
"C71467",1,"Luminespib",10/2/2018 0:00:00,-1,0,0,0,"HSP90AA1",
"C71467",2,"Luminespib",10/2/2018 0:00:00,-1,0,0,0,"HSP90AB1",
"C71529",1,"CBP501",3/5/2019 0:00:00,-1,0,0,0,"CHK1",
"C71529",2,"CBP501",3/5/2019 0:00:00,-1,0,0,0,"MAPKAPK2",
"C71531",1,"Ganitumab",12/4/2018 0:00:00,-1,0,0,0,"IGF1R",
"C71535",1,"Indoximod",10/30/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C71539",1,"Angiogenesis Inhibitor GT-111",,-1,0,0,0,,
"C71540",1,"Allogeneic CD4+ Memory Th1-like T Cells/Microparticle-bound Anti-CD3/anti-CD28",,-1,0,0,0,,
"C716",1,"Omeprazole",4/1/2019 0:00:00,-1,0,0,0,,
"C71622",1,"Sunitinib",6/20/2017 0:00:00,-1,0,0,0,"KDR",
"C71622",2,"Sunitinib",6/20/2017 0:00:00,-1,0,0,0,"PDGFRB",
"C71622",3,"Sunitinib",6/20/2017 0:00:00,-1,0,0,0,"KIT",
"C71622",4,"Sunitinib",6/20/2017 0:00:00,-1,0,0,0,"FLT3",
"C71631",1,"Leucovorin",3/1/2018 0:00:00,-1,0,0,0,,
"C71693",1,"Apomab",10/24/2018 0:00:00,-1,0,0,0,"TNFRSF10B","wildtype"
"C71704",1,"Voxtalisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C71704",2,"Voxtalisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C71704",3,"Voxtalisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C71704",4,"Voxtalisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C71704",5,"Voxtalisib",10/2/2018 0:00:00,-1,0,0,0,"PRKDC",
"C71705",1,"Pilaralisib",10/1/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C71705",2,"Pilaralisib",10/1/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C71705",3,"Pilaralisib",10/1/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C71705",4,"Pilaralisib",10/1/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C71711",1,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"AKT1","wildtype"
"C71711",2,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"AKT2","wildtype"
"C71711",3,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"AKT3","wildtype"
"C71711",4,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKCH","wildtype"
"C71711",5,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKCQ","wildtype"
"C71711",6,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKX","wildtype"
"C71711",7,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKCD","wildtype"
"C71711",8,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKCB","wildtype"
"C71711",9,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKCE","wildtype"
"C71711",10,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKACA","wildtype"
"C71711",11,"GSK690693",10/24/2018 0:00:00,-1,0,0,0,"PRKG1","wildtype"
"C71716",1,"Givinostat",,-1,0,0,0,,
"C71717",1,"Alisertib",2/19/2019 0:00:00,-1,0,0,0,"AURKA",
"C71721",1,"Olaparib",11/8/2018 0:00:00,-1,0,0,0,"PARP1","wildtype"
"C71721",2,"Olaparib",11/8/2018 0:00:00,-1,0,0,0,"PARP2","wildtype"
"C71722",1,"Evofosfamide",10/2/2018 0:00:00,-1,0,0,0,,
"C71744",1,"Enzalutamide",7/18/2017 0:00:00,-1,0,0,0,"AR",
"C71750",1,"Amuvatinib",10/2/2018 0:00:00,-1,0,0,0,"KIT",
"C71750",2,"Amuvatinib",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C71750",3,"Amuvatinib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C71757",1,"Cytokine-Induced Killer Cells",,-1,0,0,0,,
"C71759",1,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C71759",2,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C71759",3,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"FLT4","wildtype"
"C71759",4,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C71759",5,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C71759",6,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C71759",7,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C71759",8,"Linifanib",10/24/2018 0:00:00,-1,0,0,0,"TEK","wildtype"
"C71896",1,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"FLT1",
"C71896",2,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C71896",3,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"FLT4",
"C71896",4,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"KIT",
"C71896",5,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C71896",6,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C71896",7,"Motesanib",10/2/2018 0:00:00,-1,0,0,0,"RET",
"C723",1,"Oxymetholone",10/24/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C72560",1,"Pomalidomide",3/13/2018 0:00:00,-1,0,0,0,,
"C73146",1,"Vicriviroc Maleate",,-1,0,0,0,,
"C73261",1,"Bendamustine",3/1/2018 0:00:00,-1,0,0,0,,
"C73589",1,"Vicriviroc",,-1,0,0,0,,
"C73598",1,"Bazedoxifene",3/6/2019 0:00:00,-1,0,0,0,,
"C736",1,"Pertussis Toxin",10/24/2018 0:00:00,-1,0,0,0,,
"C74001",1,"Tiomolibdate Diammonium",3/7/2019 0:00:00,-1,0,0,0,,
"C74002",1,"Fluciclovine F18",3/6/2019 0:00:00,-1,0,0,0,,
"C74005",1,"Anti-CD30 Monoclonal Antibody XmAb2513",,-1,0,0,0,,
"C74007",1,"Daratumumab",10/31/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C74008",1,"CP-870,893",10/31/2018 0:00:00,-1,0,0,0,"CD40","wildtype"
"C74010",1,"Carotuximab",10/17/2017 0:00:00,-1,0,0,0,"CD105",
"C74011",1,"Dalotuzumab",10/24/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C74012",1,"Apatinib",1/16/2018 0:00:00,-1,0,0,0,"KDR",
"C74012",2,"Apatinib",1/16/2018 0:00:00,-1,0,0,0,"KIT",
"C74012",3,"Apatinib",1/16/2018 0:00:00,-1,0,0,0,"SRC",
"C74017",1,"CD3/CD28 Costimulated Autologous T-Cells",10/30/2018 0:00:00,-1,0,-1,0,,
"C74038",1,"Vismodegib",7/18/2017 0:00:00,-1,0,0,0,"PTCH",
"C74038",2,"Vismodegib",7/18/2017 0:00:00,-1,0,0,0,"SMO",
"C74040",1,"SNX-5542 Mesylate",10/24/2018 0:00:00,-1,0,0,0,"HSP90AA1","wildtype"
"C74040",2,"SNX-5542 Mesylate",10/24/2018 0:00:00,-1,0,0,0,"HSP90AB1","wildtype"
"C74040",3,"SNX-5542 Mesylate",10/24/2018 0:00:00,-1,0,0,0,"HSP90","wildtype"
"C74043",1,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"INSR",
"C74043",2,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"IGR1R",
"C74043",3,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"NTRK2",
"C74043",4,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C74043",5,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"NTRK1",
"C74043",6,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"AURKA",
"C74043",7,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"AURKB",
"C74043",8,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"RON",
"C74043",9,"BMS-754807",10/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C74055",1,"CRS-207",3/1/2018 0:00:00,-1,0,0,0,,
"C74059",1,"Refametinib",10/2/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C74059",2,"Refametinib",10/2/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C74060",1,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"AXL",
"C74060",2,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"MST1R",
"C74060",3,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"MET",
"C74060",4,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"TYRO3",
"C74060",5,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"MERTK",
"C74060",6,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C74060",7,"BMS-777607",10/2/2018 0:00:00,-1,0,0,0,"AURKB",
"C74061",1,"Crizotinib",6/20/2017 0:00:00,-1,0,0,0,"ALK",
"C74061",2,"Crizotinib",6/20/2017 0:00:00,-1,0,0,0,"c-Met",
"C74062",1,"SGX523",10/2/2018 0:00:00,-1,0,0,0,"MET",
"C74063",1,"Mixed Bacteria Vaccine",,-1,0,0,0,,
"C74065",1,"Nab-Rapamycin",3/1/2018 0:00:00,-1,0,0,0,"FKBP1A",
"C74067",1,"DNX-2401",3/1/2018 0:00:00,-1,0,0,0,,
"C74069",1,"Etirinotecan Pegol",4/20/2018 0:00:00,-1,0,0,0,"CD8",
"C74072",1,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C74072",2,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"MTOR",
"C74072",3,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C74072",4,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C74072",5,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C74072",6,"Dactolisib",10/2/2018 0:00:00,-1,0,0,0,"ATR",
"C74073",1,"BGT226",10/2/2018 0:00:00,-1,0,0,0,"MTOR",
"C74073",2,"BGT226",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C74073",3,"BGT226",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C74073",4,"BGT226",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C74074",1,"FP253",10/24/2018 0:00:00,-1,0,0,0,,
"C74076",1,"Rexinoid NRX 194204",,-1,0,0,0,,
"C74077",1,"KX2-391",10/2/2018 0:00:00,-1,0,0,0,"SRC",
"C74084",1,"SD-101",6/20/2017 0:00:00,-1,0,0,0,"TLR9",
"C74090",1,"VEGFR2-169 Peptide Vaccine",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"C74091",1,"WT1-Sensitized Allogeneic T-Lymphocytes",10/24/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C745",1,"Picibanil",,-1,0,0,0,,
"C74547",1,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C74547",2,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C74547",3,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C74547",4,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"KIT",
"C74547",5,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C74547",6,"Pazopanib",3/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C74584",1,"Lanreotide Acetate",12/5/2017 0:00:00,-1,0,0,0,"SSTR2",
"C74584",2,"Lanreotide Acetate",12/5/2017 0:00:00,-1,0,0,0,"SSTR5",
"C74594",1,"Nutlin-3a",10/1/2018 0:00:00,-1,0,0,0,"MDM2",
"C74595",1,"ADXS11-001",3/1/2018 0:00:00,-1,0,0,0,,
"C74940",1,"Alvocidib",10/3/2018 0:00:00,-1,0,0,0,"CDK1",
"C74940",2,"Alvocidib",10/3/2018 0:00:00,-1,0,0,0,"CDK2",
"C74940",3,"Alvocidib",10/3/2018 0:00:00,-1,0,0,0,"CDK4",
"C74940",4,"Alvocidib",10/3/2018 0:00:00,-1,0,0,0,"CDK6",
"C74940",5,"Alvocidib",10/3/2018 0:00:00,-1,0,0,0,"CDK7",
"C76199",1,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C76199",2,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"KIT",
"C76199",3,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"FGFR1",
"C76199",4,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"FLT4",
"C76199",5,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"FGFR3",
"C76199",6,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"FLT1",
"C76199",7,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"KDR",
"C76199",8,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"CSF1R",
"C76199",9,"Dovitinib",10/3/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C76243",1,"Targeted Molecular Therapy",9/17/2018 0:00:00,-1,0,0,0,"general",
"C76394",1,"Preladenant",12/5/2017 0:00:00,-1,0,0,0,"ADORA2A",
"C76497",1,"Golotimod",,-1,0,0,0,,
"C76890",1,"Roflumilast",10/15/2018 0:00:00,-1,0,0,0,"PDE4A","wildtype"
"C76890",2,"Roflumilast",10/15/2018 0:00:00,-1,0,0,0,"PDE4B","wildtype"
"C76890",3,"Roflumilast",10/15/2018 0:00:00,-1,0,0,0,"PDE4C","wildtype"
"C769",1,"Prednisolone",10/3/2018 0:00:00,-1,0,0,0,,
"C76969",1,"Atiprimod Dihydrochloride",10/24/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C76970",1,"Atiprimod Dimaleate",10/15/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C76970",2,"Atiprimod Dimaleate",10/15/2018 0:00:00,-1,0,0,0,"AKT1","wildtype"
"C76970",3,"Atiprimod Dimaleate",10/15/2018 0:00:00,-1,0,0,0,"AKT2","wildtype"
"C76970",4,"Atiprimod Dimaleate",10/15/2018 0:00:00,-1,0,0,0,"AKT3","wildtype"
"C76970",5,"Atiprimod Dimaleate",10/15/2018 0:00:00,-1,0,0,0,"JAK2","wildtype"
"C770",1,"Prednisone",3/1/2018 0:00:00,-1,0,0,0,,
"C77330",1,"Pyrvinium",10/3/2018 0:00:00,-1,0,0,0,,
"C77333",1,"Abiraterone",10/3/2018 0:00:00,-1,0,0,0,"CYP17A1",
"C77392",1,"Enzastaurin",10/3/2018 0:00:00,-1,0,0,0,"PRKCB",
"C77392",2,"Enzastaurin",10/3/2018 0:00:00,-1,0,0,0,"PRKCA",
"C77392",3,"Enzastaurin",10/3/2018 0:00:00,-1,0,0,0,"PRKCG",
"C77392",4,"Enzastaurin",10/3/2018 0:00:00,-1,0,0,0,"PRKCE",
"C77588",1,"Canertinib",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"C77588",2,"Canertinib",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"C77854",1,"Solitomab",10/24/2018 0:00:00,-1,0,0,0,"EPCAM","wildtype"
"C77854",2,"Solitomab",,-1,0,0,0,"CD3D",
"C77854",3,"Solitomab",10/24/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C77854",4,"Solitomab",10/24/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C77854",5,"Solitomab",10/24/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C77857",1,"rHIgM12B7",10/24/2018 0:00:00,-1,0,0,0,"PDCD1LG2","wildtype"
"C77861",1,"BMS-833923",10/24/2018 0:00:00,-1,0,0,0,"SMO","wildtype"
"C77865",1,"Anti-CEA IgCD28TCR-Transduced Autologous T Cells",,-1,0,0,0,,
"C77866",1,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C77866",2,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C77866",3,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"ERBB4","wildtype"
"C77866",4,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C77866",5,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"LCK","wildtype"
"C77866",6,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"FYN","wildtype"
"C77866",7,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"YES","wildtype"
"C77866",8,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"LYN","wildtype"
"C77866",9,"JNJ-26483327",10/15/2018 0:00:00,-1,0,0,0,"FLT4","wildtype"
"C77872",1,"Ganetespib",3/1/2018 0:00:00,-1,0,0,0,"HSP90",
"C77875",1,"HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"LY6K","wildtype"
"C77875",2,"HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"IGF2BP3","wildtype"
"C77875",3,"HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C77875",4,"HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C77876",1,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"MET",
"C77876",2,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"TEK",
"C77876",3,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C77876",4,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C77876",5,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C77876",6,"Glesatinib",3/1/2018 0:00:00,-1,0,0,0,"MST1R",
"C77879",1,"CYT107",4/24/2019 0:00:00,-1,0,0,0,,
"C77886",1,"MDX-1401",5/23/2017 0:00:00,-1,0,0,0,"TNFRSF8",
"C77887",1,"Sapitinib",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"C77887",2,"Sapitinib",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"C77887",3,"Sapitinib",10/3/2018 0:00:00,-1,0,0,0,"ERBB3",
"C77888",1,"Ruxolitinib",9/11/2018 0:00:00,-1,0,0,0,"JAK1",
"C77888",2,"Ruxolitinib",9/11/2018 0:00:00,-1,0,0,0,"JAK2",
"C77893",1,"JNJ-38877605",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C77895",1,"VEGFR1-1084",10/31/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C77896",1,"Tucatinib",7/16/2018 0:00:00,-1,0,0,0,"ERBB2",
"C77897",1,"HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"TTK","wildtype"
"C77897",2,"HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"IGF2BP3","wildtype"
"C77904",1,"Serdemetan",10/3/2018 0:00:00,-1,0,0,0,"TP53",
"C77904",2,"Serdemetan",,-1,0,0,0,"MDM2",
"C77905",1,"HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C77905",2,"HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C77906",1,"Pevonedistat",8/21/2018 0:00:00,-1,0,0,0,"NAE1",
"C77907",1,"Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003",,-1,0,0,0,,
"C77908",1,"Trametinib",7/18/2017 0:00:00,-1,0,0,0,"MAP2K1",
"C77908",2,"Trametinib",7/18/2017 0:00:00,-1,0,0,0,"MAP2K2",
"C77910",1,"Ad-sig-hMUC-1/ecdCD40L Vaccine",,-1,0,0,0,,
"C77970",1,"HGS1036",10/23/2018 0:00:00,-1,0,0,0,"FGFR1",
"C77970",2,"HGS1036",10/23/2018 0:00:00,-1,0,0,0,"FGFR2",
"C77970",3,"HGS1036",10/23/2018 0:00:00,-1,0,0,0,"FGFR3",
"C77970",4,"HGS1036",10/23/2018 0:00:00,-1,0,0,0,"FGFR4",
"C77971",1,"MKC-1106-MT",10/24/2018 0:00:00,-1,0,0,0,,
"C78084",1,"Methoxyamine",3/6/2019 0:00:00,-1,0,0,0,,
"C78085",1,"Methoxyamine Hydrochloride",3/7/2019 0:00:00,-1,0,0,0,,
"C78187",1,"MDX-1411",5/23/2017 0:00:00,-1,0,0,0,"CD70",
"C78190",1,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C78190",2,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"RET",
"C78190",3,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"AURKA",
"C78190",4,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"FLT4",
"C78190",5,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"SRC",
"C78190",6,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"NTRK1",
"C78190",7,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"CSF1R",
"C78190",8,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"LCK",
"C78190",9,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"PTK2",
"C78190",10,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C78190",11,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"KDR",
"C78190",12,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"BLK",
"C78190",13,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"FGFR2",
"C78190",14,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"YES1",
"C78190",15,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"ABL1",
"C78190",16,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"FGFR1",
"C78190",17,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"FYN",
"C78190",18,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C78190",19,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"KIT",
"C78190",20,"ENMD-2076",10/3/2018 0:00:00,-1,0,0,0,"AURKB",
"C78199",1,"PF-00562271",10/24/2018 0:00:00,-1,0,0,0,"PTK2","wildtype"
"C78199",2,"PF-00562271",10/24/2018 0:00:00,-1,0,0,0,"PYK2","wildtype"
"C78204",1,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"KDR",
"C78204",2,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"FLT4",
"C78204",3,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"RET",
"C78204",4,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"KIT",
"C78204",5,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"PDGFRA",
"C78204",6,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"PDGFRB",
"C78204",7,"Regorafenib",6/20/2017 0:00:00,-1,0,0,0,"Raf kinase",
"C78449",1,"Glembatumumab Vedotin",6/20/2017 0:00:00,-1,0,0,0,"GPNMB",
"C78451",1,"DI-Leu16-IL2 Immunocytokine",,-1,0,0,0,,
"C78463",1,"PGG Beta-Glucan",12/5/2017 0:00:00,-1,0,0,0,"CD2",
"C78463",2,"PGG Beta-Glucan",12/5/2017 0:00:00,-1,0,0,0,"CD3",
"C78467",1,"CMVpp65-A*0201 Peptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C78470",1,"GSK1059615",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C78470",2,"GSK1059615",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C78470",3,"GSK1059615",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C78470",4,"GSK1059615",10/3/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C78470",5,"GSK1059615",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"C78474",1,"Tigapotide",10/24/2018 0:00:00,-1,0,0,0,,
"C78476",1,"OSI-027",10/1/2018 0:00:00,-1,0,0,0,"MTOR",
"C78476",2,"OSI-027",10/1/2018 0:00:00,-1,0,0,0,"RPTOR",
"C78476",3,"OSI-027",10/1/2018 0:00:00,-1,0,0,0,"RICTOR",
"C78483",1,"PF-04217903",10/24/2018 0:00:00,-1,0,0,0,"MET","wildtype"
"C78489",1,"Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells",,-1,0,0,0,,
"C78822",1,"STAT3 Decoy Oligonucleotide",10/24/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C78825",1,"Idelalisib",10/17/2017 0:00:00,-1,0,0,0,"PIK3CD",
"C78826",1,"Anti-DR5 Agonist Monoclonal Antibody TRA-8",,-1,0,0,0,,
"C78829",1,"CD4+ CD25+ Regulatory T Cells",10/24/2018 0:00:00,-1,0,0,0,,
"C78831",1,"HE3235",10/24/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C78837",1,"Pacritinib",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C78837",2,"Pacritinib",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C78837",3,"Pacritinib",10/3/2018 0:00:00,-1,0,0,0,"TYK2",
"C78837",4,"Pacritinib",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"C78838",1,"RO5083945",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C78844",1,"Ficlatuzumab",10/3/2018 0:00:00,-1,0,0,0,"HGF",
"C78848",1,"Sonolisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C78848",2,"Sonolisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C78848",3,"Sonolisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C78850",1,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"C78850",2,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC1",
"C78850",3,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC6",
"C78850",4,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC3",
"C78850",5,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC5",
"C78850",6,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC2",
"C78850",7,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC4",
"C78850",8,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"C78850",9,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC10",
"C78850",10,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC9",
"C78850",11,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC8",
"C78850",12,"CUDC-101",10/3/2018 0:00:00,-1,0,0,0,"HDAC7",
"C78852",1,"MDX-1105",10/31/2018 0:00:00,-1,0,0,0,"CD274","wildtype"
"C78853",1,"Patritumab",10/24/2018 0:00:00,-1,0,0,0,"ERBB3","wildtype"
"C78854",1,"Dinaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK1",
"C78854",2,"Dinaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK2",
"C78854",3,"Dinaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK5",
"C78854",4,"Dinaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK9",
"C78856",1,"AZD8055",10/1/2018 0:00:00,-1,0,0,0,"MTOR",
"C78859",1,"Seribantumab",9/28/2018 0:00:00,-1,0,0,0,"ERBB3",
"C78862",1,"Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307",,-1,0,0,0,,
"C78865",1,"GSK2130579A",10/24/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C792",1,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"SIRT1","wildtype"
"C792",2,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C792",3,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"PRKCA","wildtype"
"C792",4,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"PIK3CG","wildtype"
"C792",5,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"PIK3CD","wildtype"
"C792",6,"Quercetin",10/24/2018 0:00:00,-1,0,0,0,"PIK3CB","wildtype"
"C79798",1,"AVE1642",10/24/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C79809",1,"Defactinib",6/20/2017 0:00:00,-1,0,0,0,"FAK",
"C79825",1,"Olaratumab",9/11/2017 0:00:00,-1,0,0,0,"PDGFRA",
"C79828",1,"Cixutumumab",10/24/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C79831",1,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C79831",2,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"LYN","wildtype"
"C79831",3,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C79831",4,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C79831",5,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"ABL1","wildtype"
"C79831",6,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C79831",7,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"SRC","wildtype"
"C79831",8,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,-1,0,"HCK","wildtype"
"C79831",9,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"FGFR3","wildtype"
"C79831",10,"Masitinib Mesylate",10/25/2018 0:00:00,-1,0,0,0,"PTK2","wildtype"
"C79832",1,"ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine",,-1,0,0,0,,
"C79834",1,"Anti-Her-2-CAR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes",10/25/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C79835",1,"XL888",7/18/2017 0:00:00,-1,0,0,0,"HSP90",
"C79839",1,"MCT/LCT/Fish Oil Omega-3 Fatty Acid Lipid Emulsion",,-1,0,0,0,,
"C79844",1,"Volasertib",10/3/2018 0:00:00,-1,0,0,0,"PLK1",
"C79848",1,"E6201",10/1/2018 0:00:00,-1,0,0,0,"MAP3K1",
"C79848",2,"E6201",10/1/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C80039",1,"CPI-613",3/7/2019 0:00:00,-1,0,0,0,,
"C80041",1,"Demcizumab",6/20/2017 0:00:00,-1,0,0,0,"DLL4",
"C80044",1,"MCS110",3/1/2018 0:00:00,-1,0,0,0,"CSF1",
"C80045",1,"Enavatuzumab",,-1,0,0,0,,
"C80046",1,"Hyperacute Melanoma vaccine",3/1/2018 0:00:00,-1,0,0,0,,
"C80049",1,"P1446A-05",10/24/2018 0:00:00,-1,0,0,0,"CDK4","wildtype"
"C80052",1,"Cytomegalovirus IE-1-specific Cytotoxic T Lymphocytes",,-1,0,0,0,,
"C80058",1,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"MET",
"C80058",2,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"KDR",
"C80058",3,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"TEK",
"C80058",4,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"FLT4",
"C80058",5,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"MST1R",
"C80058",6,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C80058",7,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C80058",8,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"KIT",
"C80058",9,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"FLT1",
"C80058",10,"Foretinib",10/3/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C80059",1,"Niraparib",6/20/2017 0:00:00,-1,0,0,0,"PARP1",
"C80059",2,"Niraparib",6/20/2017 0:00:00,-1,0,0,0,"PARP2",
"C80060",1,"RO5126766",10/3/2018 0:00:00,-1,0,0,0,"RAF1",
"C80060",2,"RO5126766",10/3/2018 0:00:00,-1,0,0,0,"BRAF",
"C80060",3,"RO5126766",10/3/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C80063",1,"Saridegib",10/24/2018 0:00:00,-1,0,0,0,"SMO","wildtype"
"C80339",1,"Proxyphylline",,-1,0,0,0,,
"C80521",1,"Motolimod",11/21/2017 0:00:00,-1,0,0,0,"TLR8",
"C80631",1,"Sotrastaurin Acetate",9/27/2018 0:00:00,-1,0,0,0,"PRKCA",
"C80631",2,"Sotrastaurin Acetate",9/27/2018 0:00:00,-1,0,0,0,"PRKCG",
"C80631",3,"Sotrastaurin Acetate",9/27/2018 0:00:00,-1,0,0,0,"PRKCQ",
"C80682",1,"Talabostat Mesylate",4/24/2019 0:00:00,-1,0,0,0,,
"C80867",1,"Cediranib",12/20/2017 0:00:00,-1,0,0,0,"FLT1",
"C80867",2,"Cediranib",12/20/2017 0:00:00,-1,0,0,0,"KDR",
"C80867",3,"Cediranib",12/20/2017 0:00:00,-1,0,0,0,"FLT4",
"C809",1,"Ricin",10/24/2018 0:00:00,-1,0,0,0,,
"C80971",1,"Canakinumab",7/26/2017 0:00:00,-1,0,0,0,"IL1B",
"C80999",1,"Rocuronium",1/22/2019 0:00:00,-1,0,0,0,,
"C811",1,"Rifampin",9/11/2018 0:00:00,-1,0,0,0,"DNA-dependent RNA polymerase",
"C81540",1,"Colestipol",9/14/2018 0:00:00,-1,0,0,0,,
"C81569",1,"Ifetroban Sodium",2/21/2019 0:00:00,-1,0,0,0,,
"C81700",1,"Phenformin",9/14/2018 0:00:00,-1,0,0,0,,
"C81934",1,"Ibrutinib",1/29/2018 0:00:00,-1,0,0,0,"BTK",
"C82258",1,"Alpha-1-Proteinase Inhibitor Human",,-1,0,0,0,,
"C82348",1,"Onartuzumab",10/3/2018 0:00:00,-1,0,0,0,"MET",
"C82349",1,"AMG 900",10/3/2018 0:00:00,-1,0,0,0,"AURKA",
"C82349",2,"AMG 900",10/3/2018 0:00:00,-1,0,0,0,"AURKB",
"C82349",3,"AMG 900",10/3/2018 0:00:00,-1,0,0,0,"AURKC",
"C82349",4,"AMG 900",10/3/2018 0:00:00,-1,0,0,0,"MAPK14",
"C82350",1,"Autologous_NY-ESO-1-Melanoma-Specific_CD8_T-lymphocytes",10/31/2018 0:00:00,-1,0,0,0,"CTAG1B","wildtype"
"C82361",1,"Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101",10/31/2018 0:00:00,-1,0,0,0,,
"C82363",1,"Golvatinib",10/2/2018 0:00:00,-1,0,0,0,"MET",
"C82363",2,"Golvatinib",10/2/2018 0:00:00,-1,0,0,0,"KDR2",
"C82379",1,"CEP-11981",3/4/2019 0:00:00,-1,0,0,0,"EGFR",
"C82383",1,"PF-03084014",10/3/2018 0:00:00,-1,0,0,0,"PSEN1",
"C82383",2,"PF-03084014",10/3/2018 0:00:00,-1,0,0,0,"APH1A",
"C82383",3,"PF-03084014",10/3/2018 0:00:00,-1,0,0,0,"APH1B",
"C82385",1,"Sonidegib",7/17/2018 0:00:00,-1,0,0,0,"SMO",
"C82386",1,"Dabrafenib",7/18/2017 0:00:00,-1,0,0,0,"BRAF",
"C82387",1,"HSP990",10/24/2018 0:00:00,-1,0,0,0,"HSP90AA1","wildtype"
"C82387",2,"HSP990",10/24/2018 0:00:00,-1,0,0,0,"HSP90AB1","wildtype"
"C82387",3,"HSP990",10/24/2018 0:00:00,-1,0,0,0,"HSP90","wildtype"
"C82390",1,"Afuresertib",10/3/2018 0:00:00,-1,0,0,0,"AKT1",
"C82390",2,"Afuresertib",10/3/2018 0:00:00,-1,0,0,0,"AKT2",
"C82390",3,"Afuresertib",10/3/2018 0:00:00,-1,0,0,0,"AKT3",
"C82404",1,"SGI-1776",10/2/2018 0:00:00,-1,0,0,0,"PIM1",
"C82404",2,"SGI-1776",10/2/2018 0:00:00,-1,0,0,0,"PIM2",
"C82404",3,"SGI-1776",10/2/2018 0:00:00,-1,0,0,0,"PIM3",
"C82404",4,"SGI-1776",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"C82407",1,"PTVG-HP",3/1/2018 0:00:00,-1,0,0,0,,
"C82412",1,"Rimiducid",3/1/2018 0:00:00,-1,0,0,0,,
"C82421",1,"HLA-A*2402-Restricted URLC10 Peptides Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C82492",1,"Ado-trastuzumab emtansine",11/28/2018 0:00:00,-1,0,0,0,"ERBB2",
"C82653",1,"Ixazomib Citrate",3/6/2019 0:00:00,-1,0,0,0,,
"C82659",1,"PEGPH20",3/1/2018 0:00:00,-1,0,0,0,,
"C82661",1,"HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C82676",1,"Liposomal Irinotecan",9/17/2018 0:00:00,-1,0,0,0,"topoisomerase I",
"C82692",1,"Sheddase Inhibitor INCB007839",,-1,0,0,0,,
"C82696",1,"RO4987655",10/3/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C83804",1,"Fenofibric Acid",2/21/2019 0:00:00,-1,0,0,0,,
"C83887",1,"Linagliptin",3/1/2018 0:00:00,-1,0,0,0,"DPP4",
"C83925",1,"Lucanthone",10/25/2018 0:00:00,-1,0,0,0,"APEX1","wildtype"
"C83925",2,"Lucanthone",10/25/2018 0:00:00,-1,0,0,0,,
"C842",1,"Stanozolol",10/25/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C84217",1,"Tocilizumab",9/16/2018 0:00:00,-1,0,0,0,"IL6",
"C84237",1,"Ustekinumab",10/25/2018 0:00:00,-1,0,0,0,"IL12A","wildtype"
"C84237",2,"Ustekinumab",10/25/2018 0:00:00,-1,0,0,0,"IL12B","wildtype"
"C84837",1,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"MTOR",
"C84837",2,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"AKT",
"C84837",3,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C84837",4,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C84837",5,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C84837",6,"PF-04691502",10/23/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C84855",1,"MDX-1203",5/23/2017 0:00:00,-1,0,0,0,"CD70",
"C84858",1,"TAK-733",10/24/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C84858",2,"TAK-733",10/24/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C84859",1,"CDX-1401",6/20/2017 0:00:00,-1,0,0,0,"DEC-205",
"C84863",1,"Menadione Topical Lotion",10/24/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C84863",2,"Menadione Topical Lotion",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C84864",1,"Pimasertib",10/2/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C84864",2,"Pimasertib",10/2/2018 0:00:00,-1,0,0,0,"MAP2K2",
"C84865",1,"Binimetinib",7/18/2017 0:00:00,-1,0,0,0,"MAP2K1",
"C84865",2,"Binimetinib",7/18/2017 0:00:00,-1,0,0,0,"MAP2K2",
"C84866",1,"Galeterone",10/25/2018 0:00:00,-1,0,0,0,"CYP17A1","wildtype"
"C84866",2,"Galeterone",10/25/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C84870",1,"Uprosertib",10/3/2018 0:00:00,-1,0,0,0,"AKT1",
"C84870",2,"Uprosertib",10/3/2018 0:00:00,-1,0,0,0,"AKT2",
"C84870",3,"Uprosertib",10/3/2018 0:00:00,-1,0,0,0,"AKT3",
"C850",1,"Sulindac",10/3/2018 0:00:00,-1,0,0,0,"MTCO1",
"C850",2,"Sulindac",10/3/2018 0:00:00,-1,0,0,0,"MTCO2",
"C85444",1,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"KDR",
"C85444",2,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C85444",3,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"EPHB2",
"C85444",4,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C85444",5,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C85444",6,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C85444",7,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"KIT",
"C85444",8,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"TEK",
"C85444",9,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"EPHB4",
"C85444",10,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"FGFR1",
"C85444",11,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"MET",
"C85444",12,"Tivozanib",10/1/2018 0:00:00,-1,0,0,0,"ABL1",
"C85453",1,"IMC-EB10",10/12/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C85454",1,"Onalespib",9/11/2018 0:00:00,-1,0,0,0,"Hsp90",
"C85460",1,"Silmitasertib Sodium",4/11/2019 0:00:00,-1,0,0,0,"CK2",
"C85465",1,"APR-246",10/3/2018 0:00:00,-1,0,0,0,"TP53",
"C85469",1,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C85469",2,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C85469",3,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C85469",4,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"BRD2",
"C85469",5,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"BRD3",
"C85469",6,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"BRD4",
"C85469",7,"SF1126",10/3/2018 0:00:00,-1,0,0,0,"BRDT",
"C85475",1,"Zolbetuximab",2/21/2019 0:00:00,-1,0,0,0,,
"C85476",1,"NC-6004",3/1/2018 0:00:00,-1,0,0,0,,
"C85481",1,"Multikinase Inhibitor ARRY614",,-1,0,0,0,,
"C85486",1,"MM-111",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C85486",2,"MM-111",10/1/2018 0:00:00,-1,0,0,0,"ERBB3",
"C868",1,"Tetrahydrouridine",3/1/2018 0:00:00,-1,0,0,0,,
"C870",1,"Thalidomide",1/22/2018 0:00:00,-1,0,0,0,"TNF",
"C870",2,"Thalidomide",1/22/2018 0:00:00,-1,0,0,0,"VEGFA",
"C870",3,"Thalidomide",1/22/2018 0:00:00,-1,0,0,0,"bFGF",
"C87736",1,"Picropodophyllin",10/12/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C87764",1,"Fezakinumab",,-1,0,0,0,,
"C87765",1,"Fontolizumab",9/13/2017 0:00:00,-1,0,0,0,"IFNG",
"C87766",1,"Golimumab",10/12/2018 0:00:00,-1,0,0,0,"TNF","wildtype"
"C88055",1,"Anti-CD19-CAR Retroviral Vector-Transduced Autologous T Cells",,-1,0,0,0,,
"C88260",1,"WT1 mRNA-Electroporated Autologous Dendritic Cell Vaccine",10/12/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C88270",1,"Omipalisib",8/21/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C88270",2,"Omipalisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C88270",3,"Omipalisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C88270",4,"Omipalisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C88270",5,"Omipalisib",10/3/2018 0:00:00,-1,0,0,0,"RPTOR",
"C88270",6,"Omipalisib",10/3/2018 0:00:00,-1,0,0,0,"RICTOR",
"C88272",1,"AZD4547",7/18/2017 0:00:00,-1,0,0,0,"FGFR1",
"C88272",2,"AZD4547",7/18/2017 0:00:00,-1,0,0,0,"FGFR2",
"C88272",3,"AZD4547",7/18/2017 0:00:00,-1,0,0,0,"FGFR3",
"C88272",4,"AZD4547",7/18/2017 0:00:00,-1,0,0,0,"FGFR4",
"C88281",1,"Necitumumab",8/21/2018 0:00:00,-1,0,0,0,"EGFR",
"C88289",1,"pNGVL4a-CRT/E7(detox) DNA Vaccine",10/12/2018 0:00:00,-1,0,0,0,,
"C88293",1,"Fedratinib",10/3/2018 0:00:00,-1,0,0,0,"JAK1",
"C88293",2,"Fedratinib",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C88293",3,"Fedratinib",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"C88293",4,"Fedratinib",10/3/2018 0:00:00,-1,0,0,0,"RET",
"C88295",1,"Birinapant",11/21/2017 0:00:00,-1,0,0,0,"SMAC",
"C88295",2,"Birinapant",11/21/2017 0:00:00,-1,0,0,0,"IAP",
"C88296",1,"Dalantercept",10/3/2018 0:00:00,-1,0,0,0,,
"C88302",1,"Infigratinib",7/17/2018 0:00:00,-1,0,0,0,"FGFR1",
"C88302",2,"Infigratinib",7/17/2018 0:00:00,-1,0,0,0,"FGFR2",
"C88302",3,"Infigratinib",7/17/2018 0:00:00,-1,0,0,0,"FGFR3",
"C88302",4,"Infigratinib",7/17/2018 0:00:00,-1,0,0,0,"FGFR4",
"C88303",1,"Pexidartinib",10/31/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C88303",2,"Pexidartinib",10/31/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C88303",3,"Pexidartinib",10/31/2018 0:00:00,-1,0,0,0,"FLT3","wildtype and FLT3 internal tandem duplication (FLT3-ITD)"
"C88307",1,"MR1-1",10/12/2018 0:00:00,-1,0,0,0,"EGFR","EGFRvIII"
"C88308",1,"Plozalizumab",10/31/2018 0:00:00,-1,0,0,0,"CCR2","wildtype"
"C88309",1,"BL-8040",6/20/2017 0:00:00,-1,0,0,0,"CXCR4",
"C88311",1,"Momelotinib",10/3/2018 0:00:00,-1,0,0,0,"JAK1",
"C88311",2,"Momelotinib",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C88311",3,"Momelotinib",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"C88312",1,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK2","wildtype"
"C88312",2,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"NTRK1","wildtype"
"C88312",3,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK7","wildtype"
"C88312",4,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK4","wildtype"
"C88312",5,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK5","wildtype"
"C88312",6,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK2","wildtype"
"C88312",7,"Milciclib Maleate",10/25/2018 0:00:00,-1,0,0,0,"CDK1","wildtype"
"C88314",1,"Tepotinib",9/14/2018 0:00:00,-1,0,0,0,"MET",
"C88315",1,"Vorsetuzumab-mafodotin",5/22/2017 0:00:00,-1,0,0,0,"CD70",
"C88317",1,"HER2Bi-Armed Activated T Cells",2/5/2018 0:00:00,-1,0,0,0,"ERBB2",
"C88318",1,"HSV-1 HF10",12/19/2017 0:00:00,-1,0,0,0,,
"C88329",1,"Vistusertib",7/21/2017 0:00:00,-1,0,0,0,"MTOR",
"C88333",1,"RO4929097",10/1/2018 0:00:00,-1,0,0,0,"PSEN1",
"C88333",2,"RO4929097",10/1/2018 0:00:00,-1,0,0,0,"APH1A",
"C88333",3,"RO4929097",10/1/2018 0:00:00,-1,0,0,0,"APH1B",
"C88335",1,"Archexin",10/2/2018 0:00:00,-1,0,0,0,"AKT1",
"C88342",1,"CpG Oligodeoxynucleotide GNKG168",,-1,0,0,0,,
"C88346",1,"GSK2256098",10/3/2018 0:00:00,-1,0,0,0,"PTK2",
"C88612",1,"Ibalizumab",3/2/2018 0:00:00,-1,0,0,0,"CD4",
"C900",1,"Tretinoin",3/1/2018 0:00:00,-1,0,0,0,"retinoic acid receptors",
"C90291",1,"PKI-179",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"C90291",2,"PKI-179",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C905",1,"Trifluridine",10/3/2018 0:00:00,-1,0,0,0,,
"C90548",1,"Sapanisertib",7/18/2017 0:00:00,-1,0,0,0,"TORC1",
"C90548",2,"Sapanisertib",7/18/2017 0:00:00,-1,0,0,0,"TORC2",
"C90552",1,"Vigil",1/16/2019 0:00:00,-1,0,0,0,,
"C90553",1,"4SC-203",10/25/2018 0:00:00,-1,0,0,0,"FLT3","wildtype and FLT3 Mutants"
"C90553",2,"4SC-203",10/25/2018 0:00:00,-1,0,0,0,"FLT1","wildtype"
"C90553",3,"4SC-203",10/25/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C90553",4,"4SC-203",10/25/2018 0:00:00,-1,0,0,0,"FLT4","wildtype"
"C90564",1,"Capmatinib",6/20/2017 0:00:00,-1,0,0,0,"MET",
"C90565",1,"Buparlisib",9/27/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C90566",1,"HLA-A*2402-Restricted URLC10-CDCA1-KIF20A Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"LY6K","wildtype"
"C90566",2,"HLA-A*2402-Restricted URLC10-CDCA1-KIF20A Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"NUF2","wildtype"
"C90566",3,"HLA-A*2402-Restricted URLC10-CDCA1-KIF20A Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KIF20A","wildtype"
"C90568",1,"HLA-A*2402-Restricted CDCA1-KIF20A Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KIF20A","wildtype"
"C90568",2,"HLA-A*2402-Restricted CDCA1-KIF20A Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"NUF2","wildtype"
"C90569",1,"HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,"TYR","wildtype"
"C90569",2,"HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,"MLANA","wildtype"
"C90569",3,"HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,"PMEL","wildtype"
"C90570",1,"HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,"MAGEA1","wildtype"
"C90570",2,"HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,-1,0,0,"MAGEA2","wildtype"
"C90573",1,"XL019",10/25/2018 0:00:00,-1,0,0,0,"JAK2","wildtype"
"C90573",2,"XL019",10/25/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C90573",3,"XL019",10/25/2018 0:00:00,-1,0,0,0,"JAK1","wildtype"
"C90573",4,"XL019",10/25/2018 0:00:00,-1,0,0,0,"FLT3","wildtype"
"C90573",5,"XL019",10/25/2018 0:00:00,-1,0,0,0,"JAK3","wildtype"
"C90574",1,"AT-406",1/21/2020 0:00:00,-1,0,0,0,"BIRC7",
"C90575",1,"89Zr-Trastuzumab",9/11/2018 0:00:00,-1,0,0,0,"ERBB2",
"C90577",1,"Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2",10/31/2018 0:00:00,-1,0,0,0,,
"C90578",1,"Isatuximab",10/30/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C90579",1,"CT-P6",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"C90581",1,"MK2206",9/11/2018 0:00:00,-1,0,0,0,"AKT",
"C90582",1,"Orteronel",10/25/2018 0:00:00,-1,0,0,0,"CYP17A1","wildtype"
"C90588",1,"OPB-31121",10/24/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C90589",1,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"C90589",2,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"C90589",3,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"ERBB4",
"C90589",4,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C90589",5,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"AURKB",
"C90589",6,"TAK-285",10/3/2018 0:00:00,-1,0,0,0,"LCK",
"C90590",1,"PRO131921",10/31/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C91068",1,"PF-04929113",10/24/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C91068",2,"PF-04929113",10/24/2018 0:00:00,-1,0,0,0,"HSP90AA1","wildtype"
"C91068",3,"PF-04929113",10/24/2018 0:00:00,-1,0,0,0,"HSP90AB1","wildtype"
"C91068",4,"PF-04929113",10/24/2018 0:00:00,-1,0,0,0,"HSP90","wildtype"
"C91072",1,"Ipatasertib",11/2/2017 0:00:00,-1,0,0,0,"AKT1",
"C91072",2,"Ipatasertib",11/2/2017 0:00:00,-1,0,0,0,"AKT2",
"C91072",3,"Ipatasertib",11/2/2017 0:00:00,-1,0,0,0,"AKT3",
"C91076",1,"MVA-EBNA1/LMP2 Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C91078",1,"Ublituximab",10/31/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C91079",1,"LCL161",6/20/2017 0:00:00,-1,0,0,0,"IAP family",
"C91087",1,"Docetaxel-PNP",10/24/2018 0:00:00,-1,0,0,0,,
"C91088",1,"Autologous IL-21-Modulated CD8+ MART1-Specific T Cells",10/31/2018 0:00:00,-1,0,0,0,"MLANA","wildtype"
"C91090",1,"Carboxyamidotriazole Orotate",10/3/2018 0:00:00,-1,0,0,0,,
"C91094",1,"Balixafortide",7/1/2019 0:00:00,-1,0,0,0,"CXCR4",
"C91097",1,"EMD 1204831",10/3/2018 0:00:00,-1,0,0,0,"MET",
"C91376",1,"PRS-050-PEG40",10/24/2018 0:00:00,-1,0,0,0,"KDR","wildtype"
"C91381",1,"Sym004",9/24/2018 0:00:00,-1,0,0,0,"EGFR",
"C91385",1,"Belimumab",10/24/2018 0:00:00,-1,0,0,0,"TNFSF13B","wildtype"
"C91392",1,"Prexasertib",7/23/2018 0:00:00,-1,0,0,0,"CHK1",
"C91394",1,"AZD1480",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C91701",1,"Zanolimumab",10/31/2018 0:00:00,-1,0,0,0,"CD4","wildtype"
"C91702",1,"Pegargiminase",3/7/2019 0:00:00,-1,0,0,0,,
"C91704",1,"YIV-906",2/11/2020 0:00:00,-1,0,0,0,"CYP3A4",
"C91707",1,"GVAX Pancreatic Cancer Vaccine",3/1/2018 0:00:00,-1,0,0,0,,
"C91711",1,"Trebananib",6/21/2017 0:00:00,-1,0,0,0,"ANGPT1",
"C91711",2,"Trebananib",6/21/2017 0:00:00,-1,0,0,0,"ANGPT2",
"C91718",1,"Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed",9/14/2018 0:00:00,-1,0,0,0,,
"C91724",1,"RO5045337",10/24/2018 0:00:00,-1,0,0,0,"MDM2","wildtype"
"C91725",1,"AZD1775",6/20/2017 0:00:00,0,0,0,0,"WEE1",
"C91725",2,"Adavosertib",6/20/2017 0:00:00,-1,0,0,0,"WEE1",
"C91726",1,"OBI-821",2/28/2019 0:00:00,-1,0,0,0,,
"C91727",1,"Tabalumab",,-1,0,0,0,,
"C91731",1,"Apitolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C91731",2,"Apitolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C91731",3,"Apitolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C91731",4,"Apitolisib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C91731",5,"Apitolisib",10/2/2018 0:00:00,-1,0,-1,0,"MTOR",
"C91732",1,"Gedatolisib",7/17/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C91732",2,"Gedatolisib",7/17/2018 0:00:00,-1,0,0,0,"MTOR",
"C91733",1,"Margetuximab",7/12/2017 0:00:00,-1,0,0,0,"ERBB2",
"C91735",1,"Simtuzumab",10/3/2018 0:00:00,-1,0,0,0,"LOXL2",
"C91738",1,"NSCLC Antigen-Loaded Dendritic Cell-derived Exosomes",10/31/2018 0:00:00,-1,0,0,0,"MLANA","wildtype"
"C91738",2,"NSCLC Antigen-Loaded Dendritic Cell-derived Exosomes",10/31/2018 0:00:00,-1,0,0,0,"CTAG1B","wildtype"
"C91738",3,"NSCLC Antigen-Loaded Dendritic Cell-derived Exosomes",10/31/2018 0:00:00,-1,0,0,0,"MAGEA1","wildtype"
"C91738",4,"NSCLC Antigen-Loaded Dendritic Cell-derived Exosomes",10/31/2018 0:00:00,-1,0,0,0,"MAGEA3","wildtype"
"C925",1,"Vancomycin",2/21/2019 0:00:00,-1,0,0,0,,
"C92574",1,"Apalutamide",3/1/2018 0:00:00,-1,0,0,0,"AR",
"C92575",1,"CC-223",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"C92575",2,"CC-223",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"C92575",3,"CC-223",10/3/2018 0:00:00,-1,0,0,0,"FLT4",
"C92575",4,"CC-223",10/3/2018 0:00:00,-1,0,0,0,"PRKDC",
"C92579",1,"Roniciclib",10/24/2018 0:00:00,-1,0,0,0,"CDK1","wildtype"
"C92579",2,"Roniciclib",10/24/2018 0:00:00,-1,0,0,0,"CDK2","wildtype"
"C92579",3,"Roniciclib",10/24/2018 0:00:00,-1,0,0,0,"CDK4","wildtype"
"C92579",4,"Roniciclib",10/24/2018 0:00:00,-1,0,0,0,"CDK9","wildtype"
"C92582",1,"Epacadostat",10/31/2018 0:00:00,-1,0,0,0,"IDO1","wildtype"
"C92591",1,"RO5212054",10/24/2018 0:00:00,-1,0,0,0,"BRAF","BRAF V600E"
"C930",1,"Vinblastine",1/22/2018 0:00:00,-1,0,0,0,,
"C933",1,"Vincristine",9/11/2018 0:00:00,-1,0,0,0,,
"C939",1,"Vitamin B12",3/1/2018 0:00:00,-1,0,0,0,,
"C94206",1,"TL011",10/31/2018 0:00:00,-1,0,0,0,"MS4A1","wildtype"
"C94207",1,"MGN1703",3/1/2018 0:00:00,-1,0,0,0,"TLR9",
"C94208",1,"IMCgp100",3/1/2018 0:00:00,-1,0,0,0,,
"C94211",1,"IMA950",3/1/2018 0:00:00,-1,0,0,0,,
"C94214",1,"Alpelisib",7/17/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C94215",1,"Indoleamine 2,3-dioxygenase Peptide Vaccine",,-1,0,0,0,,
"C94216",1,"GITRL RNA-transfected Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C94217",1,"Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,"CTLA4","wildtype"
"C94218",1,"Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine",10/31/2018 0:00:00,-1,0,0,0,,
"C94219",1,"AFM13",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF8","wildtype"
"C94219",2,"AFM13",1/22/2018 0:00:00,-1,0,0,0,"FCGR3A",
"C94221",1,"GT-MAB 5.2-GEX",10/25/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C94223",1,"HLA-A*2402-Restricted CDCA1-A24-56 Peptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"NUF2","wildtype"
"C94224",1,"ARQ736",10/25/2018 0:00:00,-1,0,0,0,"BRAF","wildtype and BRAF V600E"
"C94224",2,"ARQ736",10/25/2018 0:00:00,-1,0,0,0,"CRAF","wildtype"
"C95020",1,"Lutathera",1/4/2018 0:00:00,-1,0,0,0,"SSTR",
"C95023",1,"TRX518",10/30/2018 0:00:00,-1,0,0,0,"TNFRSF18","wildtype"
"C95124",1,"Lenvatinib",6/20/2017 0:00:00,-1,0,0,0,"KDR",
"C95201",1,"AZD2461",10/3/2018 0:00:00,-1,0,0,0,"PARP1",
"C95201",2,"AZD2461",10/3/2018 0:00:00,-1,0,0,0,"PARP2",
"C95201",3,"AZD2461",10/3/2018 0:00:00,-1,0,0,0,"PARP3",
"C95201",4,"AZD2461",10/3/2018 0:00:00,-1,0,0,0,"PARP4",
"C95203",1,"AMG 337",1/16/2018 0:00:00,-1,0,0,0,"MET",
"C95206",1,"ABT-806",3/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C95207",1,"HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"NUF2","wildtype"
"C95207",2,"HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"LY6K","wildtype"
"C95207",3,"HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KIF20A","wildtype"
"C95207",4,"HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"DEPDC1","wildtype"
"C95207",5,"HLA-A*2402-Restricted CDCA1-URLC10-KIF20A-DEPDC1-MPHOSPH1 Multipeptide Vaccine",10/31/2018 0:00:00,-1,0,0,0,"KIF20B","wildtype"
"C95209",1,"Guadecitabine",7/26/2017 0:00:00,-1,0,0,0,"DNMT1",
"C95213",1,"Allogeneic Renal Cell Carcinoma Vaccine MGN1601",,-1,0,0,0,,
"C95222",1,"Fostamatinib",10/3/2018 0:00:00,-1,0,0,0,"SYK",
"C95222",2,"Fostamatinib",10/3/2018 0:00:00,-1,0,0,0,"ADORA3",
"C95225",1,"Selumetinib Sulfate",10/25/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C95225",2,"Selumetinib Sulfate",10/25/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C95226",1,"Varlitinib Tosylate",10/25/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C95226",2,"Varlitinib Tosylate",10/25/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C95229",1,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"BCR","BCR-ABL FUSION"
"C95229",2,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"ABL1","BCR-ABL FUSION"
"C95229",3,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"BCR-ABL","BCR-ABL FUSION"
"C95229",4,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C95229",5,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C95229",6,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C95229",7,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"DDR1","wildtype"
"C95229",9,"Nilotinib Hydrochloride Monohydrate",10/25/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C95701",1,"Ribociclib",11/2/2017 0:00:00,-1,0,0,0,"CDK4",
"C95701",2,"Ribociclib",11/2/2017 0:00:00,-1,0,0,0,"CDK6",
"C95702",1,"BMS-911543",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C95702",2,"BMS-911543",10/3/2018 0:00:00,-1,0,0,0,"SET2",
"C95702",3,"BMS-911543",10/3/2018 0:00:00,-1,0,0,0,"TYK2",
"C95702",4,"BMS-911543",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"C95713",1,"Z-Endoxifen Hydrochloride",3/5/2019 0:00:00,-1,0,0,0,,
"C95718",1,"Nucleotide|Targeted Therapy",10/25/2018 0:00:00,-1,0,0,0,"RAF1","wildtype"
"C95723",1,"ZSTK474",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C95723",2,"ZSTK474",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C95723",3,"ZSTK474",10/2/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C95723",4,"ZSTK474",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C95724",1,"APTO-253 HCl",10/3/2018 0:00:00,-1,0,0,0,"MTF1",
"C95726",1,"Lucitanib",9/28/2018 0:00:00,-1,0,0,0,"FLT1",
"C95726",2,"Lucitanib",9/28/2018 0:00:00,-1,0,0,0,"KDR",
"C95726",3,"Lucitanib",9/28/2018 0:00:00,-1,0,0,0,"FLT4",
"C95726",4,"Lucitanib",9/28/2018 0:00:00,-1,0,0,0,"FGFR1",
"C95726",5,"Lucitanib",9/28/2018 0:00:00,-1,0,0,0,"FGFR2",
"C95728",1,"AMG211",10/25/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"C95728",2,"AMG211",10/25/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C95728",3,"AMG211",10/25/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"C95728",4,"AMG211",10/25/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"C95728",5,"AMG211",10/25/2018 0:00:00,-1,0,0,0,"CEACAM1","wildtype"
"C95729",1,"Merestinib",3/1/2018 0:00:00,-1,0,0,0,"MET",
"C9573",1,"CVP Regimen",10/3/2018 0:00:00,-1,0,0,0,,
"C95733",1,"Talazoparib",11/20/2017 0:00:00,-1,0,0,0,"PARP1",
"C95733",2,"Talazoparib",11/20/2017 0:00:00,-1,0,0,0,"PARP2",
"C95733",3,"Talazoparib",11/20/2017 0:00:00,-1,0,0,0,"PARP3",
"C95733",4,"Talazoparib",11/20/2017 0:00:00,-1,0,0,0,"PARP4",
"C95737",1,"LY2780301",10/2/2018 0:00:00,-1,0,0,0,"AKT1",
"C95737",2,"LY2780301",10/2/2018 0:00:00,-1,0,0,0,"AKT2",
"C95737",3,"LY2780301",10/2/2018 0:00:00,-1,0,0,0,"AKT3",
"C95738",1,"GDC-0623",10/3/2018 0:00:00,-1,0,0,0,"MAP2K1",
"C95751",1,"Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells",,-1,0,0,0,,
"C95760",1,"Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05",,-1,0,0,0,,
"C95769",1,"AXP107-11",10/29/2018 0:00:00,-1,0,0,0,,
"C95772",1,"siG12D LODER",10/29/2018 0:00:00,-1,0,0,0,"KRAS","G12D"
"C95777",1,"Ponatinib",9/14/2018 0:00:00,-1,0,0,0,"BCR-ABL",
"C95785",1,"Foralumab",10/29/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"C95797",1,"Teprotumumab",10/29/2018 0:00:00,-1,0,0,0,"IGF1R","wildtype"
"C95798",1,"Vedolizumab",3/1/2018 0:00:00,-1,0,0,0,"LPAM1",
"C95800",1,"Tofacitinib",10/3/2018 0:00:00,-1,0,0,0,"JAK1",
"C95800",2,"Tofacitinib",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"C95800",3,"Tofacitinib",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"C95889",1,"OPB-51602",10/29/2018 0:00:00,-1,0,0,0,"STAT3","wildtype"
"C95896",1,"Vorolanib",9/24/2018 0:00:00,-1,0,0,0,"KDR",
"C95896",2,"Vorolanib",9/24/2018 0:00:00,-1,0,0,0,"FLT1",
"C95896",3,"Vorolanib",9/24/2018 0:00:00,-1,0,0,0,"FLT4",
"C95896",4,"Vorolanib",9/24/2018 0:00:00,-1,0,0,0,"PDGFRA",
"C95896",5,"Vorolanib",9/24/2018 0:00:00,-1,0,0,0,"PDGFRB",
"C96038",1,"MM-302",10/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C96040",1,"Anti-OX40",10/31/2018 0:00:00,-1,0,0,0,"TNFRSF4","wildtype"
"C961",1,"Gemcitabine Hydrochloride",6/20/2017 0:00:00,-1,0,0,0,"ribonucleotide reductase",
"C96221",1,"Adenovirus-Encoding E.coli PNP",10/29/2018 0:00:00,-1,0,0,0,,
"C96222",1,"VX15/2503",10/17/2017 0:00:00,-1,0,0,0,"SEMA4D",
"C96227",1,"ARRY-382",5/23/2017 0:00:00,-1,0,0,0,"CSF1R",
"C964",1,"Fludeoxyglucose F-18",9/21/2018 0:00:00,-1,0,0,0,,
"C96429",1,"Napabucasin",3/1/2018 0:00:00,-1,0,0,0,,
"C96431",1,"Ricolinostat",3/6/2019 0:00:00,-1,0,0,0,"HDAC6",
"C96432",1,"GTx-758",10/29/2018 0:00:00,-1,0,0,0,"ESR1","wildtype"
"C965",1,"2-Methoxyestradiol",10/3/2018 0:00:00,-1,0,0,0,,
"C96735",1,"Recombinant B. pertussis Adenylate Cyclase Toxin-Tyrosinase A2 Epitope Vaccine",10/29/2018 0:00:00,-1,0,0,0,"ITGB2","wildtype"
"C96735",2,"Recombinant B. pertussis Adenylate Cyclase Toxin-Tyrosinase A2 Epitope Vaccine",10/29/2018 0:00:00,-1,0,0,0,"ITGAM","wildtype"
"C96737",1,"p.DOM-WT1-37 DNA Vaccine",10/29/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C96738",1,"p.DOM-WT1-126 DNA Vaccine",10/29/2018 0:00:00,-1,0,0,0,"WT1","wildtype"
"C96742",1,"EZN-4176",10/29/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C96748",1,"Eribulin",3/1/2018 0:00:00,-1,0,0,0,,
"C96795",1,"ABT-767",10/3/2018 0:00:00,-1,0,0,0,"PARP1",
"C96795",2,"ABT-767",10/3/2018 0:00:00,-1,0,0,0,"PARP2",
"C96796",1,"Copanlisib",7/16/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C96799",1,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD1",
"C96799",2,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD2",
"C96799",3,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD3",
"C96799",4,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD4",
"C96799",5,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD5",
"C96799",6,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD6",
"C96799",7,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD7",
"C96799",8,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD8",
"C96799",9,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD9",
"C96799",10,"Vantictumab",10/3/2018 0:00:00,-1,0,0,0,"FZD10",
"C96801",1,"IMC-CS4",5/9/2017 0:00:00,-1,0,0,0,"CSF1R",
"C96802",1,"Vitamin K1-containing Urea Skin Cream",10/29/2018 0:00:00,-1,0,0,0,"EGFR","wildtype"
"C970",1,"Iobenguane I-131",3/7/2019 0:00:00,-1,0,0,0,,
"C97037",1,"Spebrutinib",10/29/2018 0:00:00,-1,0,0,0,"BTK","wildtype"
"C97038",1,"Anti-mesothelin CIR mRNA-electroporated Autologous T Cells",,-1,0,0,0,,
"C97039",1,"AMP-224",10/30/2018 0:00:00,-1,0,0,0,"PDCD1","wildtype"
"C97130",1,"RRx-001",3/1/2018 0:00:00,-1,0,0,0,,
"C97254",1,"DS-7423",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"C97254",2,"DS-7423",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C97263",1,"Chidamide",6/20/2017 0:00:00,-1,0,0,0,"HDAC",
"C97272",1,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"FLT3","wildtype and FLT3 activating internal tandem duplications"
"C97272",2,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"CSF1R","wildtype"
"C97272",3,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"KIT","wildtype"
"C97272",4,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"PDGFRA","wildtype"
"C97272",5,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"PDGFRB","wildtype"
"C97272",6,"Quizartinib Dihydrochloride",10/29/2018 0:00:00,-1,0,0,0,"RET","wildtype"
"C97273",1,"Afatinib Dimaleate",3/1/2018 0:00:00,-1,0,0,0,"EGFR",
"C97273",2,"Afatinib Dimaleate",3/1/2018 0:00:00,-1,0,0,0,"ERBB2",
"C97273",3,"Afatinib Dimaleate",3/1/2018 0:00:00,-1,0,0,0,"ERBB4",
"C97329",1,"Clonidine-containing Mucoadhesive Buccal Tablet",,-1,0,0,0,,
"C97344",1,"MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine",10/29/2018 0:00:00,-1,0,0,0,"ERRB2","wildtype"
"C97507",1,"PF-04136309",10/31/2018 0:00:00,-1,0,0,0,"CCR2","wildtype"
"C97510",1,"Enoblituzumab",4/16/2018 0:00:00,-1,0,0,0,"CD276",
"C97511",1,"SAR125844",10/3/2018 0:00:00,-1,0,0,0,"MET",
"C97660",1,"Abemaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK4",
"C97660",2,"Abemaciclib",6/20/2017 0:00:00,-1,0,0,0,"CDK6",
"C97663",1,"CWP232291",10/3/2018 0:00:00,-1,0,0,0,"KHDRBS1",
"C97915",1,"PWT33597 Mesylate",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"C97915",2,"PWT33597 Mesylate",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C97917",1,"Glycooptimized Trastuzumab-GEX",10/29/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C97937",1,"Ruxolitinib Phosphate",3/1/2018 0:00:00,-1,0,0,0,"JAK1",
"C97937",2,"Ruxolitinib Phosphate",3/1/2018 0:00:00,-1,0,0,0,"JAK2",
"C97938",1,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"MET",
"C97938",2,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"RET",
"C97938",3,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"FLT1",
"C97938",4,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"KDR",
"C97938",5,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"FLT4",
"C97938",6,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"KIT",
"C97938",7,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"FLT3",
"C97938",8,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"TEK",
"C97938",9,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"TRKB",
"C97938",10,"Cabozantinib S-malate",3/1/2018 0:00:00,-1,0,0,0,"AXL",
"C97940",1,"Ixazomib",9/14/2018 0:00:00,-1,0,0,0,"20S catalytic core of the proteasome",
"C97945",1,"Gevokizumab",9/13/2017 0:00:00,-1,0,0,0,"IL1B",
"C97947",1,"Certolizumab",7/18/2017 0:00:00,-1,0,0,0,"TNF",
"C97948",2,"NKP-1339",10/15/2018 0:00:00,-1,0,0,0,"TF","wildtype"
"C97954",1,"MOR03087",10/31/2018 0:00:00,-1,0,0,0,"CD38","wildtype"
"C97961",1,"NHS-IL12",3/1/2018 0:00:00,-1,0,0,0,,
"C97969",1,"IL17RB wt Allele",10/3/2018 0:00:00,-1,0,0,0,,
"C981",1,"Decitabine",3/1/2018 0:00:00,-1,0,0,0,,
"C98109",1,"NS-018",10/29/2018 0:00:00,-1,0,0,0,"JAK2","JAK2 wildtype and JAK2V617F"
"C98278",1,"Opaganib",3/1/2019 0:00:00,-1,0,0,0,,
"C98283",1,"Encorafenib",9/14/2018 0:00:00,-1,0,0,0,"ARAF",
"C98283",2,"Encorafenib",9/14/2018 0:00:00,-1,0,0,0,"BRAF",
"C98283",3,"Encorafenib",9/14/2018 0:00:00,-1,0,0,0,"RAF1",
"C98287",1,"ONCOS-102",3/1/2018 0:00:00,-1,0,0,0,,
"C98290",1,"APC-100",10/29/2018 0:00:00,-1,0,0,0,"AR","wildtype"
"C98293",1,"Anetumab Ravtansine",8/21/2018 0:00:00,-1,0,0,0,"mesothelin",
"C98295",1,"AMG 820",5/3/2017 0:00:00,-1,0,0,0,"CSF1R",
"C98831",1,"Brigatinib",9/14/2018 0:00:00,-1,0,0,0,"ALK",
"C98831",2,"Brigatinib",9/14/2018 0:00:00,-1,0,0,0,"EGFR",
"C98832",1,"MSC2015103B",10/29/2018 0:00:00,-1,0,0,0,"MAP2K1","wildtype"
"C98832",2,"MSC2015103B",10/29/2018 0:00:00,-1,0,0,0,"MAP2K2","wildtype"
"C98838",1,"Poziotinib",7/17/2018 0:00:00,-1,0,0,0,"EGFR",
"C98838",2,"Poziotinib",7/17/2018 0:00:00,-1,0,0,0,"ERBB2",
"C98838",3,"Poziotinib",7/17/2018 0:00:00,-1,0,0,0,"ERBB4",
"C98844",1,"Serabelisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"C99125",1,"cis-Urocanic Acid",10/29/2018 0:00:00,-1,0,0,0,,
"C99127",1,"Varlilumab",10/31/2018 0:00:00,-1,0,0,0,"CD27","wildtype"
"C99131",1,"Idasanutlin",7/12/2018 0:00:00,-1,0,0,0,"MDM2",
"C99134",1,"p38 MAPK Inhibitor LY3007113",,-1,0,0,0,,
"C99146",1,"ARQ 761",10/29/2018 0:00:00,-1,0,0,0,"TOP1","wildtype"
"C99146",2,"ARQ 761",10/29/2018 0:00:00,-1,0,0,0,"ID01","wildtype"
"C99160",1,"Icotinib hydrochloride",10/30/2018 0:00:00,-1,0,0,0,"EGFR","EGFR, EGFR L858R, EGFR L861Q, EGFR T790M, EGFR T790M, L858R"
"C99165",1,"DT01",10/2/2018 0:00:00,-1,0,0,0,,
"C99166",1,"Entolimod",,-1,0,0,0,,
"C99172",1,"ARQ 092",9/14/2018 0:00:00,-1,0,0,0,"AKT",
"C99215",1,"Allogeneic CD19-specific CAR-modified CD8 Plus Central Memory-derived Virus-specific T Cells",,-1,0,0,0,,
"C99225",1,"Duvelisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"C99225",2,"Duvelisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"C99225",3,"Duvelisib",10/3/2018 0:00:00,-1,0,0,0,"PIK3CG",
"C99228",1,"Nelipepimut-S Plus GM-CSF Vaccine",10/29/2018 0:00:00,-1,0,0,0,"ERBB2","wildtype"
"C99378",1,"VXM01",9/13/2017 0:00:00,-1,0,0,0,"KDR",
"C99380",1,"AZD1208",10/3/2018 0:00:00,-1,0,0,0,"PIM1",
"C99380",2,"AZD1208",10/3/2018 0:00:00,-1,0,0,0,"PIM2",
"C99380",3,"AZD1208",10/3/2018 0:00:00,-1,0,0,0,"PIM3",
"C99381",1,"Dexanabinol",,-1,0,0,0,,
"C99426",1,"HMGA2/CCNB1IP1 Fusion Gene",10/3/2018 0:00:00,-1,0,0,0,,
"C99459",1,"PVSRIPO",2/27/2019 0:00:00,-1,0,0,0,,
"C99460",1,"SR-T100 Gel",,-1,0,0,0,,
"C99640",1,"LY2495655",9/13/2017 0:00:00,-1,0,0,0,"MSTN",
"C99762",1,"Conditionally Replicative Adenovirus 5/3-delta24",10/29/2018 0:00:00,-1,0,0,0,,
"C99765",1,"VGX-100",10/29/2018 0:00:00,-1,0,0,0,"VEGFC","wildtype"
"C99766",1,"Adagloxad Simolenin",2/28/2019 0:00:00,-1,0,0,0,,
"C99899",1,"MM-151",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"C99905",1,"Rociletinib",10/4/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0011",1,"Anti-PD-1 antibody",11/8/2018 0:00:00,-1,-1,0,0,"PDCD1","wildtype"
"OS-0015",1,"LZM009",9/26/2017 0:00:00,0,-1,0,0,"PDCD1",
"OS-0020",1,"MK-2118",9/20/2018 0:00:00,-1,0,0,0,"STING",
"OS-0026",1,"BMS-986242",12/18/2017 0:00:00,-1,0,0,0,,
"OS-0034",1,"MK-5890",2/26/2018 0:00:00,-1,0,0,0,,
"OS-0048",1,"HER2 BATs",5/21/2018 0:00:00,-1,0,0,0,,
"OS-0049",1,"BMS-986213",6/8/2018 0:00:00,-1,0,0,0,"PDCD1",
"OS-0049",2,"BMS-986213",6/8/2018 0:00:00,-1,0,0,0,"LAG3",
"OS-0059",1,"MK-4830",8/13/2018 0:00:00,-1,0,0,0,,
"OS-0061",1,"9B12",8/21/2018 0:00:00,-1,0,0,0,"TNFRSF4",
"OS-0066",1,"MCLA-158",9/24/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0066",2,"MCLA-158",9/24/2018 0:00:00,-1,0,0,0,"LGR5",
"OS-0067",1,"VX-11e",9/27/2018 0:00:00,-1,0,0,0,"MAPK1",
"OS-0068",1,"AZD6482",11/2/2018 0:00:00,0,0,0,0,"PIK3CB","wildtype"
"OS-0068",2,"AZD6482",11/2/2018 0:00:00,0,0,0,0,"PIK3CA","wildtype"
"OS-0068",4,"AZD6482",11/2/2018 0:00:00,0,0,0,0,"PIK3CD","wildtype"
"OS-0068",5,"AZD6482",11/2/2018 0:00:00,0,0,0,0,"PRKDC","wildtype"
"OS-0069",1,"NVP-AEW541",9/27/2018 0:00:00,-1,0,0,0,"IGF1R",
"OS-0069",2,"NVP-AEW541",9/27/2018 0:00:00,-1,0,0,0,"INSR",
"OS-0069",3,"NVP-AEW541",9/27/2018 0:00:00,-1,0,0,0,"TEK",
"OS-0069",4,"NVP-AEW541",9/27/2018 0:00:00,-1,0,0,0,"FLT1",
"OS-0069",5,"NVP-AEW541",9/27/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0071",1,"unspecified IGF-1R antibody",9/27/2018 0:00:00,-1,0,0,0,"IGF1R",
"OS-0072",1,"GSK2334470",9/28/2018 0:00:00,-1,0,0,0,"PDK1",
"OS-0073",1,"PLX4720",9/28/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0073",2,"PLX4720",9/28/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0074",1,"WEHI-539",9/28/2018 0:00:00,-1,0,0,0,"BCL2L1",
"OS-0075",1,"SCH772984",9/28/2018 0:00:00,-1,0,0,0,"MAPK3",
"OS-0075",2,"SCH772984",9/28/2018 0:00:00,-1,0,0,0,"MAPK1",
"OS-0077",1,"A66",9/28/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0078",1,"PF-573328",9/28/2018 0:00:00,-1,0,0,0,"PTK2",
"OS-0079",1,"TAK-632",9/28/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0079",2,"TAK-632",9/28/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0080",1,"CX-6258 HCl",10/1/2018 0:00:00,-1,0,0,0,"PIM1",
"OS-0080",2,"CX-6258 HCl",10/1/2018 0:00:00,-1,0,0,0,"PIM2",
"OS-0080",3,"CX-6258 HCl",10/1/2018 0:00:00,-1,0,0,0,"PIM3",
"OS-0081",1,"GSK2830371",10/1/2018 0:00:00,-1,0,0,0,"PPM1D",
"OS-0084",1,"YU238259",10/1/2018 0:00:00,-1,0,0,0,"HDR",
"OS-0086",1,"U0126-EtOH",10/1/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0086",2,"U0126-EtOH",10/1/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0087",1,"SP600125",10/1/2018 0:00:00,-1,0,0,0,"MAPK8",
"OS-0087",2,"SP600125",10/1/2018 0:00:00,-1,0,0,0,"MAPK9",
"OS-0087",3,"SP600125",10/1/2018 0:00:00,-1,0,0,0,"AURKA",
"OS-0087",4,"SP600125",10/1/2018 0:00:00,-1,0,0,0,"NTRK1",
"OS-0087",5,"SP600125",10/1/2018 0:00:00,-1,0,0,0,"MAPK10",
"OS-0088",1,"MRK-003",10/1/2018 0:00:00,-1,0,0,0,"PSEN1",
"OS-0088",2,"MRK-003",10/1/2018 0:00:00,-1,0,0,0,"APH1A",
"OS-0088",3,"MRK-003",10/1/2018 0:00:00,-1,0,0,0,"APH1B",
"OS-0089",1,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0089",2,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0089",3,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"AURKB",
"OS-0089",4,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0089",5,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0089",6,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"CDK2",
"OS-0089",7,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"GSK3B",
"OS-0089",8,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"PDGFRA",
"OS-0089",9,"TAK-632",10/1/2018 0:00:00,-1,0,0,0,"MAPK14",
"OS-0090",1,"BI2536",10/1/2018 0:00:00,-1,0,0,0,"PLK1",
"OS-0090",2,"BI2536",10/1/2018 0:00:00,-1,0,0,0,"PLK2",
"OS-0090",3,"BI2536",10/1/2018 0:00:00,-1,0,0,0,"PLK3",
"OS-0091",1,"LSN3074753",10/2/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0091",2,"LSN3074753",10/2/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0091",3,"LSN3074753",10/2/2018 0:00:00,-1,0,0,0,"ARAF",
"OS-0092",1,"EAI045",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0093",1,"XAV939",10/2/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0093",2,"XAV939",10/2/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0094",1,"PKF118-310",10/2/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0095",1,"G007-LK",10/10/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0095",2,"G007-LK",10/10/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0097",1,"GDC0879",10/2/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0098",1,"MS417",10/2/2018 0:00:00,-1,0,0,0,"BRD4",
"OS-0099",1,"WZ4002",10/2/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0100",1,"PHA-665752",10/2/2018 0:00:00,-1,0,0,0,"MET",
"OS-0100",2,"PHA-665752",10/2/2018 0:00:00,-1,0,0,0,"MST1R",
"OS-0100",3,"PHA-665752",10/2/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0101",1,"PF-573228",10/2/2018 0:00:00,-1,0,0,0,"PTK2",
"OS-0102",1,"PF-431396",10/2/2018 0:00:00,-1,0,0,0,"PTK2",
"OS-0102",2,"PF-431396",10/2/2018 0:00:00,-1,0,0,0,"PTK2B",
"OS-0103",1,"NPS-1034",10/2/2018 0:00:00,-1,0,0,0,"AXL",
"OS-0103",2,"NPS-1034",10/2/2018 0:00:00,-1,0,0,0,"MET",
"OS-0104",1,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0104",2,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0104",3,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0104",4,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0104",5,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0104",6,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRA",
"OS-0104",7,"Torkinib",10/2/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0105",1,"S63845",10/2/2018 0:00:00,-1,0,0,0,"MCL1",
"OS-0107",1,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"CHEK1",
"OS-0107",2,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"CHEK2",
"OS-0107",3,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0107",4,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"CDK2",
"OS-0107",5,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"CDK4",
"OS-0107",6,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"PDGFRA",
"OS-0107",7,"CHIR-124",10/2/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0108",1,"NSC59984",10/2/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0108",2,"NSC59984",10/2/2018 0:00:00,-1,0,0,0,"TP73",
"OS-0109",1,"G-749",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0109",2,"G-749",10/2/2018 0:00:00,-1,0,0,0,"MERTK",
"OS-0109",3,"G-749",10/2/2018 0:00:00,-1,0,0,0,"AURKB",
"OS-0109",4,"G-749",10/2/2018 0:00:00,-1,0,0,0,"RET",
"OS-0110",1,"TCS 359",10/2/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0112",1,"APS-2-79",10/2/2018 0:00:00,-1,0,0,0,"KSR2",
"OS-0113",1,"AGI-5198",10/2/2018 0:00:00,-1,0,0,0,"IDH1",
"OS-0114",1,"Miransertib",10/2/2018 0:00:00,-1,0,0,0,"AKT1",
"OS-0114",2,"Miransertib",10/2/2018 0:00:00,-1,0,0,0,"AKT2",
"OS-0114",3,"Miransertib",10/2/2018 0:00:00,-1,0,0,0,"AKT3",
"OS-0115",1,"SBI-0640756",10/2/2018 0:00:00,-1,0,0,0,"EIF4G1",
"OS-0116",1,"TW-37",10/2/2018 0:00:00,-1,0,0,0,"MCL1",
"OS-0116",2,"TW-37",10/2/2018 0:00:00,-1,0,0,0,"BCL2",
"OS-0116",3,"TW-37",10/2/2018 0:00:00,-1,0,0,0,"BCL2L1",
"OS-0117",1,"SRA737",10/2/2018 0:00:00,-1,0,0,0,"CHEK1",
"OS-0117",2,"SRA737",10/2/2018 0:00:00,-1,0,0,0,"CHEK2",
"OS-0118",1,"PD98509",10/2/2018 0:00:00,-1,0,0,0,"MAP2K",
"OS-0119",1,"KU-0063794",10/2/2018 0:00:00,-1,0,0,0,"RPTOR",
"OS-0119",2,"KU-0063794",10/2/2018 0:00:00,-1,0,0,0,"RICTOR",
"OS-0120",1,"CTX-1",10/2/2018 0:00:00,-1,0,0,0,"MDM4",
"OS-0121",1,"TGX-221",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0121",2,"TGX-221",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0122",1,"AG490",10/3/2018 0:00:00,-1,-1,0,0,"EGFR",
"OS-0122",2,"AG490",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0122",3,"AG490",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0122",4,"AG490",10/3/2018 0:00:00,-1,0,0,0,"JAK3",
"OS-0123",1,"JQ1",10/3/2018 0:00:00,-1,0,0,0,"BRD4",
"OS-0123",2,"JQ1",10/3/2018 0:00:00,-1,0,0,0,"BRD2",
"OS-0124",1,"LY411575",10/3/2018 0:00:00,-1,0,0,0,"PSEN1",
"OS-0124",2,"LY411575",10/3/2018 0:00:00,-1,0,0,0,"APH1A",
"OS-0124",3,"LY411575",10/3/2018 0:00:00,-1,0,0,0,"APH1B",
"OS-0125",1,"EI1",10/3/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0126",1,"A-1155463",10/3/2018 0:00:00,-1,0,0,0,"BCL2L1",
"OS-0127",1,"A-395",10/3/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0128",1,"A-443654",10/3/2018 0:00:00,-1,0,0,0,"AKT1",
"OS-0129",1,"ACY-957",10/3/2018 0:00:00,-1,0,0,0,"HDAC",
"OS-0129",2,"ACY-957",10/3/2018 0:00:00,-1,0,0,0,"HDAC2",
"OS-0130",1,"Ad.p53-DC vaccine",10/3/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0131",1,"AFM24",10/3/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0132",1,"AGI-5198",11/2/2018 0:00:00,0,0,0,0,"IDH1","IDH1 R132H|IDH1 R132C"
"OS-0133",1,"23814",10/3/2018 0:00:00,-1,0,0,0,"NOTCH1",
"OS-0134",1,"AGL2043",10/3/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0135",1,"ALW-II-41-27",10/3/2018 0:00:00,-1,0,0,0,"EPHA2",
"OS-0136",1,"AMG208",10/3/2018 0:00:00,-1,0,0,0,"MET",
"OS-0137",1,"ARS-853",10/3/2018 0:00:00,-1,0,0,0,"KRAS",
"OS-0138",1,"ARX-788",10/3/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0139",1,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"AKT2",
"OS-0139",2,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"PRKACA",
"OS-0139",3,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"AKT1",
"OS-0139",4,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"AKT3",
"OS-0139",5,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"RPS6KB1",
"OS-0139",6,"AT-7867",10/3/2018 0:00:00,-1,0,0,0,"RPS6KA1",
"OS-0140",1,"Aurora Kinase Inhibitor II",10/3/2018 0:00:00,-1,0,0,0,"AURKA",
"OS-0140",2,"Aurora Kinase Inhibitor II",10/3/2018 0:00:00,-1,0,0,0,"AURKB",
"OS-0141",1,"AZ20",10/3/2018 0:00:00,-1,0,0,0,"ATR",
"OS-0141",2,"AZ20",10/3/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0142",1,"AZ6089",10/3/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0142",2,"AZ6089",10/3/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0142",3,"AZ6089",10/3/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0142",4,"AZ6089",10/3/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0143",1,"AZ628",10/3/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0143",2,"AZ628",10/3/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0144",1,"AZ8010",10/3/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0144",2,"AZ8010",10/3/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0144",3,"AZ8010",10/3/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0145",1,"AZ960",10/3/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0146",1,"AZD3463",10/3/2018 0:00:00,-1,0,0,0,"IGF1R",
"OS-0146",2,"AZD3463",10/3/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0147",1,"AZD6482",10/3/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0147",2,"AZD6482",10/3/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0147",3,"AZD6482",10/3/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0147",4,"AZD6482",10/3/2018 0:00:00,-1,0,0,0,"PRKDC",
"OS-0148",1,"AZ-TAK1",10/3/2018 0:00:00,-1,0,0,0,"MAP3K7",
"OS-0149",1,"BAY 61-3606",10/3/2018 0:00:00,-1,0,0,0,"SYK",
"OS-0150",1,"BAY1217389",10/3/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0151",1,"Belizatinib",10/3/2018 0:00:00,-1,0,0,0,"NTRK1",
"OS-0151",2,"Belizatinib",10/3/2018 0:00:00,-1,0,0,0,"NTRK2",
"OS-0151",3,"Belizatinib",10/3/2018 0:00:00,-1,0,0,0,"NTRK3",
"OS-0151",4,"Belizatinib",10/3/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0153",1,"BI-69A11",10/3/2018 0:00:00,-1,0,0,0,"AKT1",
"OS-0155",1,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0155",2,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"KIT",
"OS-0155",3,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"PDGFRA",
"OS-0155",4,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0155",5,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"RET",
"OS-0155",6,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"SRC",
"OS-0155",7,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"FLT1",
"OS-0155",8,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0155",9,"BPR1J373",10/3/2018 0:00:00,-1,0,0,0,"FLT4",
"OS-0156",1,"BPTES",10/4/2018 0:00:00,-1,0,0,0,"GLS",
"OS-0157",1,"CCT031374",10/4/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0158",1,"CCT036477",10/4/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0159",1,"CCT070535",10/4/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0160",1,"CCT128930",10/4/2018 0:00:00,-1,0,0,0,"AKT2",
"OS-0160",2,"CCT128930",10/4/2018 0:00:00,-1,0,0,0,"RPS6KB1",
"OS-0160",3,"CCT128930",10/4/2018 0:00:00,-1,0,0,0,"PRKACA",
"OS-0161",1,"CCT196969",10/4/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0161",2,"CCT196969",10/4/2018 0:00:00,-1,0,0,0,"LCK",
"OS-0161",3,"CCT196969",10/4/2018 0:00:00,-1,0,0,0,"SRC",
"OS-0161",4,"CCT196969",10/4/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0162",1,"CCT241161",10/4/2018 0:00:00,-1,0,0,0,"ARAF",
"OS-0162",2,"CCT241161",10/4/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0162",3,"CCT241161",10/4/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0162",4,"CCT241161",10/4/2018 0:00:00,-1,0,0,0,"SRC",
"OS-0162",5,"CCT241161",10/4/2018 0:00:00,-1,0,0,0,"LCK",
"OS-0163",1,"CEP-28122",10/4/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0165",1,"CGP049090",10/4/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0165",2,"CGP049090",10/4/2018 0:00:00,-1,0,0,0,"TCFL2",
"OS-0167",1,"CHZ868",10/4/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0168",1,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"HRAS",
"OS-0168",2,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"KRAS",
"OS-0168",3,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"NRAS",
"OS-0168",4,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"RHO",
"OS-0168",5,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"RAB1A",
"OS-0168",6,"CID1067700",10/4/2018 0:00:00,-1,0,0,0,"RAB1B",
"OS-0169",1,"CLM3",10/4/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0169",2,"CLM3",10/4/2018 0:00:00,-1,0,0,0,"RET",
"OS-0169",3,"CLM3",10/4/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0169",4,"CLM3",10/4/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0171",1,"CP-31398",10/4/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0172",1,"CPUY201112",10/4/2018 0:00:00,-1,0,0,0,"HSP90A1A",
"OS-0173",1,"cryptotanshinone",10/4/2018 0:00:00,-1,0,0,0,"STAT3",
"OS-0174",1,"CX-6258",10/4/2018 0:00:00,-1,0,0,0,"PIM1",
"OS-0174",2,"CX-6258",10/4/2018 0:00:00,-1,0,0,0,"PIM2",
"OS-0174",3,"CX-6258",10/4/2018 0:00:00,-1,0,0,0,"PIM3",
"OS-0175",1,"DEL-22379",10/4/2018 0:00:00,-1,0,0,0,"MAPK1",
"OS-0176",1,"Depatuxizumab mafodotin",10/4/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0177",1,"DETD-35",10/4/2018 0:00:00,-1,0,0,0,"MAPK1",
"OS-0177",2,"DETD-35",10/4/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0178",1,"DHM25",10/4/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0179",1,"DS6051b",10/4/2018 0:00:00,-1,0,0,0,"NTRK1",
"OS-0179",2,"DS6051b",10/4/2018 0:00:00,-1,0,0,0,"NTRK2",
"OS-0179",3,"DS6051b",10/4/2018 0:00:00,-1,0,0,0,"NTRK3",
"OS-0179",4,"DS6051b",10/4/2018 0:00:00,-1,0,0,0,"ROS1",
"OS-0180",1,"DT-061",10/4/2018 0:00:00,-1,0,0,0,"PP2A",
"OS-0181",1,"DZNeP",10/5/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0182",1,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0182",2,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0182",3,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0182",4,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0182",5,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"RET",
"OS-0182",6,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"KIT",
"OS-0182",7,"EBI-907",10/5/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0183",1,"EED226",10/5/2018 0:00:00,-1,0,0,0,"EED",
"OS-0184",1,"EKI-285",10/5/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0185",1,"Emibetuzumab",10/5/2018 0:00:00,-1,0,0,0,"HGF",
"OS-0186",2,"EPZ004777",10/5/2018 0:00:00,-1,0,0,0,"DOT1L",
"OS-0187",1,"EPZ005687",10/5/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0188",1,"FF-284",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0188",2,"FF-284",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0188",3,"FF-284",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0188",4,"FF-284",10/5/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0189",1,"FH535",10/5/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0189",2,"FH535",10/5/2018 0:00:00,-1,0,0,0,"PPARG",
"OS-0189",3,"FH535",10/5/2018 0:00:00,-1,0,0,0,"PPARD",
"OS-0190",1,"FIIN-01",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0190",2,"FIIN-01",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0190",3,"FIIN-01",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0190",4,"FIIN-01",10/5/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0191",1,"FIIN-2",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0191",2,"FIIN-2",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0191",3,"FIIN-2",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0191",4,"FIIN-2",10/5/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0192",1,"FTI-277",10/5/2018 0:00:00,-1,0,0,0,"FNTA",
"OS-0192",2,"FTI-277",10/5/2018 0:00:00,-1,0,0,0,"FNTB",
"OS-0193",1,"ZK304709",10/5/2018 0:00:00,-1,-1,0,0,"CDK1",
"OS-0193",2,"ZK304709",10/5/2018 0:00:00,-1,0,0,0,"CDK2",
"OS-0193",3,"ZK304709",10/5/2018 0:00:00,-1,0,0,0,"CDK4",
"OS-0193",4,"ZK304709",10/5/2018 0:00:00,-1,0,0,0,"CDK7",
"OS-0193",5,"ZK304709",10/5/2018 0:00:00,-1,0,0,0,"CDK9",
"OS-0194",1,"YW3-56",10/5/2018 0:00:00,-1,0,0,0,"PAD12",
"OS-0194",2,"YW3-56",10/5/2018 0:00:00,-1,0,0,0,"PAD14",
"OS-0195",1,"YM-024",10/5/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0195",2,"YM-024",10/5/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0196",1,"Y078-DM4",10/5/2018 0:00:00,-1,0,0,0,"RET",
"OS-0197",1,"Y078-DM1",10/5/2018 0:00:00,-1,0,0,0,"RET",
"OS-0198",1,"XMD15-44",10/5/2018 0:00:00,-1,0,0,0,"RET",
"OS-0199",1,"WYE-125132",10/5/2018 0:00:00,-1,0,0,0,"RPTOR",
"OS-0199",2,"WYE-125132",10/5/2018 0:00:00,-1,0,0,0,"RICTOR",
"OS-0200",1,"Withacnistin",10/5/2018 0:00:00,-1,0,0,0,"STAT3",
"OS-0200",2,"Withacnistin",10/5/2018 0:00:00,-1,0,0,0,"STAT5",
"OS-0201",1,"VRT11E",10/5/2018 0:00:00,-1,0,0,0,"MAPK1",
"OS-0202",1,"UNC1999",10/5/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0202",2,"UNC1999",10/5/2018 0:00:00,-1,0,0,0,"EZH1",
"OS-0203",1,"UNC2025",10/5/2018 0:00:00,-1,0,0,0,"MERTK",
"OS-0203",2,"UNC2025",10/5/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0203",3,"UNC2025",10/5/2018 0:00:00,-1,0,0,0,"AXL",
"OS-0203",4,"UNC2025",10/5/2018 0:00:00,-1,0,0,0,"TYRO3",
"OS-0204",1,"UC-857993",10/5/2018 0:00:00,-1,0,0,0,"SOS1",
"OS-0205",1,"UC-773587",10/5/2018 0:00:00,-1,0,0,0,"SOS1",
"OS-0206",1,"Tubastatin A",10/5/2018 0:00:00,-1,0,0,0,"HDAC",
"OS-0207",1,"Torin 1",10/5/2018 0:00:00,-1,0,0,0,"RPTOR",
"OS-0207",2,"Torin 1",10/5/2018 0:00:00,-1,0,0,0,"RICTOR",
"OS-0207",3,"Torin 1",10/5/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0207",4,"Torin 1",10/5/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0207",5,"Torin 1",10/5/2018 0:00:00,-1,0,-1,0,"C2",
"OS-0209",1,"TC-A2317",10/5/2018 0:00:00,-1,0,0,0,"AURKA",
"OS-0210",1,"TASIN-1",10/5/2018 0:00:00,-1,0,0,0,"APC",
"OS-0212",1,"TAS-115",10/5/2018 0:00:00,-1,0,0,0,"MET",
"OS-0212",2,"TAS-115",10/5/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0213",1,"TAE684",10/5/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0214",1,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"PYK2",
"OS-0214",2,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"PTK2",
"OS-0214",3,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"INSR",
"OS-0214",4,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"IGF1R",
"OS-0214",5,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"MET",
"OS-0214",6,"TAE226",10/5/2018 0:00:00,-1,0,0,0,"FLT4",
"OS-0214",7,"TAE226",10/5/2018 0:00:00,-1,0,-1,0,"FLT1",
"OS-0215",1,"SU11274",10/5/2018 0:00:00,-1,0,0,0,"MET",
"OS-0215",2,"SU11274",10/5/2018 0:00:00,-1,0,0,0,"MST1R",
"OS-0216",1,"StAx-35",10/5/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0217",1,"ST2825",10/5/2018 0:00:00,-1,0,0,0,"MYD88",
"OS-0218",1,"ST-162",10/5/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0218",2,"ST-162",10/5/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0218",3,"ST-162",10/5/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0218",4,"ST-162",10/5/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0218",5,"ST-162",10/5/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0219",1,"SSR128129E",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0219",2,"SSR128129E",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0219",3,"SSR128129E",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0219",4,"SSR128129E",10/5/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0220",1,"SR9011",10/5/2018 0:00:00,-1,0,0,0,"NR1D1",
"OS-0220",2,"SR9011",10/5/2018 0:00:00,-1,0,0,0,"NR1D2",
"OS-0221",1,"SR9009",10/5/2018 0:00:00,-1,0,0,0,"NR1D1",
"OS-0221",2,"SR9009",10/5/2018 0:00:00,-1,0,0,0,"NR1D2",
"OS-0222",1,"Spliceostatin A",10/5/2018 0:00:00,-1,0,0,0,"SF3B1",
"OS-0223",1,"SML-10-70-1",10/5/2018 0:00:00,-1,0,0,0,"KRAS",
"OS-0224",1,"SHP099",10/5/2018 0:00:00,-1,0,0,0,"PTPN11",
"OS-0225",1,"SH-1242",10/5/2018 0:00:00,-1,0,0,0,"HSP90AA1",
"OS-0226",1,"SEL210",10/5/2018 0:00:00,-1,0,0,0,"MNK1",
"OS-0226",2,"SEL210",10/5/2018 0:00:00,-1,0,0,0,"MNK2",
"OS-0227",1,"SD-093",10/5/2018 0:00:00,-1,0,0,0,"TGFBR1",
"OS-0229",1,"SBI-755199",10/5/2018 0:00:00,-1,0,0,0,"EIF4G1",
"OS-0231",1,"SBI-0640726",10/5/2018 0:00:00,-1,0,0,0,"EIF4G1",
"OS-0232",1,"SB590885",10/5/2018 0:00:00,-1,0,-1,0,"BRAF",
"OS-0232",2,"SB590885",10/5/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0233",1,"SANT1",10/5/2018 0:00:00,-1,0,0,0,"SMO",
"OS-0234",1,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"MET",
"OS-0234",2,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"MERTK",
"OS-0234",3,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"AXL",
"OS-0234",4,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0234",5,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0234",6,"S-49076",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0235",1,"S3I-201",10/5/2018 0:00:00,-1,0,0,0,"STAT3",
"OS-0236",1,"S-222611",10/5/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0236",2,"S-222611",10/5/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0237",1,"Ropotrectinib",10/5/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0237",2,"Ropotrectinib",10/5/2018 0:00:00,-1,0,0,0,"SRC",
"OS-0238",1,"RO4927350",10/5/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0238",2,"RO4927350",10/5/2018 0:00:00,-1,0,0,0,"MAP2K2",
"OS-0239",1,"RG7112",10/5/2018 0:00:00,-1,0,0,0,"MDM2",
"OS-0240",1,"RAF709",10/5/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0240",2,"RAF709",10/5/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0241",1,"PZ-1",10/5/2018 0:00:00,-1,0,0,0,"RET",
"OS-0241",2,"PZ-1",10/5/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0242",1,"PW12",10/5/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0243",1,"PT2399",10/5/2018 0:00:00,-1,-1,0,0,"EPAS1",
"OS-0244",1,"Prodigiosin",10/5/2018 0:00:00,-1,0,0,0,"TP73",
"OS-0245",1,"PRN1109",10/5/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0245",2,"PRN1109",10/5/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0245",3,"PRN1109",10/5/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0245",4,"PRN1109",10/5/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0246",1,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"PDGFRA",
"OS-0246",2,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0246",3,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"HCK",
"OS-0246",4,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0246",5,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0246",6,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"SRC",
"OS-0246",7,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"ABL1",
"OS-0246",8,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0246",9,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0246",10,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"PRKDC",
"OS-0246",11,"PP-121",10/5/2018 0:00:00,-1,0,0,0,"EPHB4",
"OS-0247",1,"Pyridone 6",10/8/2018 0:00:00,-1,0,-1,0,"JAK1",
"OS-0247",2,"Pyridone 6",10/8/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0247",3,"Pyridone 6",10/8/2018 0:00:00,-1,0,0,0,"JAK3",
"OS-0247",4,"Pyridone 6",10/8/2018 0:00:00,-1,0,0,0,"TYK2",
"OS-0248",1,"PMED-1",10/8/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0248",2,"PMED-1",10/8/2018 0:00:00,-1,0,0,0,"CREBBP",
"OS-0249",1,"PLX7904",10/8/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0250",1,"PKI-402",10/8/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0250",2,"PKI-402",10/8/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0250",3,"PKI-402",10/8/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0250",4,"PKI-402",10/8/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0250",5,"PKI-402",10/8/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0251",1,"PKF115-584",10/8/2018 0:00:00,-1,0,0,0,"PRKCA",
"OS-0251",2,"PKF115-584",10/8/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0252",1,"PK11007",10/8/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0253",1,"PI-273",10/8/2018 0:00:00,-1,0,0,0,"PIK4A",
"OS-0254",1,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"PRKDC",
"OS-0254",2,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0254",3,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"PIK3CB",
"OS-0254",4,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0254",5,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0254",6,"PI-103",10/8/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0255",1,"PHT-427",10/8/2018 0:00:00,-1,0,0,0,"AKT",
"OS-0255",2,"PHT-427",10/8/2018 0:00:00,-1,0,0,0,"PDPK1",
"OS-0256",1,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"AURKA",
"OS-0256",2,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"AURKB",
"OS-0256",3,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"AURKC",
"OS-0256",4,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0256",5,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"PLK1",
"OS-0256",6,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0256",7,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"FLT4",
"OS-0256",8,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0256",9,"PHA-680632",10/8/2018 0:00:00,-1,0,0,0,"LCK",
"OS-0257",1,"PF-4989216",10/8/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0257",2,"PF-4989216",10/8/2018 0:00:00,-1,0,0,0,"PIK3CD",
"OS-0257",3,"PF-4989216",10/8/2018 0:00:00,-1,0,0,0,"PIK3CG",
"OS-0258",1,"PF3644022",10/8/2018 0:00:00,-1,0,0,0,"MAPKAPK2",
"OS-0259",1,"PET-16",10/8/2018 0:00:00,-1,0,0,0,"HSPA1A",
"OS-0260",1,"PD98059",10/8/2018 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0261",1,"PD173074",10/8/2018 0:00:00,-1,0,0,0,"FGFR1",
"OS-0261",2,"PD173074",10/8/2018 0:00:00,-1,0,0,0,"FGFR2",
"OS-0261",3,"PD173074",10/8/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0261",4,"PD173074",10/8/2018 0:00:00,-1,0,0,0,"FGFR4",
"OS-0261",5,"PD173074",10/8/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0262",1,"PD0166285",10/8/2018 0:00:00,-1,0,0,0,"WEE1",
"OS-0262",2,"PD0166285",10/8/2018 0:00:00,-1,0,-1,0,"MYT1",
"OS-0262",3,"PD0166285",10/8/2018 0:00:00,-1,0,0,0,"CHEK1",
"OS-0263",1,"Panulisib",10/8/2018 0:00:00,-1,0,0,0,"PIK3CA",
"OS-0263",2,"Panulisib",10/8/2018 0:00:00,-1,0,0,0,"MTOR",
"OS-0263",3,"Panulisib",10/8/2018 0:00:00,-1,0,0,0,"ALK",
"OS-0263",4,"Panulisib",10/8/2018 0:00:00,-1,0,0,0,"PRKDC",
"OS-0264",1,"Pamiparib",10/8/2018 0:00:00,-1,0,0,0,"PARP1",
"OS-0264",2,"Pamiparib",10/8/2018 0:00:00,-1,0,0,0,"PARP2",
"OS-0265",1,"OP449",10/8/2018 0:00:00,-1,0,0,0,"PTPA",
"OS-0267",1,"OBX1-012",10/8/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0268",1,"OBX1-012",10/8/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0269",1,"NVP-BVB808",10/8/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0270",1,"NVP-BSK805",10/8/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0270",2,"NVP-BSK805",10/8/2018 0:00:00,-1,0,0,0,"TYK2",
"OS-0270",3,"NVP-BSK805",10/8/2018 0:00:00,-1,0,0,0,"JAK3",
"OS-0270",4,"NVP-BSK805",10/8/2018 0:00:00,-1,0,0,0,"JAK1",
"OS-0271",1,"NU6027",10/8/2018 0:00:00,-1,0,0,0,"ATR",
"OS-0271",2,"NU6027",10/8/2018 0:00:00,-1,0,0,0,"CDK2",
"OS-0271",3,"NU6027",10/8/2018 0:00:00,-1,0,0,0,"PRKDC",
"OS-0271",4,"NU6027",10/8/2018 0:00:00,-1,0,0,0,"CDK1",
"OS-0272",1,"NU1025",10/8/2018 0:00:00,-1,0,0,0,"PARP1",
"OS-0273",1,"NTRC 0066-0",10/8/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0274",1,"NSC319726",10/8/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0275",1,"NMS-P715",10/8/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0276",1,"NMS-P118",10/8/2018 0:00:00,-1,0,0,0,"PARP1",
"OS-0276",2,"NMS-P118",10/8/2018 0:00:00,-1,0,0,0,"PARP2",
"OS-0277",1,"NIBR3049",10/8/2018 0:00:00,-1,0,0,0,"JAK3",
"OS-0277",2,"NIBR3049",10/8/2018 0:00:00,-1,0,0,0,"GSK3B",
"OS-0277",3,"NIBR3049",10/8/2018 0:00:00,-1,0,0,0,"PRKCA",
"OS-0278",1,"NGI-1",10/8/2018 0:00:00,-1,0,0,0,"STT3A",
"OS-0278",2,"NGI-1",10/8/2018 0:00:00,-1,0,0,0,"STT3B",
"OS-0279",1,"NAX014",10/8/2018 0:00:00,-1,0,0,0,,
"OS-0280",1,"NAV-2729",10/8/2018 0:00:00,-1,0,0,0,"ARF6",
"OS-0282",1,"MYL-1401O",10/8/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0283",1,"MRT-92",10/8/2018 0:00:00,-1,0,0,0,"SMO",
"OS-0284",1,"MPI-0479605",10/8/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0285",1,"MK-8745",10/8/2018 0:00:00,-1,0,0,0,"AURKA",
"OS-0286",1,"MI-63",10/8/2018 0:00:00,-1,0,0,0,"MDM2",
"OS-0287",1,"A-1210477",10/9/2018 0:00:00,-1,0,0,0,"MCL1",
"OS-0289",1,"GSK126",10/9/2018 0:00:00,-1,-1,-1,0,"EZH2",
"OS-0290",1,"BI 882370",10/9/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0291",1,"CEP-8983",10/9/2018 0:00:00,-1,0,0,0,"PARP1",
"OS-0291",2,"CEP-8983",10/9/2018 0:00:00,-1,0,0,0,"PARP2",
"OS-0292",1,"DS-1205b",10/9/2018 0:00:00,-1,0,0,0,"AXL",
"OS-0293",1,"G-631",10/9/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0293",2,"G-631",10/9/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0295",1,"Go6976",10/9/2018 0:00:00,-1,0,0,0,"PRKCA",
"OS-0295",2,"Go6976",10/9/2018 0:00:00,-1,0,0,0,"PRKCB",
"OS-0295",3,"Go6976",10/9/2018 0:00:00,-1,0,0,0,"JAK2",
"OS-0295",4,"Go6976",10/9/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0296",1,"GSK343",10/9/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0296",2,"GSK343",10/9/2018 0:00:00,-1,0,0,0,"EZH1",
"OS-0297",1,"GTP-14564",10/9/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0297",2,"GTP-14564",10/9/2018 0:00:00,-1,0,0,0,"CSF1R",
"OS-0297",3,"GTP-14564",10/9/2018 0:00:00,-1,0,0,0,"KIT",
"OS-0297",4,"GTP-14564",10/9/2018 0:00:00,-1,0,0,0,"PDGFRB",
"OS-0298",1,"HG-6-63-01",10/9/2018 0:00:00,-1,0,0,0,"RET",
"OS-0299",1,"ICG-001",10/9/2018 0:00:00,-1,0,0,0,"CREBBP",
"OS-0300",1,"HMN-214",10/9/2018 0:00:00,-1,0,0,0,"PLK1",
"OS-0301",1,"II-B08",10/9/2018 0:00:00,-1,0,0,0,"PTPN11",
"OS-0302",1,"INU-152",10/9/2018 0:00:00,-1,0,0,0,"ARAF",
"OS-0302",2,"INU-152",10/9/2018 0:00:00,-1,0,0,0,"RAF1",
"OS-0302",3,"INU-152",10/9/2018 0:00:00,-1,0,0,0,"BRAF",
"OS-0303",1,"IWR-1",10/9/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0303",2,"IWR-1",10/9/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0304",1,"JANEX-1",10/9/2018 0:00:00,-1,0,0,0,"JAK3",
"OS-0304",2,"JANEX-1",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0305",1,"JQEZ5",10/9/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0306",1,"JW55",10/9/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0306",2,"JW55",10/9/2018 0:00:00,-1,0,0,0,"TNKS2",
"OS-0307",1,"JW67",10/9/2018 0:00:00,-1,0,0,0,,
"OS-0308",1,"JW74",10/9/2018 0:00:00,-1,-1,0,0,,
"OS-0309",1,"K-756",10/9/2018 0:00:00,-1,0,0,0,"TNKS",
"OS-0309",2,"K-756",10/9/2018 0:00:00,-1,0,0,0,"AXIN1",
"OS-0310",1,"Ki23819",10/9/2018 0:00:00,-1,0,0,0,"FLT3",
"OS-0311",1,"KPT-185",10/9/2018 0:00:00,-1,0,0,0,"XPO1",
"OS-0312",1,"KRC-00509",10/9/2018 0:00:00,-1,0,0,0,"MET",
"OS-0313",1,"KRC-00715",10/9/2018 0:00:00,-1,0,0,0,"MET",
"OS-0314",1,"KRIBB11",10/9/2018 0:00:00,-1,0,0,0,"HSF1",
"OS-0315",1,"KU004",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0315",2,"KU004",10/9/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0316",1,"KU-55933",10/9/2018 0:00:00,-1,0,0,0,"ATM",
"OS-0317",1,"KU-60019",10/9/2018 0:00:00,-1,0,0,0,"ATM",
"OS-0318",1,"MC3629",10/9/2018 0:00:00,-1,0,0,0,"EZH2",
"OS-0319",1,"M-COPA",10/9/2018 0:00:00,-1,0,0,0,"ARF1",
"OS-0320",1,"MI130004",10/9/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0321",1,"MI-503",10/9/2018 0:00:00,-1,0,0,0,"MEN1",
"OS-0321",2,"MI-503",10/9/2018 0:00:00,-1,0,0,0,"KMT2A",
"OS-0323",1,"Mps1-IN-1",10/9/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0324",1,"Mps-BAY2b",10/9/2018 0:00:00,-1,0,0,0,"TTK",
"OS-0325",1,"anti-EGFR CAR T",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0326",1,"Anti-VEGFR2 CAR CD8 lymphocytes",10/9/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0327",1,"Aphanin",10/9/2018 0:00:00,-1,0,0,0,"KRAS",
"OS-0327",2,"Aphanin",10/9/2018 0:00:00,-1,0,0,0,"STAT3",
"OS-0327",3,"Aphanin",10/9/2018 0:00:00,-1,0,0,0,"AKT1",
"OS-0327",4,"Aphanin",10/9/2018 0:00:00,-1,0,0,0,"MYC",
"OS-0328",1,"AR-mTOR-26",10/9/2018 0:00:00,-1,0,0,0,"RPTOR",
"OS-0328",2,"AR-mTOR-26",10/9/2018 0:00:00,-1,0,0,0,"RICTOR",
"OS-0329",1,"EGFRBi-armed autologous activated T cells",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0329",2,"EGFRBi-armed autologous activated T cells",11/2/2018 0:00:00,-1,0,0,0,"CD3D","wildtype"
"OS-0329",3,"EGFRBi-armed autologous activated T cells",11/2/2018 0:00:00,-1,0,0,0,"CD3E","wildtype"
"OS-0329",4,"EGFRBi-armed autologous activated T cells",11/2/2018 0:00:00,-1,0,0,0,"CD3G","wildtype"
"OS-0329",5,"EGFRBi-armed autologous activated T cells",11/2/2018 0:00:00,-1,0,0,0,"CD3","wildtype"
"OS-0330",1,"HER2 CAR-T cells",10/9/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0331",1,"HER2-pulsed DC1 vaccine",10/9/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0332",1,"Hertuzumab-vc-MMAE",10/9/2018 0:00:00,-1,0,0,0,"ERBB2",
"OS-0333",1,"iCRT-14",10/9/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0334",1,"iCRT-3",10/9/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0335",1,"iCRT-5",10/9/2018 0:00:00,-1,0,0,0,"CTNNB1",
"OS-0336",1,"KRAS mutant-specific TIL",10/9/2018 0:00:00,-1,0,0,0,"KRAS",
"OS-0337",1,"KTN0073-IgG1",10/9/2018 0:00:00,-1,0,0,0,"MET",
"OS-0338",1,"KTN0073-IgG2",10/9/2018 0:00:00,-1,0,0,0,"MET",
"OS-0339",1,"MF tricyclic",10/9/2018 0:00:00,-1,0,0,0,"MTCO2",
"OS-0340",1,"N-Arachidonoyl Dopamine",10/9/2018 0:00:00,-1,0,0,0,"RAS",
"OS-0341",1,"HLA-A2 p53:264-272 vaccine",10/9/2018 0:00:00,-1,0,0,0,,
"OS-0342",1,"p53-SLP vaccine",10/9/2018 0:00:00,-1,0,0,0,,
"OS-0343",1,"R3Mab",10/9/2018 0:00:00,-1,0,0,0,"FGFR3",
"OS-0344",1,"ReACp53",10/9/2018 0:00:00,-1,0,0,0,"TP53",
"OS-0345",1,"unspecified EGFR antibody",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0346",1,"unspecified ERBB3 antibody",10/9/2018 0:00:00,-1,0,0,0,"ERBB3",
"OS-0347",1,"unspecified EGFR tyrosine kinase inhibitor",10/9/2018 0:00:00,-1,0,0,0,"EGFR",
"OS-0348",1,"unspecified PD-1 antibody",10/9/2018 0:00:00,-1,0,0,0,"PDCD1",
"OS-0349",1,"unspecified VEGFR2 antibody",10/9/2018 0:00:00,-1,0,0,0,"KDR",
"OS-0355",1,"SOX",10/26/2018 0:00:00,-1,0,0,0,,
"OS-0362",1,"Lifileucel",12/3/2018 0:00:00,-1,0,0,0,,
"OS-0363",1,"ADG106",12/10/2018 0:00:00,-1,0,0,0,"CD137",
"OS-0367",1,"tabelecleucel",12/18/2018 0:00:00,-1,0,0,0,,
"OS-0376",1,"telotristat ethyl",1/11/2019 0:00:00,-1,0,0,0,,
"OS-0378",1,"VSV-IFN?-NIS",1/11/2019 0:00:00,-1,0,0,0,,
"OS-0379",1,"galinpepimut-S",1/15/2019 0:00:00,-1,0,0,0,"WT1",
"OS-0382",1,"13C-glucose",1/17/2019 0:00:00,-1,0,0,0,,
"OS-0390",1,"ilixadencel",1/23/2019 0:00:00,-1,0,0,0,,
"OS-0392",1,"PF-06952229",1/23/2019 0:00:00,-1,0,0,0,,
"OS-0398",1,"MRx0518",1/31/2019 0:00:00,-1,0,0,0,,
"OS-0402",1,"veledimex",2/1/2019 0:00:00,-1,0,0,0,,
"OS-0405",1,"Pravastatin Pill",2/6/2019 0:00:00,-1,0,0,0,,
"OS-0406",1,"OSE2101",2/8/2019 0:00:00,-1,0,0,0,,
"OS-0410",1,"AZD9833",2/11/2019 0:00:00,-1,0,0,0,"ER",
"OS-0415",1,"FOLFIRINOX",2/12/2019 0:00:00,-1,0,0,0,,
"OS-0419",1,"Pexa-Vec",2/12/2019 0:00:00,-1,0,0,0,,
"OS-0424",1,"INBRX-105",2/19/2019 0:00:00,-1,0,0,0,"CD274",
"OS-0426",1,"CC-115",2/20/2019 0:00:00,-1,0,0,0,"MTOR",
"OS-0426",2,"CC-115",2/20/2019 0:00:00,-1,0,0,0,"DNA-PK",
"OS-0429",1,"NBF-006",2/21/2019 0:00:00,-1,0,0,0,"GSTP",
"OS-0440",1,"AdV-tk",2/28/2019 0:00:00,-1,0,0,0,,
"OS-0444",1,"ACTR T Cell Product",3/4/2019 0:00:00,-1,0,0,0,,
"OS-0445",1,"adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH",3/4/2019 0:00:00,-1,0,0,0,,
"OS-0447",1,"Imiquimod Cream",4/1/2019 0:00:00,-1,0,0,0,,
"OS-0448",1,"Cibisatamab",4/1/2019 0:00:00,-1,0,0,0,"CD3",
"OS-0452",1,"BMS-986277",4/2/2019 0:00:00,-1,0,0,0,,
"OS-0453",1,"PTK7-ADC",4/2/2019 0:00:00,-1,0,0,0,"PTK7",
"OS-0454",1,"OTS167PO",4/2/2019 0:00:00,-1,0,0,0,"MELK",
"OS-0462",1,"TPST-1120",4/11/2019 0:00:00,-1,0,0,0,"PPARaplha",
"OS-0468",1,"Leronlimab",5/21/2019 0:00:00,-1,0,0,0,"CCR5",
"OS-0469",1,"Avadomide",5/21/2019 0:00:00,-1,0,0,0,"CRBN",
"OS-0473",1,"HL-085",7/1/2019 0:00:00,-1,0,0,0,"MAP2K1",
"OS-0476",1,"MK-0482",7/1/2019 0:00:00,-1,0,0,0,,
"OS-0478",1,"DKY709",7/29/2019 0:00:00,-1,0,0,0,,
"OS-0484",1,"609A",10/10/2019 0:00:00,-1,0,0,0,"PDCD1",
"OS-0485",1,"14C-labeled poziotinib",8/12/2019 0:00:00,-1,0,0,0,"EGFR",
"OS-0485",2,"14C-labeled poziotinib",8/12/2019 0:00:00,-1,0,0,0,"ERBB2",
"OS-0485",3,"14C-labeled poziotinib",8/12/2019 0:00:00,-1,0,0,0,"ERBB4",
"OS-0490",1,"BMS-986288",8/27/2019 0:00:00,-1,0,0,0,,
"OS-0492",1,"2141 V-11",9/10/2019 0:00:00,-1,0,0,0,"CD40",
"OS-0493",1,"GS-4224",9/10/2019 0:00:00,-1,0,0,0,"CD274",
"OS-0494",1,"LY2880070",9/10/2019 0:00:00,-1,0,0,0,"CHK1",
"OS-0496",1,"SGN-CD228A",9/24/2019 0:00:00,-1,0,0,0,"TLR8",
"OS-0499",1,"MEDI5752",10/18/2019 0:00:00,-1,0,0,0,"CTLA4",
"OS-0502",1,"89Zr-DFO-Atezolizumab",10/21/2019 0:00:00,-1,0,0,0,"CD274","wildtype"
"OS-0503",1,"DS-7300a",11/5/2019 0:00:00,-1,0,0,0,"CD276",
"OS-0504",1,"TAB004",11/5/2019 0:00:00,-1,0,0,0,"MUC1",
"OS-0506",1,"LVGN6051",11/18/2019 0:00:00,-1,0,0,0,"CD137",
"OS-0507",1,"LY3435151",11/18/2019 0:00:00,-1,0,0,0,,
"OS-0511",1,"BT5528",12/9/2019 0:00:00,-1,0,0,0,"EphA2",
"OS-0519",1,"eFT226",12/23/2019 0:00:00,-1,0,0,0,"EIF4A",
"OS-0521",1,"DF1001",12/23/2019 0:00:00,-1,0,0,0,"HER2",
"OS-0522",1,"PF-06940434",12/23/2019 0:00:00,-1,0,0,0,,
"OS-0524",1,"LY3484356",12/23/2019 0:00:00,-1,0,0,0,"ER",
"OS-0525",1,"INBRX-106",12/23/2019 0:00:00,-1,0,0,0,"OX40",
"OS-0528",1,"LY3475070",1/21/2020 0:00:00,-1,0,0,0,"CD73",
"OS-0532",1,"BDTX-189",1/21/2020 0:00:00,-1,0,0,0,"EGFR",
"OS-0532",2,"BDTX-189",1/21/2020 0:00:00,-1,0,0,0,"ERBB2",
"OS-0534",1,"CCW702",2/11/2020 0:00:00,-1,0,0,0,"CD3",
"OS-0535",1,"SO-C101",2/11/2020 0:00:00,-1,0,0,0,,
"OS-0536",1,"BDC-1001",3/3/2020 0:00:00,-1,0,0,0,"TLR7",
"OS-0536",2,"BDC-1001",3/3/2020 0:00:00,-1,0,0,0,"TLR8",
"OS-0537",1,"AFM24",3/3/2020 0:00:00,-1,0,0,0,"EGFR",
"OS-0537",2,"AFM24",3/3/2020 0:00:00,-1,0,0,0,"CD16A",
"OS-0538",1,"RLY-1971",3/3/2020 0:00:00,-1,0,0,0,"PTPN11",
